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THESIS ABSTRACT 
Background  
Laboratory testing plays a fundamental role in the screening, diagnoses and monitoring 
of many conditions. Given the increased pressures on the Irish health service, improving 
inefficiencies and reducing waste, while maintaining the quality of care is at the forefront 
of healthcare planning. Promoting optimal laboratory service utilisation could play a key 
role in reducing health expenditure, in particular by preventing the unnecessary use of 
costly downstream services that often arise as a result of testing. 
Aims and objectives 
The overall aim of this thesis was to design, implement and evaluate a behaviour change 
intervention for optimising serum immunoglobulin test use in primary care.  
The thesis objectives were as follows: 
1. To conduct a systematic review of the existing literature on the effectiveness 
of previous interventions targeting primary care test use. 
2. Identify the barriers and enablers of improving test ordering for serum 
immunoglobulins among General Practitioners (GPs), using semi-structured 
interviews. 
3. Identify the intervention components (behaviour change techniques and 
mode(s) of delivery) that could overcome the modifiable barriers and enhance 
the enablers. 
xx 
 
4. Determine which GP and practice characteristics are associated with higher 
serum immunoglobulin test ordering patterns in the South of Ireland. 
5. To implement and evaluate a behaviour change intervention targeting GP 
serum immunoglobulin test use in the Cork-Kerry region. 
Structure and Methods 
The published literature to date was synthesised in a systematic review (Chapter 3). This 
review was conducted in accordance with the Effective Practice and Organisation of Care 
(EPOC) guidelines and quality appraised using the Cochrane Collaboration risk of bias 
tool. A theory-based paper identifying the modifiable barriers and enablers to test ordering 
behaviour change and the selection of intervention components to overcome these is 
presented in Chapter 4. This involved using a combination of behaviour change models 
including the Theoretical Domains Framework (TDF), the behaviour change wheel 
constructs; capabilities, opportunities, motivations of behaviour (COM-B) and Behaviour 
Change Techniques (BCTs) to identify intervention functions best suited to targeting GP 
test ordering behaviour. The GP and practice characteristics associated with higher test 
ordering patterns are described in Chapter 5. These were identified by performing a multi-
level analysis of all GP test orders in the studied region for a one-year time period, using 
routine laboratory data. The design of the intervention material and details on the 
implementation plans are provided in Chapter 6. Results of the effect of the intervention 
using nine-month follow up data are described in Chapter 7. This was performed using 
interrupted time-series with segmented Poisson regression models to assess the pre-and 
xxi 
 
post-intervention trend for serum immunoglobulin testing among GPs in the Cork-Kerry 
region of Ireland. Finally, a discussion of the key findings, strengths and limitations of 
the thesis and recommendations for future research are addressed (Chapter 8). 
Key Findings 
A number of different interventions were of variable efficacy at changing GP test ordering 
behaviour. However, generalisability across tests and methodological weakness were 
identified in these studies (Chapter 3). GP factors contributing to higher immunoglobulin 
test ordering in our sample included female gender and fewer years of clinical experience 
(Chapter 5). The lack of clear guidelines and knowledge on how to interpret the test results 
posed greatest problems for GPs. Four key intervention functions were identified for 
overcoming these modifiable barriers to effective test use; education, persuasion, 
enablement and environmental restructuring (Chapter 4). Following the introduction of a 
guideline and education-based strategy targeting the two key issues (by incorporating the 
four functions), test orders for serum immunoglobulins dropped significantly. A nine-
month evaluation of the effectiveness of this intervention found a statistically significant 
1.5% reduction in the fortnight-to-fortnight test ordering trend for serum 
immunoglobulins (Chapter 7). 
Conclusions  
This research provides an important overview of the behavioural factors influencing 
laboratory testing among GPs. The incorporation of behavioural theory, specifically the 
COM-B, TDF and BCT taxonomy, has supported the identification of factors such as 
xxii 
 
knowledge and the social and environmental context, which are key for understanding 
testing behaviours. Combining these context specific "mechanisms of change" with 
international evidence on what has previously worked, assisted in the development of an 
effective behaviour change intervention targeting serum immunoglobulin test use in 
primary care.  
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1. INTRODUCTION 
1.1 Introduction 
One of the most consistent findings in health services research relates to gaps between 
ideal (as determined by scientific evidence) and actual care [1]. Laboratory testing is 
a fundamental diagnostic tool for supporting medical decisions [2]. It is essential for 
the screening, diagnosis and monitoring of disease, and thus indispensable in the 
practice of health care. However, demand for laboratory testing is increasing 
disproportionately to other medical activity, and the tests involved are becoming 
increasingly complex [3]. Moreover, evidence suggests that many tests are ordered 
unnecessarily [4, 5]. This thesis documents the GP ordering practice around the use of 
a frequently ordered complex test – serum immunoglobulin levels and 
immunoglobulin electrophoresis. It presents the evidence base, and outcome for the 
systematic design, implementation and evaluation of a behaviour change intervention 
focused on test ordering (using serum immunoglobulins as an exemplar) in primary 
care in the South of Ireland. 
1.2 Research setting and data sources 
This thesis utilises routine laboratory data on all GP serum immunoglobulin test orders 
in two adjacent counties in the South of Ireland, collectively known as the Cork-Kerry 
region. Approximately 500 GPs provide primary care services to over 665,000 people 
living in the region. All serum immunoglobulin test orders requested by these GPs are 
analysed in the same biochemistry laboratories in Cork University Hospital (CUH) 
and University Hospital Kerry (UHK). The laboratories share a laboratory information 
system (LIS) called APEX. Data relating to all test orders, including patient 
2 
 
information, test results, requesting GP data and practice surgery data are stored on 
the hospital's laboratory information technology (IT) system. For the purpose of this 
PhD, the routine data from both testing sites were extracted using Cognos Impromptu 
software and exported to Stata version 12 for statistical analysis. Other data sources 
utilised for this research included the Health Service Executive Primary Care 
Reimbursement Scheme (HSE-PCRS) claims data and Medical Council registration 
data. All data were merged using unique GP identifiers and patient hospital Medical 
Record Numbers (MRNs). Data sources, data cleaning and statistical analysis 
procedures are explained in detail in the methods sections of the papers and chapters 
throughout the thesis. 
1.3 Overall aims and objectives 
The overall aim of this thesis was to optimise serum immunoglobulin test use among 
GPs, through the design, implementation and evaluation of a behaviour change 
intervention and to develop a behaviour change example which could be applicable to 
other laboratory ordering in future.  
In particular, the objectives were to: 
1.  Conduct a systematic review to synthesise the evidence to date on what 
interventions have been effective at improving test ordering behaviour in 
primary care. 
2. Identify the barriers and enablers of improving test ordering for serum 
immunoglobulins among GPs (using semi-structured interviews). 
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3.  Identify the intervention components (behaviour change techniques 
and mode(s) of delivery) that could overcome the modifiable barriers 
and enhance the enablers. 
4. Determine which GP and practice characteristics are associated with 
high and low serum immunoglobulin test ordering patterns in the South 
of Ireland. 
5. To implement and evaluate a behaviour change intervention targeting 
serum immunoglobulin use in the Cork-Kerry region. 
1.4 Thesis outline 
This thesis includes four papers addressing the specific objectives outlined in section 
1.3. 
Chapter two provides background information on the structure of the Irish healthcare 
system and laboratory testing in the context of General Practice in Ireland. It also 
provides the rationale for focusing on serum immunoglobulin tests, and why these 
tests are particularly problematic in primary care.  
Chapter three. The first objective of this thesis was explored by conducting a 
systematic review to examine the existing literature regarding the effectiveness of 
behaviour change interventions targeting primary care testing patterns. The review 
was guided by the Effective Practice and Organisation of Care (EPOC) statement and 
potential biases were assessed using the Cochrane Collaboration's risk of bias tool [6]. 
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This systematic review was published in Implementation Science and is presented in 
chapter three of this thesis. 
Chapter four. Objectives two and three were addressed using a combination of 
theoretical, qualitative methods. The barriers and enablers for test ordering were 
explored through semi-structured interviews with sixteen GPs. These interviews were 
analysed using the Theoretical Domains Framework (TDF), which mapped the 
constructs; capabilities, opportunities, motivations of behaviour (COM-B). Finally, 
Behaviour Change Techniques (BCTs) were used to identify intervention functions 
best suited to targeting GP test ordering behaviour. This methods paper was published 
in Implementation Science and is presented in chapter four of this thesis.  
Chapter five describes the potential GP and practice characteristics that need to be 
considered when studying GP serum immunoglobulin test ordering patterns (objective 
four). This paper involved the multilevel analysis of GP test orders for one year (2013), 
controlling for GP patient list size and composition.  
Chapter six. Having identified the best-suited intervention strategy in papers one to 
three, chapter six presents the intervention study protocol. This chapter describes the 
study design, intervention materials, methodical considerations and statistical analysis 
plan followed to evaluate the laboratory based intervention.  
Chapter seven presents the results of the nine-month post-intervention follow-up. This 
paper involved assessing the change in pre-and post-intervention test ordering patterns 
for serum immunoglobulins among GPs in the region, using routine laboratory data 
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from January 2012-July 2016. Data were analysed using an interrupted time series 
design with segmented Poisson regression models. 
Chapter eight provides an overall discussion of the main findings, the strengths and 
limitations of this thesis and suggestions for future research. 
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2. BACKGROUND 
2.1 Introduction 
This chapter provides background information on the structure of the Irish healthcare 
system and the role of the laboratory and GPs in test ordering. It also describes the 
rationale behind selecting serum immunoglobulin tests, and why they are particularly 
problematic tests in primary care.   
2.2 The Irish healthcare system 
Ireland has a mixed health care system, financed both publically and privately. Public 
expenditure accounts for approximately 70-80% of total health care resources, and is 
mainly funded through general taxation [7]. Private expenditure includes both out-of-
pocket payments and private health insurance contribution.  
2.2.1 Context of General Practice in the Irish Health Service 
In Ireland, GPs deliver primary care services. The majority of GPs are self-employed 
private practitioners providing services to the general population. A large proportion 
of general practitioners (but not all) provide free GP care to approximately two million 
people (44% of the population) through state contract arrangements [7]. The remainder 
of the population of Ireland generally pay for their GP visits on a per consultation 
basis. Individual patients who are eligible for free GP care are covered by the state-
run General Medical Services (GMS) programme and hold either a Medical Card or a 
GP Visit Card. Medical Card holders must be below a certain income to qualify and, 
are eligible for free GP care, a range of medications and other products free of charge 
[7]. Medical Cards may also be granted on a discretionary basis for patients with 
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severe or chronic illness. The majority of those over 70 years of age will hold a 
Medical Card, subject to means testing. Specialist registration for GPs was introduced 
by the Medical Council in 2007. Under the terms of the Health Provision of General 
Practitioner Services Act 2012, it became mandatory for a GP to be on the specialist 
register of the Medical Council in order to obtain a GMS contract [8].  
Certain people in Ireland who do not qualify for a medical card may apply to the HSE 
for a GP Visit Card, which allows them to visit their GP free of charge. Within the 
current Government Health Reform Programme, ‘Future Health’12, priority is given 
to the introduction of free GP care for the entire population of Ireland on a phased 
basis [8]. The first phase of policy implementation involved the introduction of free 
GP care to children under the age of six in July 2015. This was extended to the over 
70s in August 2015. Proposals exist to extend free GP care to the under 12’s and the 
under 18’s, with the gradual extension of free GP care to the population of Ireland. 
Within the provision of services, GPs have free access to laboratory testing. Extension 
of free GP service to patients has never been accompanied by a budget provision to 
deal with the probable associated increase in laboratory requests. The laboratory costs 
are borne in the hospital budgets and GPs (who are responsible for over 50% of the 
workload in most hospital laboratories) are usually unaware of costs, volume and 
workload increases in the laboratory medicine service. 
2.3 Rationale behind study 
Across Europe, delivering and financing health care in the primary care sector is quite 
differently organised [9]. There is evidence that the gatekeeping role of GPs increase 
the efficacy of the system and reduces costs [10]. A key priority for the health service 
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is to identify poor practices in relation to waste within the health service, specifically 
in laboratory service provision. The volume of test orders from GPs has risen 
significantly for many tests [11]. Laboratory tests must be appropriately ordered, 
reported promptly, correctly interpreted and inform future diagnosis and treatment of 
the patient [12]. However, evidence indicates the wasteful use of laboratory resources, 
with several studies reporting that between 25% and 40% of all test orders are 
unnecessary [13, 14]. For clinical biochemistry tests, such as immunoglobulins, this is 
expected to be higher, ranging from 26% to 98% of the total number of laboratory 
tests [15, 16]. However, the use of laboratory tests varies between countries, for 
example, being five times greater as a proportion of medical expenditure in the United 
States (US) compared with the United Kingdom (UK) or Ireland [17]. Further, many 
countries operate mixed public/private sector health economies with differing factors 
driving demand. As a result, any intervention attempting to influence laboratory 
demand must consider the context of the health-care system in which it is operating.  
2.4 Laboratory use in Ireland 
Laboratory testing is an integral part of the day-to-day practice of medicine, 
underlying around 70% of diagnoses and treatment decisions and 30% of GP 
encounters [18]. In Ireland, approximately 76 million tests are carried out annually 
[19]. These tests originate from various sources including accident and emergency, 
inpatient, outpatient and primary care, with 50% from the latter [19]. Laboratory 
services cost the Health Service Executive (HSE) approximately €469 million a year, 
representing 3-4% of the national health budget [19]. 
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2.4.1 Cork University Hospital laboratory  
The laboratory at Cork University Hospital (CUH) provides an Irish National 
Accreditation Board (INAB) accredited analytical and interpretative service on the 
management of patients with metabolic disturbances. In 2012, approximately 3.3 
million tests were carried out on 606,953 blood samples received by the pathology 
laboratories at CUH [20]. Some key haematological laboratory tests performed in 
2012 include, full blood counts (N=472,763), vitamin B12 (N=172,024), serum folate 
(N=171,370), and serum immunoglobulins (N=12,256). Approximately, 50% of these 
test orders came from primary care [20]. The CUH laboratories also provide backup 
services and analyses to South Infirmary Victoria University Hospital (SIVUH) 
Mallow General Hospital (MGH), Bantry General Hospital (BGH) and perform some 
analysis for University Hospital Kerry (UHK).  
Haematology laboratory activity at CUH saw an increase in some specialised testing 
of 150% while high volume tests such as white cell counts increased by 3% in 2012 
compared to figures for 2011 [20]. Test requests rise annually by 3-6% despite a 
similar level of morbidity in the population [20]. This suggests that some requests may 
be unnecessary, have a limited evidence base or be requested for non-medical reasons.  
2.5 The complexity of laboratory testing 
Determining the clinical relevance of tests is challenging for many reasons. Firstly, 
physicians order laboratory tests for a number reasons, and a given test has varying 
clinical relevance when used in different settings or for different reasons [21]. 
Secondly, laboratory tests are interpreted based on individual clinical scenarios, not as 
isolated or independent results and clinical details are frequently absent from the 
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request form [21]. Finally, diagnoses are based on both objective and subjective 
information and physicians presented with the same information may have differing 
interpretations of the importance or relevance of a test result [21].  
Both clinicians and laboratory scientists recognise that clinical medicine is not a 
simple matter of matching signs and symptoms with the results of laboratory tests to 
generate a diagnosis and treatment plan. Most tests may be of more or less relevance 
to the individual patient depending on the physicians’ interpretation of clinical history, 
review of systems, family history, signs and symptoms, physical examination, and the 
results of other tests or studies. For this reason, exploring the use of a test with specific 
requesting guidelines, requiring specialist clinical input for interpretation and 
management of significant abnormal results may be most useful and clinically 
important.  
Often these specialist tests are ‘low-volume’ tests in the primary care setting. Research 
suggests that inappropriate testing is three times higher for ‘low-volume’ compared to 
‘high-volume’ tests (32% vs 10%) [14]. ‘Low-volume’ can be defined as a test that is 
ordered at least ten times less frequently than the most commonly ordered tests [14]. 
Inappropriate testing may be more likely to occur with ‘low-volume’ tests due to a 
lack of familiarity with best treatment practices for the conditions under scrutiny [14].   
As a result, this thesis explored serum immunoglobulin test ordering in primary care. 
Suspected inefficient test use in primary care was identified through local clinical 
laboratory auditing. In addition, borderline abnormal results were generating 
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significant numbers of referrals to haematology outpatients, some of which were 
unnecessary. 
2.6 Serum immunoglobulin tests 
For the purpose of this study, serum immunoglobulin test use among GPs in the South 
of Ireland was studied. Serum immunoglobulin tests should be ordered as part of the 
primary screen for suspected plasma cell dyscrasias (myeloma, lymphoma, chronic 
lymphatic leukaemia, heavy chain disease, and amyloidosis) [22]. Depending on the 
condition (e.g. myeloma), serum immunoglobulin tests may also be ordered 
periodically to monitor disease progression [22]. Low immunoglobulin levels define 
deficiencies of the humoral immune system (rare and mostly relevant in paediatric 
practice) while high immunoglobulin levels are observed in liver diseases, chronic 
inflammatory diseases, haematological disorders, infections (polyclonal 
gammopathy) and as monoclonal paraprotein in malignancies (myeloma and 
lymphoma) [23]. The interpretation of serum immunoglobulin test results often 
requires specialist input and can lead to other costly activities such as referral to 
secondary care. 
2.6.1 Clinical impact of immunoglobulin test ordering patterns  
In order to reduce waiting times for clinic appointments and provide increased service 
options, the haematology department at CUH commenced a virtual haematology clinic 
in 2009. The clinic is conducted through written correspondence with GPs following 
a review of laboratory data on the patient. In 2011, following an audit of this service, 
some problematic referral patterns were identified, particularly in relation to 
laboratory testing. That is high volumes of referrals which, following consultant 
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haematologist assessment, were predicted to be unlikely to add value clinically for 
specific haematology conditions. Analysis of the virtual clinic data showed that GPs 
were having difficulty identifying immunoglobulin results which were sinister from 
those that were likely to be transiently abnormal or those that simply require 
occasional monitoring.  
Identifying this issue in the virtual clinic led to further consideration of the use of 
laboratory services, including the ordering of serum immunoglobulins. In 2013, GPs 
in the Cork-Kerry region ordered serum immunoglobulin tests for approximately 
6,000 patients. From these requests, 1,052 patients were found to have a detectable 
paraprotein on serum protein electrophoresis. Paraproteins with an IgG level >10g/L 
or IgA level >5g/L, were deemed significantly high enough to warrant follow-up or 
referral to Haematology. In total, 2.4% (25/1,052 patients) exhibited paraprotein levels 
meeting these criteria. Three patient groups were identified among these 25 patients. 
The first comprised of three patients (0.29%) with concerning paraproteins indicating 
progression to myeloma, of which all were referred to and investigated by 
haematology. The second group were nine known myeloma patients that required 
monitoring (0.86%). The final group consisted of 13 monoclonal gammopathy of 
uncertain significance (MGUS) patients with stable paraproteins (1.24%), none with 
a significant health impact in 2013. 
2.6.2 Unnecesssary serum immunoglobulin test use 
The ‘necessity’ of laboratory tests can be viewed from several perspectives, in 
particular between primary and secondary care settings. However, from the 
perspective of making a positive diagnosis of a blood dyscrasia, immunoglobulin 
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testing can be overutilized or underutilized. Overutilization refers to tests that are 
ordered but not indicated, while underutilization refers to tests indicated but not 
ordered [14]. Overutilization can result in unnecessary blood draws and other follow 
up medical procedures [14]. It also increases the likelihood of false-positive results, 
which can lead to incorrect diagnoses, increased costs, and adverse outcomes due to 
unwarranted additional intervention. The pre-test probability of disease in general 
practice is relatively low, meaning false positive tests are common, even in tests with 
reasonable specificity. Specialist tests like serum immunoglobulins’ are often difficult 
for GPs to interpret. The practical implication of this is that results which show the 
very common finding of a polyclonal gammopathy (benign reactive finding) are 
sometimes interpreted as myeloma or pre-myeloma and generate unnecessary referrals 
with attendant patient and GP anxiety. These scenarios along with false-positive 
results can lead to a cascade of further tests, so-called ‘investigation momentum’ [24].  
Physicians typically judge the likelihood of a patient having a particular diagnosis by 
considering information from several sources and combining these separate 
assessments. However, the diagnostic implications of laboratory results are generally 
considered more consciously and formally based on their published performance data. 
The power of diagnostic tests is usually reported either as sensitivity and specificity, 
or their derived likelihood or diagnostic odds ratios, or as their positive predictive 
values (PPV) and negative predictive values (NPV) [25].  
2.6.3 Role of serum immunoglobulins in diagnosis 
The predictive value of serum immunoglobulin tests is limited when performed in 
settings in which the prevalence of myeloma is low, such as screening and for younger 
population, particularly females. Moreover, the PPV and NPV depend not only on its 
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sensitivity and specificity, but also on the likelihood of disease before the test is done 
(referred to as prior probability, prior likelihood, or prevalence of disease). A 
monoclonal spike (or paraprotein) on serum protein electrophoresis (SPEP) is a 
frequent finding in the general population and typically indicates an asymptomatic, 
pre-malignant condition called monoclonal gammopathy of undetermined 
significance (MGUS) [26]. MGUS occurs in around 3% of people older than 50 and 
is associated with a lifelong, low risk of progression to multiple myeloma or a related 
plasma cell dyscrasia.  Patients with MGUS are divided into different categories based 
on low risk, intermediate risk, and high risk. If the serum monoclonal protein is <15 
g/L, IgG type, and the free light chain ratio is normal, then the risk of eventual 
progression to multiple myeloma or related malignancy is low [27]. In this low-risk 
setting, a baseline bone marrow examination or skeletal survey is not routinely 
indicated if the clinical evaluation and laboratory values suggest MGUS [27]. Patients 
should be followed with SPEP six months after diagnosis and if stable can be followed 
every 2-3 years (or sooner if symptoms suggestive of disease progression arise) [27]. 
However, patients that fall in the intermediate and high risk MGUS category are 
managed differently. They usually have a serum monoclonal protein >15 g/L, IgA or 
IgM type, and/or an abnormal free light chain ratio. In this situation, a bone marrow 
biopsy should be carried out at baseline. These patients are followed with SPEP, 
complete blood count, serum calcium and creatinine levels six months after diagnosis 
and then yearly for life. Finally, those patients with smoldering (asymptomatic) 
multiple myeloma always receive a baseline bone marrow biopsy and mandatory 
skeletal survey [28].  
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Multiple myeloma is a cancer of the plasma cells in the bone marrow [29]. It is the 
second most common haematological cancer after lymphoma, with approximmately 
200 patients diagnosed in Ireland each year. The cause of multiple myeloma is 
unknown and risk factors include age, radiation, agricultural exposures and familial 
risk. Prevalence is more common in those over 50 years, with higher male 
predominance. According to the Wilson and Jungner criteria, there should be a suitable 
and acceptable diagnostic test for the disease and good treatment options [30] 
Screening for multiple myeloma can be done by blood and urine protein 
electrophoresis, which is minimally invasive and relatively easy to perform. On 
detecting a monoclonal protein, a distinction between MGUS or Multiple myeloma 
should be made by further study, possibly including a bone marrow biopsy [31]. 
Myeloma is an incurable (though treatable) cancer. Because of this, if a GP suspects 
the diagnoisis for any reason or has clinical concerns, however unlikely, there can be 
significant utility in a negative test. Our study does not address this issue specifically. 
2.7 PhD framework 
This PhD set out to design, implement and evaluate a behaviour change intervention 
targeting problematic serum immunoglobulin testing in primary care. To do so, the 
stages of developing an intervention using the theory-based approaches outlined by 
French and colleagues were followed [32]. The authors developed a four-step 
framework for developing a theory-informed intervention (Table 2.1). The four steps 
represent: identifying the problem (who needs to do what, differently?); assessing the 
problem (using a theoretical framework, which barriers and enablers need to be 
addressed?); forming possible solutions (which intervention components could 
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overcome the modifiable barriers and enhance the enablers?); and evaluating the 
selected intervention (how can behaviour change be measured and understood?) [32]. 
Table 2.1 Steps for developing a theory-informed implementation intervention [32] 
Step      Tasks 
STEP 1: Who needs to do what, 
differently? 
• Identify the evidence-practice gap 
• Specify the behaviour change needed to 
reduce the evidence-practice gap 
• Specify the health professional group 
whose behaviour needs changing 
STEP 2: Using a theoretical 
framework, which barriers and 
enablers need to be addressed? 
• From the literature, and experience of the 
development team, select which 
theory(ies), or theoretical framework(s), 
are likely to inform the pathways of 
change 
• Use the chosen theory(ies), or framework, 
to identify the pathway(s) of change and 
the possible barriers and enablers to that 
pathway 
• Use qualitative and/or quantitative 
methods to identify barriers and enablers 
to behaviour change 
STEP 3: Which intervention 
components (behaviour change 
techniques and mode(s) of 
delivery) could overcome the 
modifiable barriers and enhance 
the enablers? 
• Use the chosen theory or framework, to 
identify potential behaviour change 
techniques to overcome the barriers and 
enhance the enablers 
• Identify evidence to inform the selection 
of potential behaviour change techniques 
and modes of delivery 
• Identify what is likely to be feasible, 
locally relevant, and acceptable and 
combine identified components into an 
acceptable intervention that can be 
delivered 
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STEP 4: How can behaviour 
change be measured and 
understood? 
• Identify mediators of change to 
investigate the proposed pathways of 
change 
• Select appropriate outcome measures 
• Determine feasibility of outcomes to be 
measured 
 
Table 2.2 outlines the application of this framework to design, implement and evaluate 
a behaviour change intervention using serum immunoglobulin test requesting as a 
model, for use among GPs in the South of Ireland. It also provides a reference to the 
papers and chapters corresponding to the tasks fulfilled.  
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Table 2.2 The four steps of designing a theory-based intervention [32] applied to develop and evaluate an intervention targeting serum 
immunoglobulin testing in primary care in the South of Ireland 
Steps Tasks Action taken Papers  PhD Chapter 
STEP 1:  
Who needs to do what, 
differently?  
Identify the drivers of higher 
GP serum immunoglobulin test 
ordering patterns.  
A cross-sectional study identifying   
the GP and practice characteristics 
associated with higher test ordering. 
Determinants 
of testing  
5 
STEP 2:  
Using a theoretical 
framework, which barriers 
and enablers need to be 
addressed? 
Using behaviour change theory, 
explore GP attitudes towards 
testing, and potential barriers 
and enablers for behaviour 
change. 
Interviews carried out with GPs. 
Analysed and coded using theoretical 
domains framework, which were then 
mapped to the COM-B constructs to 
identify the best intervention strategy. 
Theoretical 
design 
4 
STEP 3: 
Which intervention 
components (behaviour 
change techniques and 
mode(s) of delivery) could 
overcome the modifiable 
barriers and enhance the 
enablers? 
Carry out a systematic review 
of the literature to identify 
previously effective 
interventions. 
 
Conduct GP interviews to 
identify feasible strategies. 
A systematic review of previous 
interventions was completed, and 
results combined with findings of the 
interviews to ensure the intervention 
considers potential barriers and 
enablers in the context of Irish GP 
practice and structure. 
Systematic 
review  
 
 
Theoretical 
design  
3 
 
 
 
4 
STEP 4:  
How can behaviour change be 
measured and understood? 
Assess the trend in the volume 
of serum immunoglobulin test 
orders before and after the 
intervention.  
The effect of the intervention was 
evaluated using an interrupted time 
series, with segmented Poisson 
regression models.  
Evaluation of 
Intervention  
           7 
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3.1 Abstract 
Background: Laboratory testing is an integral part of day-to-day primary care 
practice, with approximately 30% of patient encounters resulting in a request. 
However, research suggests that a large proportion of requests do not benefit patient 
care and are avoidable. The aim of this systematic review was to comprehensively 
search the literature for studies evaluating the effectiveness of interventions to 
improve primary care physician use of laboratory tests. 
Methods: A search of PubMed, Cochrane Library, Embase and SCOPUS (from 
inception to 09/02/14) was conducted. The following study designs were considered: 
systematic reviews, randomised controlled trials (RCTs), controlled clinical trials 
(CCTs), controlled before and after studies (CBAs) and interrupted time series 
analysis (ITSs). Studies were quality appraised using a modified version of the 
Effective Practice and Organisation of Care (EPOC) checklist. The population of 
interest were primary care physicians. Interventions were considered if they aimed to 
improve laboratory testing in primary care. The outcome of interest was the volume 
of laboratory tests.  
Results: In total, 6,166 titles and abstracts were reviewed, followed by 87 full texts. 
Of these, 11 papers were eligible for inclusion in the systematic review. This included 
four RCTs, six CBAs and one ITS study. The types of interventions examined included 
education, feedback, guidelines, education with feedback, feedback with guidelines 
and changing order forms. The quality of included studies varied with seven studies 
deemed to have a low risk of bias, three with unclear risk of bias and one with a high 
risk of bias. All but one study found significant reductions in the volume of tests 
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following the intervention, with effect sizes ranging from 1.2% to 60%. Due to 
heterogeneity meta-analysis was not performed. 
Conclusions: Interventions such as educational strategies, feedback, and changing test 
order forms may improve the efficient use of laboratory tests in primary care, however 
the level of evidence is quite low and the quality is poor. The reproducibility of 
findings from different laboratories is also difficult to ascertain from the literature. 
Some standardisation of both interventions and outcome measures is required to 
enable formal meta-analysis. 
Key words: interventions, primary care, behaviour change, healthcare interventions, 
laboratory testing 
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3.2 Background 
Laboratory testing is an integral part of day-to-day practice in medicine and supports 
approximately 70% of diagnoses and treatment decisions [18]. Further, among 
primary care physicians, an estimated 30% of patient visits result in a laboratory 
request [33]. Healthcare budgets worldwide are facing increasing pressure to reduce 
costs and remove inefficiencies, while maintaining quality and safety. Laboratory 
testing is a major component of healthcare budgets in absolute terms and demand for 
testing is increasing faster than medical activity [34]. In the National Health Service 
(NHS) in England, for example, an estimated £2.5 billion per annum is spent on 
laboratory services accounting for 3-4% of the UK national health budget [3, 35]. 
Despite this relatively small proportion of healthcare budget expenditure, laboratory 
testing often underpins more costly downstream care such as outpatient visits and 
radiology requests.  
The unnecessary use of laboratory services has been highlighted by a meta-analysis of 
108 studies involving 1.6 million results from 46 of the 50 most commonly ordered 
lab tests in medicine [14]. This found that, on average, 30% of all tests are likely to be 
unnecessary [14, 36]. With respect to primary care, US research has found that 
physicians order diagnostic laboratory tests for approximately 30% of patient visits 
[37]. Authors reported that test ordering factors including unnecessary test requests 
were responsible for 13% of testing process errors in primary care [38].  
The overuse of laboratory services can stem from the physician, the patient and the 
broader policy context. For example, some studies have found that many physicians 
report uncertainty over when to order tests and how to interpret test results [33].  
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Reasons given for this include lack of knowledge about indications, costs, insurance 
restrictions and inconsistent names for the same test [37]. Meanwhile, patients have 
high expectations that blood tests are performed and have little understanding of the 
limitations of testing [36, 39]. Other factors include a lack of knowledge regarding the 
financial effect of laboratory testing on the health care system [40] and the increasing 
volume of laboratory tests available to physicians [3]. Furthermore, system level 
factors associated with laboratory testing patterns have been identified and include 
limitations of laboratory and/or surgery information technology systems [3, 41]. As a 
result, it has been recommended that the theoretical and contextual factors responsible 
for changing primary care physician behaviour should also be considered when 
designing interventions [42-45].  
A number of approaches for reducing unnecessary test ordering in primary care have 
implemented. These comprise of interventions aimed at tackling both the 
overutilization and underutilization of tests through strategies such as including cost 
displays on electronic order forms, facilitating educational workshops and providing 
feedback to physicians on their test ordering patterns [46-48]. However, the 
effectiveness of these strategies vary, and, to date no systematic reviews have focused 
solely on studies evaluating test ordering behaviours of primary care physicians. 
Hence, the objective of this systematic review was to systematically and 
comprehensively search the literature for studies evaluating the effectiveness of 
interventions aimed at nudging primary care physicians’ ordering practice further in a 
direction which will maximally impact patient care. 
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3.3 Methods  
3.3.1 Primary objective 
The main objective of this systematic review was to synthesise the available published 
literature on interventions focused on improving the appropriateness of laboratory 
requesting patterns from primary care.  
3.3.2 Primary outcomes 
The outcome of interest in this review was objectively measured provider performance 
(request rates or appropriateness of requests). 
3.3.3 Types of studies 
Systematic reviews, randomised controlled trials (RCTs), non-randomised controlled 
trials (NRCTs), controlled before-after studies (CBAs) and interrupted time series 
analysis (ITSs) were considered for this review. 
3.3.4 Types of interventions 
The review focused on interventions to change laboratory requesting patterns or 
improve laboratory requesting appropriateness. 
3.3.5 Data sources 
The following databases were searched for potentially eligible studies: PubMed (1966 
to Feb 9th 2014) the Cochrane Library (1993 to Feb 9th 2014), Embase (1974 to Feb 
9th 2014) and SCOPUS (1960 to Feb 9th 2014). Updated searches of the electronic 
databases were performed in November 2014 to ensure additional relevant papers 
were not published since. 
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3.3.6 Inclusion criteria 
This review included interventions aimed at improving laboratory requesting patterns 
where objectively measured provider performance (requesting rates or appropriateness 
of requests) served as the dependent variable. Intervention studies were only 
considered if participants were primary care physicians, defined as any medically 
qualified physician providing primary health care and including general practitioners, 
family doctors, family physicians or family practitioners.  
3.3.7 Search strategy 
PubMed was searched for potentially eligible studies by combining relevant medical 
subject headings (MeSH terms) with subheadings and text words (e.g. “utilisation,” 
“laboratory test (s)”). Only citations on human subjects were included. Search terms 
and search findings are provided in Appendix 3. For completeness, searches were 
repeated without subheadings and the results of these two searches were combined. 
The same methods were used for searching the Cochrane Library, Embase (Elsevier) 
and Scopus databases. Electronic searches were supplemented by cross-checking the 
reference lists of all identified studies. Duplicate citations were identified and removed 
using EndNote citation manager.  
3.3.8 Data collection and analysis 
SLC carried out the electronic database searches. The search strategy for the review 
can be found in Appendix 3. Titles and abstracts of studies retrieved from the search 
strategy were reviewed independently by applying the appropriate inclusion/exclusion 
criteria. For each citation, two investigators (SLC and MRC) independently screened 
the titles and abstracts for potential relevance. The full-text article was obtained for all 
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potentially eligible studies. Any disagreements between SLC and MRC were resolved 
through discussion with a third reviewer (JPB). 
Data were extracted from the included papers by a single reviewer (SLC). A second 
reviewer (JPB) checked data extraction sheets for errors. Information was extracted 
on study design, year of study, setting, participants, intervention characteristics and 
the reporting of results. A sample data extraction form can be found in Appendix 4. It 
was not deemed appropriate to conduct a meta-analysis due to the heterogeneity of 
interventions and outcomes across the included studies. Instead, the existing analyses 
reported in the articles reviewed were extracted and reported in a narrative format. 
3.3.9 Quality assessment of included studies 
Included studies were independently assessed for quality and risk of bias by SLC and 
JPB, with any disagreements resolved by discussion. This was performed using a 
modified version of the Cochrane Effective Practice and Organisation of Care (EPOC) 
Data Collection Checklist and Quality Criteria for studies with a control group (RCTs, 
CCTs and CBAs) and for ITSs studies [6]. The tool is specifically designed for 
interventions aiming to improve practice, and provides a risk of bias assessment for 
each of the included study designs (RCT, CCT, CBA, and ITS). This comprises of 
nine quality standards for RCTs, CCTs and CBAs: generation of allocation sequence, 
concealment of allocation, baseline outcome measurements, baseline characteristics, 
incomplete outcome data, blinding of outcome assessor, and protection against 
contamination, selective outcome reporting and other risks of bias. For ITS study 
designs, the following three quality standards were also assessed: the independence of 
the intervention from other changes, the pre-specified shape of the intervention and if 
the intervention was unlikely to affect data collection [6].  
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3.4 Results 
3.4.1 Search results 
In total, 6,166 records of papers were identified from the search of the literature 
(Figure 3.1). 5,276 records were excluded based on a title review. A further 504 
records were duplicates and also excluded. Of the 386 records remaining, 299 were 
excluded based on the abstract review. Full texts were obtained for the remaining 87 
records, of which 11 papers met the inclusion criteria and were included in the review. 
Figure 3.1 Flow diagram of the search strategy for the review 
 
 
 
 
 
 
3.4.2 Risk of bias in included studies 
Table 3.1 provides the details of quality assessment of the studies. Ten of the 11 studies 
were deemed to have a high risk of bias, while one study [49] was deemed to be of 
low risk. Randomisation and allocation concealment was adequately performed for the 
four included RCTs [48-51]. The most common reason for high risk of bias was the 
fact that participants (primary care physicians) in the intervention groups could not be 
6,166 total records 
386 Studies identified for abstract 
review: 165 (PubMed) 191 (Scopus) 
9 (Cochrane) and 21 (Embase) 
 
PubMed 
(N=2,386) 
Cochrane Library 
(N=837) 
SCOPUS 
(N=681) 
EMBASE 
(N=2,262) 
87 Studies considered potentially 
relevant 
 
11 Studies included in the review 
299 excluded based on abstract 
review 
 
5,780 excluded: Duplicates (N=504) 
Title review (N=5,276) 
 
76 papers excluded based on 
inclusion/exclusion criteria  
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blinded. This introduces the risk of information bias as physicians may have altered 
their requesting behaviours based on knowledge of being assessed. Only one of the 
studies adequately blinded participants [49]. Also, a key limitation of the RCT by 
Thomas and colleagues [48] was the lack of power to detect interactions, and, hence, 
a much larger trial would be required to ensure that these interventions act 
independently. A key limitation of the included ITS study [46] was the physician-level 
design utilised with an absence of individual patient characteristics.   
3.4.3 Characteristics of studies included in the review  
Characteristics and the key findings of the included studies are presented in Table 3.2. 
Four of the studies were RCTs [48-51], six were before-after studies[47, 52-56] and 
one was an ITS [46] with a parallel control group. The included studies were 
conducted in the Netherlands [49, 50, 56], US [46], UK [48, 51], Italy [53], Israel [54, 
55], Sweden [47] and New Zealand [52] with samples ranging in size from 44 to over 
3,000 primary care physicians. The interventions covered by the review include 
education programmes [47, 49], laboratory profiles [53] clinical guidelines [50], 
guidelines and feedback combined [51], cost displays [46], the re-design of order 
forms [54-56] and the use of feedback and education strategies [48, 52].  
3.4.3.1 Clinical guidelines and policy recommendations 
In their RCT study, van Wijk et al. [50] found that decision support based on 
guidelines integrated with patient electronic records was more effective for changing 
blood test-ordering behaviour than decision support based on limited testing offered 
in modified request forms. Primary care physicians who had access to the guideline-
based system had ordered 20% fewer tests per form than did primary care physicians 
who had access to the restricted system (mean ±SD 5.5 ±0.9 tests vs. 6.9 ± 1.6 tests, 
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respectively; P= 0.003, Mann-Whitney test) [50]. Similar findings were obtained in 
the adjusted multivariate regression analysis [50]. Controlling for practice 
characteristics and historic test ordering behaviour, 19% more tests were requested by 
primary care physicians with access to the restricted order form (RR:1.19; 95% CI: 
1.10-1.29) [50]. The study also reported a difference in requesting patterns between 
the two groups for specific tests. For example, in the restricted group, 61.2% of order 
forms included an erythrocyte sedimentation rate test, compared with 44.1% in the 
guideline group (p<0.001) [50].  
In a study using a CBA design and involving over 3,000 primary care physicians in 
New Zealand, Tomlin et al. [52] assessed the effect of three different marketing 
programmes promoting clinical guidelines. Each of these programmes involved 
written material advising of guideline recommendations. Individual laboratory-test 
use feedback data was distributed to each practice and professional development 
opportunities were provided. The study found that clear information marketed to 
primary care physicians improved the quality of laboratory test ordering [52]. Some 
key findings included a 42% reduction in erythrocyte sedimentation rate tests 
following the intervention (intervention physicians: -60%, comparison physicians: -
18%, p<0.01) [52]. 
3.4.3.2 Feedback and reminders 
Baker et al. [51] evaluated the use of feedback following guidelines in their RCT. Both 
groups received guidelines followed up with feedback about their use of selected tests. 
The first group of practices received feedback about their testing for thyroid function 
tests, rheumatoid factor and urine culture requests, while the second group received 
feedback about their serum lipids and viscosity requests. Hence, both groups were 
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intervention groups, but acted as control groups for the other group. The authors 
reported no change in laboratory requests quarterly feedback over a one-year time 
period for any of the five tests studied [51]. 
A multifaceted clustered RCT by Verstappen et al. [49] aimed to optimise primary 
care physicians’ test ordering behaviour by means of practice-based strategies 
targeting tests for specific clinical problems. Thirteen groups of primary care 
physicians underwent the strategy for three clinical problems (arm A; cardiovascular 
topics, upper and lower abdominal complaints), while 13 other groups underwent the 
strategy for three other clinical problems (arm B; chronic obstructive pulmonary 
disease and asthma, general complaints, degenerative joint complaints). The strategy 
consisted of personalised graphical feedback, including a comparison of each 
physician's own data with those of colleagues; dissemination of national, evidence-
based guidelines; and regular meetings on quality improvement in small groups [49]. 
Each of the arms of the trial acted as a control for each other. Physicians discussed 
personal feedback reports in small group meetings, related them to evidence-based 
clinical guidelines, and made plans for change. Authors reported a 12% reduction in 
the volume of total tests for arm A in the intervention group versus no change in the 
control arm (p<0.001) [49]. However, for arm B of the trial, no statistically significant 
changes were identified (p=0.22) [49]. 
In a third RCT by Thomas et al. [48], the use of feedback combined with educational 
reminder messages was assessed. The feedback intervention involved the use of a 
booklet containing graphical presentations of individual practice level ordering for the 
targeted tests. Each practice was compared to regional statistics over a three-year 
period. Educational reminders were developed in conjunction with the primary care 
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physicians and were included with test results. The study found that primary care 
practices receiving either or both feedback and reminders had significantly reduced 
laboratory test utilisation (p<0.001) [48]. The combined effect of the interventions 
resulted in a 22% reduction in total number of targeted tests ordered (OR = 0.78, 95% 
CI: 0.71-0.85) versus 13% for reminders alone (OR = 0.87, 95% CI: 0.81-0.94, 
p=<0.001) and 11% for feedback alone (OR= 0.89, 95% CI: 0.83-0.94, p=0.003) [48]. 
However, feedback led to greater reductions in the number of laboratory tests ordered 
compared with reminders, although the model-based analyses suggested similar 
effects (adjusted change relative to baseline performance in audit and feedback arm 
=12%; OR for reminders = 0.89, 95% CI 0.83 to 0.93, p=0.003) [48].  
3.4.3.3 Education-based strategies 
Baricchi et al. [53] evaluated the effect of seven pathology specific laboratory profiles 
for more effective test requesting, using a CBA study design. Training sessions were 
facilitated to educate the primary care physicians in the intervention group about these 
profiles and to discuss their presumed usefulness. Authors reported a 5% reduction in 
the volume of tests requested by the intervention group one year following the 
intervention compared with a 1% increase in the control group (p= <0.001) [53].  
Also using a CBA study, Larsson et al. [47] assessed the effects of an education 
programme which involved a two-day lecture series at which each participant received 
a folder containing information relating to the guidelines for future reference. The 
authors reported significant changes (p<0.05) for nine of 14 tests [47]. They 
recommended that ordering rates for seven ratios should decrease, of which five did 
(p<0.05), and, that seven ratios should increase in volume, of which four did (p<0.05). 
None of the ratios significantly changed in the wrong direction [47].  
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3.4.3.4 Cost displays of pricing information 
Using an ITS design, Horn et al. [46] evaluated the effect of implementing cost 
displays for laboratory tests in primary care. The authors reported a reduction (1%-
2.6%) in the volume of tests ordered for five out of 27 different laboratory tests when 
the real-time display of cost information was provided electronically on patient record 
and results (estimated a reduction of between 0.4/1,000 visits per month to 5.6/1,000 
visits per month, p<0.001) [46]. However, for higher cost tests a reduction in test 
requests was observed in only one of six such tests [46].  
3.4.3.5 Changing order forms 
Kahan et al. [54] evaluated a new version of a computerised order form for three target 
tests (vitamin B12, folic acid and ferritin) using a CBA study. Test requests for 
haemoglobin and iron were evaluated as controls. The authors reported a 31%-41% 
decrease in volume of requests for the three target tests at one-month follow-up, with 
a further decrease to 36%-53% two months after the intervention [54]. In comparison, 
the effect on test requests for controls tests ranged from -2%-3% [54]. A second CBA 
study in Israel by Shalev et al. [55] evaluated changing the format of the existing 
check-box laboratory order form that is embedded in a computerised medical record. 
This involved removing twenty-six tests from the form and adding two tests. They 
found that for deleted tests there was a 27% and 19.2% reduction one and two years 
after intervention respectively (p<0.001) [55]. For unchanged tests, the percentage 
changes were +18.4% in year one and -22.4% in year two. Meanwhile, a 60.7% (year 
one) and 90%  (year two) increase in volume was found where tests were added to the 
order form (p<0.001) [55].  
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In a second CBA study, Zaat et al. [56] modified the request form so that it only had 
15 tests listed and all other tests had to be hand written. The form also required more 
information about the reason for requesting the test. Primary care physicians in the 
intervention group received a copy of a booklet with descriptions of the essential 
characteristics of the 15 important tests on the new form. The authors reported an 18% 
reduction in the volume of laboratory test requested on a monthly basis for the 
intervention group [56]. In the comparison period the difference between groups was 
significant (p<0.0001) [56].  
3.5 Discussion 
This review aimed to identify and evaluate interventions for improving the use of 
laboratory tests among primary care physicians. Intervention strategies included: 
education, feedback, guidelines, cost displays, and changing the content of order 
forms. While included studies differed considerably in relation to the tests they 
assessed, the findings were consistently in the same direction, perhaps indicating some 
publication bias. All but one [51] of the included studies reported positive effects on 
laboratory testing patterns. However, a number of the studies included in this review 
have a high risk of bias and are lacking in certain areas of methodological quality.  
Education based interventions appear to have promising effects on improving primary 
care physician laboratory testing patterns in this review [47, 49, 53]. This included 
evidence from a high-quality RCT [49]. Similar educational strategies have also been 
effective in changing other primary care behaviours including improving prescribing 
patterns for antibiotics [57], and referral for radiological assessments [58]. In 
particular, diagnoses or symptoms based education strategies involving a multi-
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disciplinary approach proved effective [49, 53]. The sustainability of education-based 
strategies is often questioned in the literature. However, follow up of long term effects 
of the education programme implemented by Larsson et el. [47] found it can be 
achieved with regular re-enforcement [59].  
Further, the literature suggests provider education is inexpensive and feasible for 
widespread delivery [60]. Larsson et al. [47] also reported direct laboratory cost 
savings of their education programme. Similarly, Verstappen et al. [61] evaluated the 
costs and cost reductions of their feedback and education based strategy [49]. 
However, as with many intervention studies, a lack of rigorous economic evaluation 
methods and poor clinical data is a key limitation of studies attempting to describe the 
economic value of their behaviour change strategies. 
The feedback-based interventions in this review were multifaceted, and their effects 
were dependent on the particular combination of strategies used [48, 51, 52]. Feedback 
strategies have also shown positive results for other test ordering activities by primary 
care physicians such as electrocardiogram use [62, 63]. In particular, enhanced 
feedback combined with brief educational reminder messages had a positive effect on 
requesting patterns [48]. The broader literature also suggests that feedback 
interventions have improved success when combined with other education-based 
strategies, including outreach visits or educational reminders [64, 65]. In primary care, 
providing feedback may change attitudes towards current practice and subsequent 
clinical outcomes, by changing self-assessment, or by directing attention to a 
particular set of guidelines [66].  
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However, Baker et al. found that feedback was ineffective for changing primary care 
physician requesting behaviour when provided following guidelines [51]. The 
literature suggests that this may be explained by baseline performance, how often 
feedback is provided and how the feedback is provided [66, 67]. Moreover, 
individualised feedback in other areas of clinical performance has been shown to be 
more effective than general feedback, in particular when it is regular and repeated [68]. 
Implementation strategies for the delivery of education-based strategies may also be 
important, in particular, the dissemination of guidelines. Decision support based on 
limited testing offered in modified request forms was less effective compared to 
decision support based on guidelines integrated with patient electronic records for 
changing blood test-ordering behaviour [50]. However, the use of guidelines is often 
criticised with respect to the sustainability of change in the long-term [40]. 
Real-time display of cost information provided electronically on patient record and 
results showed a significant but small change in laboratory testing patterns [46]. 
However, this change was dependent on specifics of the test with insignificant changes 
for five out of six of the high-cost tests [46]. Little research exists on the effectiveness 
of cost displays for altering behaviour in the primary care, however, conflicting 
evidence exists among studies that have included physicians in hospital settings [69, 
70]. In addition, diverse background health systems need to be considered when 
implementing a cost-display based strategy.  
3.5.1 Implications for the implementation of interventions 
Some multifaceted intervention strategies within the scope of this review have shown 
positive results although conflicting evidence exists in the wider literature on changing 
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healthcare professional behaviours [71, 72]. Grimshaw and colleagues highlight that 
few studies explain the rationale for the choice of a particular combination of 
interventions [72]. The authors conclude that if interventions are tailored to address 
local barriers to change then, multifaceted approaches may be more effective than 
individual interventions [72]. There is literature to support the belief that knowledge 
of pre-requesting variables contributes to the success of interventions in health 
professionals [73]. For example, some authors identified test decision points including 
primary care physicians’ preference for risk [74] and perceived needs of the patient 
for reassurance [75]. Studies have also highlighted the importance of factors 
associated with wider health system performance [74].  
Interestingly, in this review, none of the interventions appear to be designed based on 
the attitudes and behaviours responsible for laboratory testing patterns. The use of 
theory to understand such barriers has been recommended for the design of behaviour 
change interventions [42, 43]. In particular, Michie and colleagues have highlighted 
the importance of understanding the nature of the behaviour to be changed and the 
context [45]. The authors argue that designing interventions based on practitioner or 
researcher intuition rather than theory prevents an understanding of the behaviour 
change processes responsible for effective interventions [45]. To address this issue, 
they have developed a behaviour change theory, the ‘capability, opportunity, 
motivation-behaviour (COM-B) system’, which can be used as a taxonomy to map 
any identified barriers to the origin of the problem [44]. Hence, implementation 
strategies should also consider the theoretical and contextual factors responsible for 
changing primary care physician behaviour when designing interventions.  
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Similarly, the wider impacts of these interventions on the clinical outcome and the 
management of the patient need to be considered. There is a paucity of data on 
downstream effects of laboratory ordering. Few studies have attempted to link and 
quantify laboratory ordering with the subsequent ordering of radiology or out patients 
requests [76], and none have linked a reduction of laboratory orders with reduced 
follow-on requests. Further research on the proportion of laboratory requests, where 
the result (either normal or abnormal) leads to a quantifiable diagnosis, health gain or 
evidenced based health intervention - is required. Ultimately, the laboratory mission 
is to serve the patient and most studies to date have focused on the requester. Thus, 
while laboratory-based interventions to curtail inappropriate requests are valuable, 
they rarely have a patient focus. Aiming to reduce the volume of test requests may not 
be a satisfactory outcome of interest. The key drivers of demand management and 
improving the appropriateness of test requesting should include economic savings in 
the health service, but also, improved clinical outcomes for patients [3, 41]. In order 
to do so, a collaborative approach involving laboratories and clinicians may be most 
beneficial. For example, provision of interpretative comments on test reports is not 
only welcomed by users but has been suggested to influence requesting behaviour and, 
indeed, patient outcomes.  
3.5.2 Limitations of this review 
Firstly, the heterogeneity of the studies precludes a quantitative pooling of the results 
to produce any statistical inference; our study is thus essentially descriptive. Secondly, 
follow-up periods of the included studies varied, ranging from three months to two 
years. As a result, the findings may vary. Also, this review followed EPOC adapted 
guidelines when including study designs, and, included a mixture of RCTs, CBAs and 
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ITS study designs. The latter two study designs are weaker and more susceptible to 
bias due to their observational nature. Finally, not all included studies controlled for 
the same confounders, in particular, patient-level characteristics.  
Another limitation of our review is that it is possible that additional studies with non-
significant or negative effects were not published. This leads to publication bias which 
may have an impact on our findings. In particular, clinical laboratories may be carrying 
out routine audits of new strategies they have implemented, but may be not publishing 
less favourable negative results. Also, in many of the included studies, authors 
reported a suspicion of inappropriate testing as part of their motivation [46, 48-51, 53, 
55, 56].  
However, our study also has several strengths. Our literature search is exhaustive and 
provides a clears overview of the subject matter. The studies included are from 
practices within covering multiple geographic locations; thereby, the inferences of the 
review are generalizable to a large population. 
3.6 Conclusion 
Our review suggests that many different interventions may change primary care 
physician requesting patterns, in particular, multi-faceted interventions. However, due 
to the small number of studies and questionable validity and generalizability of 
findings of these studies, this review should encourage further better quality research 
in this area. While some of the included study designs are weak, the results are 
generally consistent in pointing to the need to intervene to improve test ordering 
behaviour. As a result, it is important that policy makers consider the benefits of 
providing the resources to further explore and implement some of these interventions 
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pending the conduct of better quality studies. The possibility of publication bias should 
be weighed when assessing interventions. However, due to the downstream 
expenditure resulting from laboratory testing, the cost and time associated with 
continuous quality improvement initiatives in laboratory medicine will be beneficial.  
There is a paucity of theory-based interventions in relation to test ordering behaviours 
of physicians. Further research should concentrate on improving our understanding of 
when interventions such as education or guidelines are likely to be effective and how 
to improve them. In particular, current interventions have been limited to tackling only 
one or a very few elements of the behaviour change wheel. As a result, the 
determinants of success and failure remain unclear, and interventions may not be 
applicable to specific tests. Given the difficulties inherent in translating research into 
practice, it is reasonable to question whether the interventions we describe are 
generalizable or adaptable to other health care settings and conditions. Also, future 
studies that examine the effect of combined approaches, conducted by a 
multidisciplinary team are likely to be of interest. Hence, further research is needed to 
systematically examine the contextual and organisational factors likely to influence 
the behaviour change and implementation. In addition, research focused on the impact 
on patient care, further testing and diagnosis as a result of a change in laboratory 
ordering would assist with an appropriate policy for future laboratory services. 
40 
 
Table 3.1 Overview of the characteristics of the included intervention studies and the key findings 
Reference Setting Design Participants Type Intervention Comparator Follow-up Effect of intervention 
Horn et al. 
[46] 
USA ITS 215 primary 
care 
physicians 
(Five group 
practices) 
 
Changing 
the order 
form 
Cost displays within 
electronic health 
record at time of 
ordering  
(153 physicians) 
 
Control group: 
no cost 
information  
(62 physicians) 
12-month pre- 
and six-month 
post-
intervention 
Difference-in-difference 
approach. 1-2.6% reduction. 
20% The cost displays 
resulted in a reduction of 0.4-
5.6 laboratory orders per 
1,000 visits per month 
(p<0.001). 
Kahan et al. 
[54] 
Israel CBA Not disclosed Changing 
the order 
form 
A new version of 
electronic order form 
Older version of 
computerised 
order form 
Six months pre-
and four 
months post-
intervention 
31-41% reduction relative to 
the pre-intervention month, 
with 36-58% reduction the 
following month. -2-3% 
changes for control tests. 
Shalev et al. 
[55] 
Israel CBA 865 primary 
care 
physicians 
Changing 
the order 
form 
Changing the number of 
tests on the order form 
(27 tests removed and 
two added – reducing 
the number of tests 
available using a check-
box form from 51 to 26) 
Standard form 
prior to 
intervention 
12 months pre- 
and 24 months 
post-
intervention 
For deleted tests, there was a 
27% and 19.2% reduction one 
and two years after the 
intervention, respectively. 
Zaat et al. 
[74] 
Netherlands CBA 75 primary 
care 
physicians 
Changing 
the order 
form 
Volume of tests on 
order form reduced 
(hand written request if 
test not displayed)  
(47 physicians) 
Standard form 
(28 physicians) 
Five-months 
pre- (control) 
and 12 months 
post-
intervention 
18% reduction in the number 
of tests requested monthly in 
experimental group after the 
intervention compared to the 
control doctors. 
Barrichi et 
al. [53] 
Italy CBA 44 primary 
care 
physicians 
Education Pathology-specific 
laboratory algorithms 
for seven common 
clinical scenarios were 
tested. Education was 
provided (eight 
Current practice 12 months pre- 
and 12 months 
post-
intervention  
(data on test 
requests for 
5% reduction in the volume of 
tests requested by the 
intervention district one year 
following the intervention 
(retrospective audit) compared 
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training sessions) to 
the physicians about 
the algorithms and 
their use (23 
physicians). 
randomly 
selected 30 
days in each 
period) 
with a 1% increase in the 
control district. 
Larsson et 
al. [47] 
Sweden CBA 63 primary 
care 
physicians 
(19 practices) 
Education An education 
programme 
 (two-day lecture 
series) 
Current practice  
(Two practices) 
Five months 
pre- 
intervention 
and four 
months post- 
intervention 
Seven ratios were 
recommended to decrease in 
volume; five did at p<0.05. 
Seven were expected to 
increase in volume; four did at 
p<0.05. 
Verstappen 
et al. [49] 
Netherlands RCT 174 primary 
care 
physicians 
(26 practices) 
Education A primary care 
physician based 
strategy focused on 
clinical problems and 
associated tests  
(85 physicians in arm 
A and 89 physicians in 
arm B) 
Each group 
acted as a 
control for the 
other 
Six-months 
pre- and six-
months post-
intervention 
12% reduction in the volume 
of total tests in the 
intervention group versus no 
change in the control arm. 
16% reduction of 
inappropriate tests for the 
intervention group. 
van Wijk et 
al. [50] 
Netherlands RCT 60 primary 
care 
physicians  
(44 practices) 
Guidelines Guideline-based order 
form (29 physicians) 
versus restricted 
guideline based 
electronic order form 
(31 physicians) 
Each group 
acted as a 
control for the 
other 
Study period: 
1st July 1994- 
30th June 1995 
Decision support based on 
guidelines was more effective 
in changing blood test 
ordering than decision support 
based on initially displaying a 
limited number of tests. 
Primary care physicians who 
used BloodLink-Guideline 
requested 20% fewer tests on 
average than did practitioners 
who used BloodLink-
Restricted (mean [±SD], 5.5 ± 
0.9 tests vs. 6.9 ± 1.6 tests 
(p=0.003). 
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Baker et al. 
[51] 
UK RCT 96  primary 
care 
physicians 
(33 practices) 
Guidelines  
Feedback 
58 GPs (17 practices) 
guidelines followed by 
feedback about the 
numbers of thyroid 
function, rheumatoid 
factor test and urine 
cultures they ordered 
(quarterly for one year) 
38 GPs (16 
practices) 
received  
guidelines then 
feedback about 
lipid and 
plasma 
viscosity tests 
(each a control 
group for the 
other) 
Baseline and 
one year post 
intervention 
No effect. No change in 
volume of tests per 1,000 
requested in either of the 
study groups for any of the 
tests 
Thomas et 
al.[48] 
UK RCT 370  primary 
care 
physicians 
(85 practices) 
Feedback 
Education 
Quarterly feedback of 
requesting rates and 
reminder messages. 
Practices allocated to 
one of four groups: 
control (20 practices), 
enhanced feedback 
alone (22 practices), 
reminder messages 
alone (22 practices), or 
both enhanced 
feedback and reminder 
messages  
(21 practices) 
Current practice 12 months pre- 
and post-
intervention 
11% reduction in requests for 
practices receiving enhanced 
feedback or reminder 
messages OR: 0.89, 95% CI: 
0.83-0.93) compared with 
control group. 
Tomlin et al. 
[52] 
New Zealand CBA 3,160, 3,140 
& 3,335  
primary care 
physicians 
Guidelines 
Feedback 
Education 
Three marketing 
programmes 
(guidelines, individual 
feedback & 
professional 
development) 
Locum and 
other physicians 
not targeted by 
the programmes 
Two years pre- 
and post- 
intervention 
60% reduction in the number 
of ESR tests by the 
intervention group following 
the intervention versus an 
18% reduction in comparison 
doctors after the intervention. 
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Table 3.2 Quality assessment of the included studies 
Author Intervention Design Independent of other changes 
Knowledge of 
allocated 
intervention 
Unlikely to 
affect data 
collection 
Shape of effect 
pre-specified Attrition bias 
Selective 
reporting 
Other risk of 
bias 
Overall 
risk 
Horn et al. 
[46] 
Changing 
order form 
ITS  Low risk 
The study had a 
control group  
High risk 
Participants 
knew which 
intervention 
they were 
receiving 
 
Low risk 
Sources and 
data collection 
methods same 
before and after 
intervention 
Low risk 
Specified 
Unclear risk 
Missing data 
unclear 
 
Low risk 
Appropriate 
outcomes 
reported 
Low risk 
No other 
potential bias 
High risk 
Author Intervention Design 
Random 
sequence 
generation 
Allocation 
concealment 
Protection 
against 
contamination 
Blinding  Attrition bias Selective reporting 
Similar at 
baseline 
Overall 
risk 
Shalev et 
al. [55] 
Changing 
order form 
CBA  High risk  
CBA study 
High risk  
CBA study  
 
N/A 
No control 
group 
High risk 
No blinding 
Low risk 
No missing 
data 
Low risk 
Appropriate 
outcomes 
reported 
N/A 
No control 
group  
High risk 
Kahan et 
al. [54] 
Changing 
order form 
CBA 
 
High risk  
CBA study 
High risk  
CBA study 
N/A 
No control 
group 
High risk 
No blinding 
Low risk 
No missing 
data 
Low risk 
Appropriate 
outcomes 
reported 
N/A 
No control 
group 
High risk 
Zaat et al. 
[74] 
Changing 
order form 
CBA High risk  
CBA study 
High risk  
CBA study 
Unclear risk 
No information 
in text 
High risk 
Participants knew 
what they had been 
allocated to 
Low risk 
No missing 
data 
Low risk 
Appropriate 
outcomes 
reported 
Unclear risk 
No information 
in text on 
baseline 
characteristics, 
baseline 
outcomes 
similar (Fig 
1/2) 
 
High risk 
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Baricchi et 
al. [77] 
Education CBA  High risk  
CBA study 
High risk  
CBA study 
Unclear risk 
No information 
in text 
High risk 
Participants knew 
what they had been 
allocated to. 
Low risk 
No missing 
data 
Low risk 
Appropriate 
outcomes 
reported 
Unclear risk 
No information 
in text 
High risk 
 
Larson et 
al. [47] 
Education CBA High risk  
CBA study 
High risk  
CBA study 
Unclear risk 
No information 
in text 
High risk 
Participants knew 
what they had been 
allocated to. 
Low risk 
No missing 
data 
Low risk 
Appropriate 
outcomes 
reported 
Unclear risk 
No information 
in text 
High risk 
Verstappen 
et al. [49] 
Education RCT Low risk 
Blocked 
randomization 
Low risk 
Cluster trial, 
allocation after 
recruitment 
completed 
Low risk 
Independent 
clinics 
Low risk 
Controls were 
blinded, hence 
preventing the 
Hawthorne effect. 
Low risk 
No missing 
data 
Low risk 
 
Appropriate 
outcomes 
reported 
Low risk 
Outcomes 
measured at 
baseline and 
baseline 
characteristics 
reported and 
similar 
Low risk 
van Wijk et 
al. [50] 
Guidelines RCT Low risk 
“researcher not 
involved in the 
study…performed 
the randomisation 
using random-
numbers table” 
Low risk 
“each practice 
assigned by 
simple random 
allocation” 
Low risk 
Separate 
practices 
High risk 
All participants 
knew what they 
had been allocated 
to. Test ordering in 
controls may have 
been affected. 
Low risk 
Missing data 
similar 
between 
groups and all 
participants 
accounted for   
Low risk 
Appropriate 
outcomes 
reported 
Low risk 
Similar 
baseline 
characteristics 
High risk 
Baker et al. 
[51] 
Guidelines & 
Feedback 
RCT Low risk 
Random number 
table 
Low risk 
Cluster trial, 
allocation after 
recruitment 
completed 
Low risk 
primary care 
physicians 
work separately 
High risk  
Participants knew 
what they had been 
allocated to. Test 
ordering in 
controls may have 
been affected. 
Low risk 
No sites lost to 
follow-up 
Low risk 
Appropriate 
outcomes 
reported 
High risk 
Participants in 
group 2 had 
fewer patients’ 
and GPs than 
group 1 
High risk 
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Thomas et 
al.[48] 
Feedback & 
Education 
Cluster 
RCT 
Low risk 
 “cluster 
randomization...wi
th a minimization 
procedure” 
Low risk 
Cluster trial, 
allocation after 
recruitment 
completed. 
Low risk 
Separate 
practices 
High risk 
Participants knew 
what they had been 
allocated to. Test 
ordering in 
controls may have 
been affected. 
Low risk 
No missing 
data 
Low risk 
Appropriate 
outcomes 
reported 
Low risk 
Similar 
baseline 
characteristics 
High risk 
Tomlin et 
al. [78] 
Guidelines, 
Feedback & 
Education 
CBA  High risk  
CBA study  
 
High risk  
CBA study 
High risk 
“Changes...mig
ht be explained 
by 
….contaminati
on of the 
comparison 
group” 
High risk 
Participants knew 
what they had been 
allocated to. Test 
ordering in 
controls may have 
been affected. 
Low risk 
No missing 
data 
Low risk 
Appropriate 
outcomes 
reported 
High risk 
Intervention 
group included 
GPs only while 
control group 
included locum 
GPs also. 
High risk 
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4.1 Abstract 
Background Research suggests that variation in laboratory requesting patterns may 
indicate unnecessary test use. Requesting patterns for serum immunoglobulins vary 
significantly between General Practitioners (GPs). This study aims to explore GP 
views on testing to identify the determinants of behaviour and recommend feasible 
intervention strategies for improving immunoglobulin test use in primary care.  
Methods Qualitative semi-structured interviews were conducted with GPs requesting 
laboratory tests at Cork University Hospital or University Hospital Kerry in the South 
of Ireland. GPs were identified using a Health Service Executive laboratory list of GPs 
in the Cork-Kerry region. A random sample of GPs (stratified by GP requesting 
patterns) was generated from this list. GPs were purposively sampled based on the 
criteria of: location (urban/rural); length of time qualified and practice size (single-
handed/group). Interviews were carried out between December 2014 and February 
2015. Interviews were transcribed verbatim using NVivo 10 software and analysed 
using the framework analysis method. Emerging themes were mapped to the 
theoretical domains framework (TDF), which outlines 12 domains that can enable or 
inhibit behaviour change. The behaviour change wheel and behaviour change 
technique (BCT) taxonomy were then used to identify potential intervention 
strategies.  
Results Sixteen GPs were interviewed, (ten males and six females). Findings suggest 
that intervention strategies should specifically target the key barriers to effective test 
ordering, while considering the context of primary care practice. Seven domains from 
the TDF were perceived to influence immunoglobulin test ordering behaviours, and 
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were identified as ‘mechanisms for change’ (knowledge, environmental context and 
resources, social/professional role and identity, beliefs about capabilities, beliefs about 
consequences, memory, attention and decision-making processes, and behavioural 
regulation). Using these TDF domains, seven BCTs emerged as feasible ‘intervention 
content’ for targeting GPs ordering behaviour. These included instructions on how to 
effectively request the test (how to perform behaviour), information on GPs’ use of 
the test (feedback on behaviour), information about patient consequences resulting 
from not doing the test (information about health consequences), laboratory/consultant 
based advice/education (credible source), altering the test ordering form (restructuring 
the physical environment), providing guidelines (prompts/cues) and adding 
interpretive comments to the results (adding objects to the environment). These BCTs 
aligned to four intervention functions: education, persuasion, environmental 
restructuring and enablement.  
Conclusions This study has effectively applied behaviour change theory to identify 
feasible strategies for improving immunoglobulin test use in primary care using the 
TDF, ‘Behaviour Change Wheel’ and BCT taxonomy. The identified BCTs will form 
the basis of a theory-based intervention to improve the use of immunoglobulin tests 
among GPs. Future research will involve the development and evaluation of this 
intervention. 
Keywords laboratory testing, primary care, interventions, Theoretical Domains 
Framework, behaviour change techniques, Behaviour Change Wheel 
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4.2 Background 
Laboratory testing plays an increasingly important role in the diagnosis and 
monitoring of conditions managed by General Practitioners (GPs). An estimated 30% 
of all patient encounters result in a test order, and care planning has become 
increasingly dependent on the results of laboratory tests [79, 80]. This has led to 
greater scrutiny of the appropriateness of test ordering, with suggestions that as many 
as 70% of all tests may be unnecessary depending on the context of care [81-83]. 
Considerable variation in test ordering patterns by GPs has been identified, further 
supporting the likelihood that some ordered tests are unnecessary [84-86]. Further, in 
a recent US survey of over 1,700 participants, GPs reported uncertainty about ordering 
tests in 14.7% of diagnostic encounters and uncertainty in interpreting results in 8.3% 
of these encounters [33]. Healthcare services worldwide are under pressure to reduce 
their costs and a review commissioned by the UK Department of Health estimated that 
costs could be reduced by as much as 20% by improving utilisation of pathology 
services [87]. + 
Inappropriate laboratory testing includes both over- and under-utilisation. Over-
utilisation is wasteful, can increase the likelihood of false positives, poor treatment 
decisions and adverse outcomes due to unnecessary interventions [14]. Under-
utilisation may result in morbidity resulting from delayed or missed diagnoses. 
Overuse and underuse of tests can both lead to longer hospital stays and contribute to 
legal liability. One large review of laboratory testing patterns found inappropriate 
testing was three times higher for low volume than high volume tests (32% vs 10%) 
[83]. ‘Low volume’ in this study implied a test that was ordered at least ten times less 
frequently than the most commonly ordered tests [83]. Inappropriate testing is more 
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likely to occur with low-volume tests which may be due to a lack of familiarity with 
best treatment practices for the conditions under scrutiny [14].   
Our study explores the use of two related low-volume blood tests in primary care, 
serum immunoglobulins quantitation and immunoglobulin electrophoresis. These 
tests should be ordered as part of the primary screen for suspected plasma cell 
dyscrasias (myeloma, lymphoma, chronic lymphatic leukaemia, heavy chain disease, 
and amyloidosis).  Immunoglobulins alone may also be requested as part of the 
diagnostic investigation of patients with recurrent documented infections [22]. 
Low serum immunoglobulin levels indicate a deficiency of the humoral immune 
system, while high immunoglobulin levels (with normal electrophoresis) are observed 
in liver diseases, infections and chronic inflammatory diseases. Raised levels with 
abnormal electrophoresis may indicate blood dyscrasia [23]. High levels of 
immunoglobulins are a feature of many clinical conditions in older patients but are 
only really diagnostically useful in specific haematological disorders such as myeloma 
and lymphoma.  The clinical features of these conditions can be vague and non-
specific and overlap with the symptoms of a wide range of other conditions.  Thus, in 
older patients, immunoglobulin testing is probably best undertaken as a second-line 
investigation where there are other tests (such as a full blood count) which indicate the 
possibility of a blood dyscrasia. Knowing when to order immunoglobulins, therefore, 
can be challenging for GPs and may require a clinical judgement in the context of 
rather non-specific clinical features. Their interpretation is also difficult and often 
requires specialist input. Furthermore, once abnormal levels have been detected this 
can lead to other costly activities such as referral to secondary care that may ultimately 
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prove to have been futile. To date, no previous studies have studied GPs’ serum 
immunoglobulin test ordering behaviour.   
A recent systematic review identified a number of effective interventions for reducing 
inappropriate test ordering, defined as testing practices that do not lead to patient 
benefits [88]. Educational strategies [47, 49, 77], cost displays [89], changing order 
forms [54] and various methods of disseminating guidelines [48, 50] displayed 
positive effects. Ten out of 11 studies included in the review found significant 
reductions in the volume of tests following an intervention, with effect sizes ranging 
from 1.2 to 60% [88]. However, the positive effects of these interventions were often 
short-term, and none lasted longer than two years [88]. Implementation science 
experts have suggested that theory-based, targeted behaviour change techniques may 
maximise the potential long-term effects of such interventions [90]. In particular, there 
is a need to identify the key enablers and barriers to successful implementation of 
interventions in this area and to improve their design so that sustainability is ensured 
[91].  
A growing body of literature supports the use of psychological theories in the 
development of behaviour change interventions [90, 92]. In particular, recent 
guidelines emphasise the need to report three aspects of behaviour change 
interventions [93]: the use of psychological theory to identify the factors which 
influence the target behaviour change (i.e., ‘mechanism of action’); the ‘active 
ingredients’ of behaviour change interventions (i.e., the intervention content); 
and, how this was delivered (i.e., who the intervention targeted, who delivered it, and 
in what format and setting). The theoretical domains framework (TDF) has been 
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identified as a useful tool for identifying the ‘mechanism of action’ and selecting 
behaviour change techniques (BCTs) to include in behavioural change interventions 
[44, 94]. The TDF is an elaboration of the six Capability, Opportunity and Motivation 
conditions of the ‘Behaviour Change Wheel’ (COM-B) [95] (see Figure 4.1). To date, 
a number of empirical studies have used the TDF to explore the implementation of 
BCTs with GPs including low back pain management [90] and medication prescribing 
[96]. 
Figure 4.1 The Behaviour Change Wheel 
 
The aims of this study were to use the TDF and corresponding COM-B conditions to 
identify the enablers and barriers to altering immunoglobulin test ordering behaviour 
from the perspective of GPs, and to use this information to identify the corresponding 
BCTs and feasible intervention strategies to align requesting practice with possible 
health gain, for future evaluative research. The specific GP behaviours targeted in this 
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study were serum immunoglobulin test requests that were not correctly aligned with 
the presenting symptoms of patients or were unlikely to lead to patient benefit.  
4.3 Methods 
4.3.1 Study design 
Qualitative semi-structured interviews were conducted with GPs in two adjacent 
counties in the Republic of Ireland.  
4.3.2 Sampling and recruitment 
All 587 practising GPs in the Cork-Kerry region were identified using a list provided 
by the Health Service Executive, the organisation that provides public healthcare in 
the Republic of Ireland. GPs were stratified by the volume of tests they had requested 
over the previous two years from the primary public hospitals in the region that 
provide the relevant laboratory services (Cork University Hospital and University 
Hospital Kerry). This involved categorising GPs into low (<10 tests/year), moderate 
(10-50 tests/year) and high (>50 tests/year) requesters for immunoglobulin tests. 
Within each category of requesting patterns, GPs were then purposively sampled 
based on the sampling criteria of: location (urban/rural); length of time qualified (<10 
years, 10-20 years, >20 years); and practice size (single-handed/group). GPs were sent 
a written invitation letter and study information sheet, followed by a telephone call to 
determine if they were interested in participating. A ’ten plus three’ method, which 
has been previously recommended for theory-based interview studies, was used to 
determine our initial sample size target [97]. Ten GPs were interviewed and the 
material collected was analysed at this point. Three further GPs were then interviewed 
to check if any new insights were produced. If further interviews were deemed 
necessary, they would be conducted in blocks of three with a check for data saturation 
54 
 
at the end of each block. One additional block of three interviews was necessary to 
reach data saturation, giving a total of 16 interviews. Written informed consent was 
obtained from all participants prior to the interview. 
4.3.3 Semi-structured interview process 
Face-to-face semi-structured interviews were carried out in the primary care setting 
by one researcher (SLC) between December 2014 and February 2015. The interview 
topic guide was developed based on the second version of the TDF [98] and discussion 
among the authors and is summarised in Appendix 5. The topic guide and interview 
process were piloted by interviewing two GPs. Following this pilot, there were no 
changes to the topic guide, but refinements were made to the probes that were used to 
explore GP responses and to the interviewing style. These pilot interviews were 
facilitated in the same manner as the remaining interviews and are included in the final 
analysis with consent from the interviewees. Interviews were recorded and transcribed 
verbatim. NVivo 10 software was used to facilitate data analysis. 
4.3.4 Data analysis 
Stage one. Data analysis followed the Framework analysis approach [99]. Data 
familiarisation was carried out by re-reading the transcripts and listening back to 
interview recordings. Following open-coding, emergent themes were mapped onto the 
domains of the TDF and corresponding Capability, Opportunity, Motivation 
conditions. When themes were relevant to more than one domain, they were initially 
coded to both domains. All transcripts were coded by the researcher who conducted 
the interviews (SLC), and a subset of six interviews (including a sample of urban/rural, 
male/female and more/less experienced GPs) were independently coded and analysed 
by a second researcher (SMMH) as a method of verification of the initial analysis. 
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Coding and mapping by the independent researchers (SLC and SMMH) were 
compared. There were no major disagreements. Minor differences arose in relation to 
the mapping of codes to TDF domains, particularly when codes mapped to more than 
one domain. Any differences were resolved by consensus discussion; the researchers 
referred back to the original transcripts to reassess the context of the codes, and 
discussed the particular code in light of the breadth of data from other transcripts 
mapped to that TDF domain drawing on SLC’s knowledge of all the interviews 
conducted and analysed.  
Stage two. The BCT taxonomy, version 1 was then used to recommend potential 
‘intervention components’, that is, strategies to improve laboratory testing in primary 
care [94, 100]. This taxonomy has been developed in order to standardise the content 
and reporting of intervention studies [94] and includes 93 BCTs grouped within 16 
categories with detailed definitions of each [94]. This process involved mapping the 
BCTs to the TDF domains and corresponding capability, opportunity and motivation 
conditions of the ‘behaviour change wheel’ identified in stage 1 [100]. The full list of 
BCTs has previously been applied to the TDF by a group of behaviour change experts 
[44]. We used this list [44] along with a more recently published list (resulting from 
an expert mapping exercise) [101] as a reference tool for guiding our selection of 
BCTs. Our multidisciplinary research team reviewed the BCTs that had been mapped 
to key domains in order to reach consensus on the BCTs that should be selected for 
the intervention development. This selection process was guided by the interview data 
and focused on identifying barriers and facilitators that could feasibly be targeted 
based on the available intervention resources. For example, if time and perceived 
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workload were reported as major barriers to GP testing behaviours, BCTs that could 
be delivered more efficiently were to be prioritised.  
4.3.5 Ethical approval 
Ethical approval for the study was obtained from the Cork Research Ethics Committee 
(ref: ECM (ii) 07/01/14). 
4.4 Results 
4.4.1 Sample demographics 
In total, sixteen GPs were interviewed, including ten males and six females. Table 4.1 
provides details of the participants’ characteristics categorised by location type 
(urban/rural).  
Table 4.1 Characteristics of GPs interviewed based on urban/rural setting 
GP characteristics Urban (n=8) Rural (n=8) Total (N=16) 
Gender    
  Male 5  4  9  
  Female 3 4  7  
Age Group    
  30-40 2 2  4  
  40-50 4 2  6  
  50-60 0 2  2  
  >60 2 2  4  
Training practice*    
  Yes 5 5 10 
  No 3 3   6  
Practice nurse^    
  Yes 5 5 10  
  No 3 3   6 
Practice type    
  Solo GP 2 2   4  
  Group practice 6 6 12  
*Training practice: a practice that facilitates trainee GPs on the Irish medical training scheme.  
^ Practice nurse refers to whether the practice has a practice nurse employed.  
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4.4.2 Summary of findings from analysis at the level of theoretical domains  
The analysis identified seven domains of the TDF that were relevant to 18 emerging 
themes (Table 4.2). These findings are described in greater detail below. The 
remaining domains that were not identified (intention, optimism, goals, emotion, 
social influences) are not discussed as not enough references to the relevant constructs 
were made.  
Table 4.2 TDF domains identified and the corresponding key themes that evolved 
TDF domains             Themes 
Knowledge*  
 
 
 Limited knowledge of when to use immunoglobulin 
tests effectively. 
 GPs expressed difficulty with interpreting the results 
(particularly borderline abnormal results).  
 Lack of knowledge of how to effectively manage 
patients when the result is abnormal (when to refer).  
Environmental 
context and 
resources 
 Lack of clear guidelines on when to use an 
immunoglobulin test in primary care.  
 Need for instructions on when to refer patients with 
abnormal results. 
Beliefs about 
consequences 
 Excessive follow-up workload that comes with doing 
an Immunoglobulin test.  
Beliefs about 
capabilities 
 Feel they are poor at triaging patients for potential 
myeloma. 
 GPs find interpreting immunoglobulin results 
difficult.  
 Concern at what to do with an abnormal test result, 
in particular, borderline abnormal results. 
Social/profession
al role 
 Happy to do the tests for specialist monitoring 
purposes. 
 Many GPs feel it’s not a common test in primary 
care. 
Memory, 
Attention and 
Decision Process 
 A follow-up test performed on the basis of results of 
another test. 
 Not a priority in primary care. 
 Older patients with chronic back pain trigger the test 
for many. 
 Small minority use them regularly for screening. 
Behavioural 
regulation 
 Education and guidelines mentioned the most. 
 Electronic strategy highlighted as feasible/ systems-
level strategy.  
 Multidisciplinary approach.  
*Knowledge and skills were merged due to overlapping constructs 
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The main domains from the TDF which emerged were: ‘knowledge’, ‘skill’, 
‘environmental context and resources’, ‘social/professional role and identity’, ‘beliefs 
about capabilities’, ‘beliefs about consequences’, ‘memory, attention and decision-
making processes’ and ‘behavioural regulation’. 
4.4.2.1 Knowledge and skill 
The domains ‘Knowledge’ and ‘Skill’ were merged as the constructs overlapped. That 
is, GPs primarily referred to ‘procedural’ knowledge and where competence or ability 
(skills) was mentioned, it was always linked to a lack of knowledge. Participants 
reported that knowledge was a key barrier when requesting immunoglobulins. In 
particular, GPs identified a number of different scenarios when they would request the 
test including “recurrent infections”, “respiratory problems” and “back pain”. The 
majority of GPs stated that they would be considering potential “myeloma” when they 
are requesting, however, a small minority of GPs identified other conditions including 
“rheumatoid arthritis” and “anaemia”. GPs reported that a need for greater guidance 
and training on when to use serum immunoglobulin tests would be beneficial.  
“No, my natural feeling towards it would be I feel that I don't know 
enough about them. And I might be getting more value out of them if I 
knew more you know yeah”. (GP 6)  
“It’s confusing I mean it’s just a confusing area for us and when do we 
request them anyway?” (GP 2) 
The interpretation of immunoglobulin results was identified as a challenge by almost 
all GPs interviewed. In particular, they discussed difficulty interpreting borderline 
abnormal results and making treatment decisions for these cases.  
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“Well, it can be difficult to interpret. So often if there is a difficulty with 
them you basically have to ring the lab to confirm before you discuss with 
the patient because at that stage anyway you're talking about referring 
the patient on anyway”. (GP 3) 
“I find them very hard to interpret, and I end up ringing haematology 
about the interpretation”. (GP 4)  
4.4.2.2 Environmental context and resources 
The majority of GPs mentioned a lack of clear guidelines on when to request an 
immunoglobulin test. GPs reported that they often phone the laboratory for advice in 
the absence of clear requesting and interpretative guidelines. GPs highlighted that this 
was time consuming, however, they commended the support of laboratory staff. 
“I find the labs very good to be honest with you. They'll put you onto the 
consultant that's on duty at the time or if not they'll ring you back. So I've 
never had a problem with it”. (GP 9)  
Patient management post testing was also mentioned as a concern. In particular, a lack 
of information on the usefulness of the test for managing patients in primary care. For 
example, one GP used the test for screening patients but expressed that he did not 
know what to do with the result.  
“…I suppose there are some issues like that I have to get advice from the 
haematologists where I'm you know at a loss where do we go from here. 
Do we just put it up on their record and leave it there as background 
information or do we proceed further with investigations”. (GP 10) 
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4.4.2.3 Beliefs about capabilities 
In general, the majority of GPs admitted a lack of confidence in their ability to use 
serum immunoglobulin tests, in particular, managing their patients who receive an 
abnormal result. Many reported that they often had to phone the laboratory and speak 
to the haematology registrar or consultant. Other stated that they often just referred 
these patients. 
“I feel my ability to triage them is poor, and you don't want to be ringing 
the haem reg (haematology registrar) all of the time”. (GP 13) 
“So, if I get an abnormal result, I'd either want to speak to a haem reg 
(haematology registrar) or refer on because I wouldn't be confident in 
managing an abnormal result”.  (GP 11) 
“If it's minor and it's fractional and the patient is well, I'm happy to do 
nothing. If it’s significant and I'm just unsure, that's when I ring the reg 
(haematology registrar) or consultant”. (GP 4) 
4.4.2.4 Beliefs about consequences 
GPs stated the workload created by doing the tests was a deterrent, in particular having 
to liaise with the laboratory or haematology department.  
“Exactly, because ironically in my experience doing immunoglobulins 
will lead to workload perhaps because I'm going to have to liaise with 
my hospital specialist colleagues’ ah because to get their opinion on them 
actually”. (GP 15)  
Also, a small number of GPs mentioned: “fear of litigation” and “fear of missing a 
myeloma” as other potential consequences leading to what they described as 
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potentially ineffective use of the test. Again, these consequences related back to their 
perceived lack of knowledge. 
4.4.2.5 Social/professional role and identity 
Some GPs reported that they request a large volume of immunoglobulins, often as a 
screening test. However, the majority of GPs referred to the test as a second or third 
line test, performed subsequent to previous tests. They stated that they considered 
immunoglobulins a rare test and one they would not perform regularly. 
“We have a reg (registrar) and am we have two practice nurses and at 
the induction for the registrar there are certain blood tests we advise 
them not to perform regularly; this would be one of the ones we advise 
not to perform regularly”. (GP 4) 
GPs highlighted that while they feel the test should be available in primary care, they 
often consider it a secondary care test and in few cases highlighted their gatekeeping 
role in using the test. 
“You see GP's often wouldn't see them because if they are being 
monitored by haem (haematology). In fairness GP practices do them, but 
they probably do some with their forms to their nurse, but the GP won't 
see them. And often, if they come in with the form, it is the consultant’s 
name of the form, and their results don't come back to us”.  (GP 13) 
Finally, younger female GPs (in their 30s) suggested that they may request fewer tests 
due to their patient demographics. They commented that the majority of their patients 
are younger females and children who are less likely to require the test.  
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“I see pretty much all women and children, and so I would have very 
little need. There is a very small number of older patients”. (GP 13) 
“I think that because I am a young female GP I don’t see a huge pile 
(volume) of older patients – so what I do is kiddies (children) and 
contraception and a lot of antenatal care and gynae (gynaecological) 
stuff”. (GP 9) 
In particular, each of them highlighted that patients often grow with them (the GP) in 
terms of age, and suggested that more experienced male GPs may appropriately 
request more.  
4.4.2.6 Memory, Attention and Decision Process 
When asked about what prompts them to perform the test, GPs had many contrasting 
reasons, with many highlighting that they were unsure of when to do them. GPs 
discussed some key symptoms that would influence their decision-making process 
such a “chronic back pain”, “persistent infections” or in some cases simply “age”. 
These factors varied between GPs; however, almost all GPs mentioned myeloma as 
the potential endpoint diagnosis from doing the test.  
“I use them primarily in situations where I think there might be 
something significant. So usually you tend to see it used in say recurrent 
infections or more particularly in patients who might potentially have 
multiple myeloma”.  (GP 5)  
Some GPs mentioned that they request the test to monitor patients with an existing 
diagnosis at the request of the consultant, where results of previous tests are available. 
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“Once they have been into the consultant and the consultant has said this 
is...just check it every 12 months, that's fine by me. I'll check it if its. I'll 
look at the results. I can very easily compare them to the last results on 
my computer and I can tell if it’s changing or if it's not changing”. (GP 
2) 
4.4.2.7 Behavioural regulation 
GPs suggested potential strategies to help improve testing in primary care. GPs 
primarily requested education and guidelines on when to test, but also on how to 
interpret the results. 
“I guess education is what we need really. You know what value it will 
be to us for our patient and for, obviously for information for helping the 
patient”. (GP 4) 
“Yeah I suppose we need a one-page protocol so we know where we are 
going with this thing you know”. (GP 10) 
In particular, they discussed the feasibility and receptiveness of educational based 
interventions in primary care. A key barrier according to the GPs was ensuring 
sustainable strategies are selected. 
“Well I suppose the easy answer would be to say training or education 
or a booklet or a pamphlet but there's a great risk that if you produce a 
document like that it will be quickly glanced at, thrown in the bin, or what 
I would be doing, I would put it in a filling place, and I'd never look at it 
again. So you need to do something that is sustained and continuous 
actually I would say”. (GP 4) 
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“I think the education strategy has to be built in with reminders”. (GP 2) 
Two GPs discussed penalties, incentives, feedback and restrictive strategies. However, 
when discussed in detail, GPs concluded that the lack of knowledge would potentially 
hamper the effects of such strategies.  
“Another thing of course would be either penalty or incentivisation 
whereby if and it's a sad thing to say but we respond to incentives. So if 
you over-prescribe, sorry over-request to a ridiculous degree you know 
four times the average then there should be some kind of a penalty. Or, 
if you're within certain ranges some kind of incentive. And, I think that 
would affect real change”. (GP 12) 
“I think am the form…if you want a particular test that is out of the 
ordinary, I think that you should have to justify your reasons in the 
clinical details box for the test”. (GP 9) 
Importantly, GPs stressed that a systems level approach needs to be followed, where 
possible at the laboratory level providing education or the use of an algorithm. 
“I think it has to be at the systems level. Cause (because) I think a once-
off workshop or once off piece of paper coming out to the practice won’t 
make a difference here”. (GP 14) 
“It has to be at the systems level. I think it has to be centrally delivered 
from the Department of Haematology”. (GP 14) 
“Well I suppose if you had your algorithm so if you had like so complaints 
or five scenarios where so if the come in with this you should be ordering 
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an S pep and you should be looking for such and such on the results. So 
if you did it that way”. (GP 16)  
“Yeah, maybe like a performer or an algorithm or some kind may be 
useful alright”. (GP 12) 
However, GPs mentioned that any strategy developed to improve the use of laboratory 
tests should be primary care responsive and consider the differing motivations of GPs 
versus specialist physicians. For example, many GPs stated that they perform 
laboratory tests to ‘rule out’ a diagnosis while, specialist physicians may be more 
likely to carry out tests to ‘rule in’ or confirm a diagnosis.  
“You know because a lot of them, if they come back abnormal are very 
useful you know and this is one of the differences between general 
practice and hospital practice, the importance of normal blood tests. 
General practitioners generally do blood tests to out rule illnesses and 
hopefully getting normal results, whereas hospital practice would be 
much more inclined to do a blood test to confirm an abnormal result or 
to look for an abnormal result”. (GP 6) 
4.4.3 Application of BCT taxonomy and identification of potential intervention 
functions 
Table 4.3 shows the final mapping of the BCTs to the identified TDF domains and 
COM-B components. Using previous work on mapping BCTs to the TDF, as outlined 
in the methods, the research team identified and selected seven BCTs with potential 
for inclusion in a future intervention involving GPs. This resulted in six of the 16 BCT 
groupings; ‘shaping knowledge’, ‘feedback and monitoring’, ‘natural consequences’, 
‘comparison of outcomes’, ‘antecedents’ and ‘associations’. Within these six 
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groupings, seven specific BCTs were found to be relevant (definitions of each of these 
can be found in Appendix 6). For example, the technique “Instructions on how to 
perform the behaviour” from the 93-item BCT taxonomy [94] was selected to target 
the GPs lack of knowledge on when to request the test, while another technique 
“prompts/cues” was used to target the feasibility of implementing an education based 
strategy. A full description of the selection and exclusion of BCTs can be found in 
Appendix 7. 
Using these BCTs, four of the ten intervention functions were deemed potentially 
useful for developing an intervention targeting the GP population. Selected BCT 
functions included ‘education’, persuasion’, ‘environmental restructure’ and 
enablement’. Subsequently, potential intervention components were devised and 
include: providing guidelines on when to request the test, clearly communicating 
situations where testing is not beneficial for patient care education and giving advice 
(attached to results) on how to interpret results and manage patients with abnormal 
levels. These intervention strategies were also suggested by GPs during the interviews, 
and are likely to assist in the development of feasible and welcome interventions. 
Table 4.3 provides details of the mapping process for selecting the BCTs and 
intervention components. For example, for the domain ‘Knowledge’, the BCTs 
‘information on how to perform the behaviour’ and ‘feedback on behaviour’ were 
selected. However, providing feedback on individual GP requesting patterns was 
deemed potentially inappropriate due to the lack of knowledge GPs expressed around 
when to request the test in the first instance.  
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Table 4.3 Suggested intervention content and mechanisms of action using the Behaviour 
Change Technique (BCT)  taxonomy (v1); behaviour change wheel Capability Opportunity 
Motivation-Behaviour (COM-B) model; and Theoretical Domains Framework (TDF) [95] 
Intervention 
component 
Mechanisms of action            Intervention content 
TDF2 COM-B1 BCT group BCTs Functions 
Information and 
training about 
immunoglobulin use 
in primary care, i.e. 
provide guidelines on 
when to request and 
how to interpret 
results. 
Kn  
MAD 
BR 
 
 
 
 
C-(Psy.) 
C-(Phys.) 
Shaping 
knowledge 
 
 
 
 
Instructions 
on how to 
perform 
behaviour 
 
 
 
Education 
 
Provide feedback on 
individual GP 
feedback (volume of 
tests). 
NOTE: not a suitable 
strategy in this 
context 
Kn 
 
C-(Psy.) 
 
Feedback and 
monitoring 
Feedback on 
behaviour 
Education 
Persuasion 
Clearly communicate 
situations where 
immunoglobulin 
testing is not 
beneficial. (i.e. 
develop an algorithm 
of scenarios where 
tests should be 
performed, supported 
by consultant 
haematologists and 
GPs. 
B Cap 
B Con 
 
 
 
M-(Refl.) Natural 
consequences 
 
 
Comparison 
of outcomes 
Information 
about health 
consequences 
 
Credible 
source 
 
 
 
Persuasion 
 
Provide notes 
detailing consultant 
advice on the test 
results (ideally 
provided on the end 
of the test results). 
Env 
S/P Id 
 
O-(Phys.) 
O-(Soc.) 
Antecedents 
 
Associations 
Restructuring 
the physical 
environment 
 
Prompts/cues 
 
Adding 
objects to the 
environment 
 
 
Environmental 
restructure 
 
Enablement 
1 COM-B components: C-(Psych), psychological capability; C-(Phys), physical capability; M-(Refl), reflective 
motivation; O-(Phys), physical opportunity; M-(Auto), automatic motivation. *Intervention functions in italics  
2TDF domain abbreviations: Kn knowledge, MAD memory, attention and decision processes; BR behavioural 
regulation; Env environmental context and resources; B Cap, beliefs about capabilities; B Con, beliefs about 
consequences; S/P Id, social/professional role and identity 
The final mapping of the relevant BCTs and corresponding intervention components 
to the COM-B and TDF models can be found in Table 4.4. 
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* TDF domain abbreviations: Kn knowledge, MAD memory, attention and decision processes; BR behavioural regulation; Env environmental context and resources; B Cap, beliefs about capabilities; B 
Con, beliefs about consequences; S/P Id, social/professional role and identity
Table 4.4 Final mapping of  relevant BCTs for the design of a strategy for improving immunoglobulin test use in primary care 
    CAPABILITY OPPORTUNITY MOTIVATION 
    Psychological Physical Social Reflective 
BCT group [94] BCT [102] Functions Support from interviews Kn* MAD BR Env S/P Id B Con B Cap 
Feedback and 
monitoring  
Feedback on 
behaviour 
Education GPs reported that they are not aware 
of how many tests they request, or if 
they request tests appropriately.  
       
Shaping 
knowledge 
 
Instructions on 
how to perform 
the behaviour 
Education GPs expressed a lack of knowledge 
about when to do the test and asked 
for standardised guidance or 
resources. 
       
Associations Prompts and cues Enablement GPs highlighted that a once off 
education strategy is not desirable. 
Instead, they suggested a reminder 
on test results. 
       
Comparison of 
outcome 
Credible source Persuasion GPs mentioned the importance of 
input from specialists with regard to 
patient management following an 
abnormal test result. 
       
Antecedents 
 
Restructuring the 
physical 
environment 
 
Environmenta
l restructure 
GPs discussed current requesting 
procedure as a potential target 
(requesting more detail on order 
forms. 
       
Antecedents Adding objects 
to the 
environment 
Environmenta
l restructure 
GPs discussed the lack of guidelines 
for interpreting test results and 
expressed interest interpretive 
comments on test results. 
       
Natural 
consequences 
Information about 
health 
consequences 
Persuasion GPs expressed concern over the 
consequences of not performing a 
test in terms of missing a myeloma 
diagnosis. 
       
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4.5 Discussion 
This study presents a systematic, theory-based approach to developing an intervention 
to improve test ordering in primary care. We found that serum immunoglobulin test 
ordering is influenced by many social and contextual factors. Using the BCT 
taxonomy, TDF and COM-B models, four potentially useful intervention functions on 
which to model future interventions have been identified. These are education, 
environmental restructuring, enablement and persuasion by specialists.  
Evidence suggests that medical professionals respond differently than other healthcare 
professionals to interventions designed to change their behaviour [103] and that 
interventions are more likely to influence change if they target the factors underlying 
barriers to behaviour change [44]. The barriers to behaviour change also differ across 
healthcare professionals, and may result from differences in training, knowledge, work 
experience, personality, and other individual characteristics [104]. To our knowledge, 
this is the first study to identify these barriers in the primary care setting and develop 
potential strategies for improving test ordering using clearly delineated behaviour 
change theories. Two key barriers identified were a lack of knowledge on when to use 
immunoglobulin tests in primary care and how to interpret the results. Until these 
knowledge deficits are addressed, an audit and feedback approach to behaviour may 
be unsuccessful as the underlying drivers of inappropriate test ordering will not have 
been addressed. This is in line with the rejection of audit and feedback by the 
interviewees and the findings of previous studies [58, 105].  
Interviewees emphasised that the passive provision of information alone is not 
sufficient to bring about behaviour change in primary care. The GPs interviewed 
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argued that highlighting a discrepancy between expected and actual test ordering rates 
may be perceived as judgmental of their professional capacity. In particular, they 
discussed their clinical motivation for performing tests and the context of primary care 
setting as key characteristics that should be considered [106].  
Interviewees suggested that helping them to improve their knowledge through, for 
example, educational reminders or external support was likely to be successful. This 
support should come from specialists (‘a credible source’) and incorporate the 
dissemination of guidelines and feedback on how best to manage the patient. This is 
consistent with other studies on the value of education based specialist support 
strategies such as interactive educational sessions coupled with the use of local opinion 
leaders/physician champions and/or feedback reports [48, 49, 88]. The interviewed 
GPs also suggested that strategies should be designed at the laboratory level, such as 
changing the order forms or adding interpretive guidance to the results.  
When designing specialist support services to guide test ordering, strategies should be 
responsive to the needs of both GPs and laboratory services.  For example, while GP 
knowledge may be a barrier to behaviour change, strategies aimed at targeting testing 
behaviour also need to consider the motivation for testing in primary care, which may 
be to rule out a diagnosis rather than to rule in one. This may require educational 
messages to draw on a different knowledge base, for example, regarding the negative 
predictive value of the test rather than just information about the positive predictive 
value.  
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Our research suggests that specialist support should be provided from a credible source 
in an encouraging and non-judgemental manner. In the instance of immunoglobulins, 
haematologists are the best equipped to do so and therefore are well placed to assist 
the laboratory to formulate advice and comment on test interpretation. This support 
may best be provided in the form of interactive learning sessions with local opinion 
leaders and feedback reports generated at the laboratory level. Basic medical education 
could also incorporate information on immunoglobulin testing guidelines and 
interpretation. 
4.5.1 Strengths and limitations  
A key strength of this study is the systematic approach followed to identify key 
theoretical domains and select BCTs to support the development of an intervention in 
primary care. In doing so, we have followed existing recommendations on designing 
theory informed behaviour change interventions [90]. By making the relationship 
between the supporting theoretical framework and our intervention development 
explicit, it may be easier to identify how different elements of any subsequently 
designed intervention contribute to observed behaviour change. Also, in addition to 
identifying mediators of behaviour change to target using an intervention, the 
interviews have supplied valuable information about the clinical context in which the 
behaviours are currently performed. This information, along with the findings of our 
previous review [88], will inform decision-making around which intervention 
approaches should be employed in future research by our research group. 
There are some limitations to this study. First, the findings reflect GPs’ perceptions of 
influences on their clinical behaviours, but we do not have data on their actual 
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behaviour in specific cases.  Finally, we have drawn on a particular set of 
psychological theories of behaviour change but there may be alternative theories or 
frameworks that might also be applicable to explain test ordering behaviour of primary 
care physicians. 
4.6 Conclusion 
This research provides an important overview of the behavioural factors influencing 
laboratory testing among GPs. The incorporation of behavioural theory, specifically 
the COM-B, TDF and BCT taxonomy, has supported the identification of factors such 
as knowledge and the social and environmental context, which are key for 
understanding testing behaviours. Selected BCTs provide the groundwork for 
developing a theory-based intervention to improve appropriate immunoglobulin 
testing in primary care. Future work will involve developing and evaluating an 
intervention using the selected BCTs. 
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5.1 Abstract  
Background 
Primary care test requests for serum immunoglobulins are rising rapidly, with 
concerns that many requests may be unnecessary. Evidence suggests certain types of 
General Practitioners (GPs) and practices are associated with higher test ordering.  
Aims 
To identify the physician and practice characteristics associated with immunoglobulin 
test ordering. 
Design and setting 
Retrospective, cross-sectional study using routine laboratory data on primary care 
serum immunoglobulin requests. 
Methods 
Data were linked with GP patient list size data. The primary outcome measure was the 
count of test requests per GP. Predictor variables were physician gender, years 
experience, practice region and type (number of GPs), GP patient list size and 
composition. Mixed-effects multilevel regression models were used to calculate 
incidence rate ratios (IRRs) with 95% confidence intervals (CI) for the associations 
between physician and practice characteristics and GP requesting. Sensitivity analysis 
was performed by limiting the model to the over 70 age category. 
Results 
In total, 5,990 immunoglobulin tests were ordered by 481 GPs in the South of Ireland 
during 2013. The number of tests ordered by individual GPs varied from one to 377. 
In the final fully adjusted Poisson regression analysis, physician factors were 
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associated with test ordering. Female gender (IRR: 1.81; 95% CI: 1.45-2.26) and less 
experience (IRR: 2.27; 95% CI: 1.47-3.51) were associated with higher requesting 
(P<0.001). None of the practice factors were associated with test ordering. Sensitivity 
analysis on the over 70 age category found similar results. 
Conclusion 
Education programmes about the nature and uses of immunoglobulins, targeted at 
female GPs and those with less experience, may be required. 
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5.2 Background 
Laboratory testing is the single highest volume medical activity in healthcare and 
demand is rising year on year in many countries [11, 107, 108]. General Practitioners 
(GPs) initiate an estimated 50% of all requests [28], while approximately 30% of all 
primary care patient visits result in a laboratory test order [33]. Over the past 20 years, 
the number of new laboratory tests available to GPs has increased rapidly [33]. The 
volume of orders from GPs has also risen significantly for the most commonly ordered 
tests [11]. Given the increasing financial pressure on health systems, judicious 
laboratory testing is imperative. A better understanding of the determinants of GP test 
ordering is necessary, as evidence suggests that between 25% and 40% of all test 
orders are unnecessary [13, 14]. Differences in test ordering patterns of GPs has been 
linked to both physician and practice-level characteristics [109]. At the physician-
level, higher test ordering has been reported in female GPs [110, 111] and GPs with 
less medical experience [112]. At the practice-level, both practice type and practice 
setting have been linked to GP test ordering patterns. Those in group practices have 
been shown to order significantly fewer tests than GPs in single handed or two-person 
practices [113]. Working in an urban practice has been positively linked to higher test 
ordering [111]. However, previous research has not considered the interaction of 
physician and practice factors in a multilevel model. Existing literature also does not 
account for individual GP patient list size or the composition of lists. 
This study focuses on a low volume test, serum immunoglobulins, which poses a 
significant challenge to GPs [114]. These tests should be ordered as part of the primary 
screen for suspected plasma cell dyscrasias (myeloma, lymphoma, chronic lymphatic 
leukaemia, heavy chain disease, and amyloidosis) or when investigating for the very 
rare causes of immune deficiency [22]. Depending on the condition (e.g. myeloma), 
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serum immunoglobulin tests may also be ordered periodically to monitor disease 
progression [22]. In the UK, one of the largest increases in GP test use between 2005 
and 2009 were for serum immunoglobulins with a relative increase of 73.4%, from 61 
tests per GP in 2005 to 106 tests per GP in 2009) [11]. 
Immunoglobulins are particularly problematic in primary care [114]. High levels are 
a feature of many clinical conditions in older patients, but their greatest diagnostic 
value is in specific haematological disorders such as myeloma and lymphoma. 
Unfortunately, clinical features of these disorders can be vague and non-specific and 
overlap with the symptoms of a wide range of other conditions. Thus, in older patients, 
immunoglobulin testing is probably best undertaken as a second-line investigation 
where there are other tests (such as a full blood count) which indicate the possibility 
of a blood dyscrasia. Knowing when to order immunoglobulins can be challenging for 
GPs and may require a clinical judgement in the context of non-specific clinical 
features. Interpretation of test results is also difficult and often requires specialist input 
[114]. In particular, the rarity of the conditions that immunoglobulins are aimed at 
suggests that factors such as GP gender, medical experience and practice setting or 
number of GPs at a practice are all likely to be important drivers of using this test 
[114]. To date, no research has been carried out on physician and practice-level 
predictors of serum immunoglobulin testing. 
The aim of this study was to identify the relationship between physician and practice 
characteristics and the volume of serum immunoglobulins requested among GPs in 
the South of Ireland, adjusting for the size and composition of GP public patient lists. 
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5.3 Methods 
5.3.1 Study design and population 
We conducted a cross-sectional study using one year (2013) of routine laboratory data 
to analyse the determinants of serum immunoglobulin test requests. The study was 
conducted in two adjacent counties (Cork and Kerry) in the South of Ireland which 
has a combined population of 664,534. All serum immunoglobulin analyses for these 
counties are processed at Cork University Hospital (CUH) and all GP test requests for 
the region are captured in our study. 
5.3.2 Dependent variable 
The dependent variable was the 2013 count of immunoglobulin test requests per GP.  
5.3.3 Predictor variables 
At the physician-level, we collected data on the following predictors of test ordering, 
the GPs’ gender and their medical experience (years since graduation). The number of 
years since the GP graduated with their medical degree was used as a proxy for the 
GPs clinical experience as per previous research [112, 115, 116].  
Practice-level predictors were practice setting (urban, rural) and the type of practice 
(single-handed, 2-4 GPs or >4 GPs). Rural is defined according to Irish census data as 
areas with no population centre above 1,500 people, with a population density below 
150 per square km, and which are not part of an urban district [117]. The number of 
GPs practising at a given practice was used to describe the practice type as per previous 
research [113].  
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Information about the number of publically funded patients cared for by each GP was 
also included in the model (Appendix 8). This was used as a proxy for clinician 
workload and was used to make the request volumes of different GPs comparable. We 
also included the age and gender composition of publically funded patient lists in our 
model as the conditions associated with serum immunoglobulins are more common in 
older and male patients [118].  
5.3.4 Data collection and cleaning 
Immunoglobulin test order counts and data about GPs and their practices were 
extracted for 2013, using Cognos Impromptu software to interrogate the hospital’s 
APEX laboratory system. The data fields requested were: request date, specimen 
number, test code, patient age, and gender, requesting GP, the location of test request, 
GP gender, surgery name, and address. The extracted data were exported from Cognos 
using Excel and imported into Stata v12 for analysis.  
Data on GP list size and the gender and age composition of these lists were obtained 
from the Health Service Executive Primary Care Reimbursement Scheme (HSE-
PSRC). In Ireland, patients under a certain income level are entitled to free health care 
through the General Medical Services (GMS) scheme. Those participating in this 
scheme are reimbursed by the HSE-PCRS for a range of services they provide to these 
patients. Information held in the HSE-PCRS database is retrievable at individual 
patient level using the GPs unique Medical Council record number. This number was 
used to merge HSE-PCRS data with the immunoglobulin laboratory data extracted at 
CUH. In 2013, 498 GPs were contracted to the GMS in the Cork-Kerry region and 
were registered to receive reimbursement for providing services to 265,000 eligible 
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GMS patients [119]. Of these patients, 54,988 were over the age of 70, representing 
approximately 97% of all the over 70s who live in Cork and Kerry [119]. 
Data on each GP’s medical experience was obtained from the Medical Council, the 
statutory, regulatory and registration body for doctors in Ireland. Medical experience 
was defined as years since GPs qualified with their medical degree and was coded to 
"<10 years", "10-20 years" and ">20 years" as per previous research [112].  
5.3.5 Data analysis 
Mixed effects multilevel regression models were used to calculate incidence rate ratios 
(IRRs) with 95% confidence intervals (CI) for the associations between GP and 
practice characteristics and requesting patterns for serum immunoglobulins. 
Multilevel analyses were used to take into account the structure of the data: physicians 
were nested within practices. The model, therefore, consists of two levels: the 
physician level (level 1) and the practice level (level 2). The outcome (test requests) 
was modelled as a count variable with a conditional Poisson distribution [120]. 
Calculating variance estimates from random effects Poisson regressions rather than 
directly from the observed rates is a more statistically rigorous approach, which 
appropriately adjusts for lack of independence in requesting rates for GP in the same 
practice. Estimated regression coefficients were expressed as IRRs with 95% 
confidence intervals (CI).  
To analyse the extent to which the final model was sensitive to the impact of not 
including non-GMS patients in the study a sub-analysis was performed by limiting the 
model to include the over 70s category only. Data were analysed using Stata v12. 
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5.4 Results 
5.4.1 Sample characteristics 
In total, 481 primary care physicians requested 5,990 serum immunoglobulins during 
2013. This represents 96.6% of all GPs registered in the GMS scheme in the Cork-
Kerry region in 2013. The remaining GPs may not have requested any 
immunoglobulins or were not active at the time. Table 5.1 provides the GP requesting 
patterns by physician and practice characteristics (both crude and adjusted for their 
standardised patient list sizes). 
Table 5.1 GP requesting patterns (2013) by physician and practice characteristics 
(crude and adjusted for patient list sizes) 
                                         Total 
GPs 
Total IG 
counts 
Mean per  
GP1(crude) 
Standard 
deviation 
Mean per  
1,000 GMS 
patients2 
Totals N=481 N=5,990 12.5 27.5 43.9 
Physician level       
GP Gender       
  Males 230 3,206 13.0 28.6 35.5 
  Females 251 2,784 12.1 26.6 60.9 
Experience       
   <10 years 68 519 7.6 9.2 49.5 
   10-20 years 125 1,108 9.1 10.1 36.9 
   >20 years 266 4,132 15.6 35.2 45.8 
List size       
   <500  299 3,649 8.9 19.9 44.0 
   500-1,000  
   >1,000  
166 
16 
1,875 
466 
31.7 
51.7 
50.4 
34.1 
43.7 
44.2 
Practice level      
Location      
   Urban 316 3,858 12.3 24.9 44.7 
   Rural 165 2,132 13.0 32.1 42.3 
Practice type      
   > 4 GPs 201 2,239 11.3 28.9 43.9 
   2-4 GPs 178 2,278 12.8 18.2 41.9 
   Single-handed 98 1,435 14.9 37.7 47.9 
 1   Mean volume of immunoglobulin requests per GP per year 
2   Standardised for GP GMS list sizes and composition (patient age and gender adjusted) – GMS patients   
   are public patients receiving free GP care 
       IG: immunoglobulins 
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5.4.2 Overview of GP requesting patterns 
The crude mean count of test requests per GP for 2013 was 12.5 (SD: 25.5; range 1 to 
377). The mean number of test orders was 43.9 per 1,000 public patients. Allowing 
for GP public list size had the greatest impact on requesting patterns by gender of the 
GP. Crude count data indicate female GPs requested fewer immunoglobulin tests 
(mean: 12.1) compared to male GPs (mean: 13.0). However, when we adjust for GP 
public patient list size and demographics, female GP test ordering rates are higher than 
males (60.9/1,000 patients versus 35.5/1,000 patients, respectively). Similarly, crude 
count data alone indicate the GPs with less than ten years' experience (mean: 7.6) order 
fewer tests than those with 10-20 years (mean: 9.1) or those with over 20 years' 
experience (mean: 15.6). GPs with less than ten years' experience had fewer patients, 
and when GMS list sizes and demographics were adjusted for, they had higher test 
ordering rates (49.5/1,000 patients). Figure 5.1 illustrates the total volume of requests 
per GP during 2013. In total, four GPs were outliers, requesting over 100 serum 
immunoglobulin tests per year.  
Figure 5.1 Total serum immunoglobulin requests per GP in Cork-Kerry region, 2013 
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Figure 5.2 Distribution of GP immunoglobulion test ordering in the Cork-Kerry 
region, 2013 
 
 
Figure 5.2 illustrates the distribution of GP test ordering among the sample, excluding 
the four outliers highlighted in figure 5.1. The obsesrved data are asymmetric (skewed 
right). 
5.4.3 Requesting patterns by patient age and gender 
In total, 30% (n=1,809) of immunoglobulin tests were requested for patients in the 
over 70 category, 25% (n=1,490) for patients in the 60-70 age category, 23% 
(n=1,377) for 45-60 age category, 16% (n=929) for 30-45 and 6% (n=385) for those 
in the under 30 age category. 61% (n=3,675) of test requests were for female patients. 
5.4.4 Physician/practice characteristics and test ordering 
Table 5.2 provides the results of the mixed-effects multilevel Poisson regression 
analysis. In model one (adjusted for GP gender and medical experience) all of the 
physician factors were associated with immunoglobulin requesting rates. Model two 
(adjusted for the physician factors plus practice location and practice type) also found 
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all of the physician factors to be associated with GP requesting rates for 
immunoglobulins. In particular, GP gender and medical experience were positively 
associated with immunoglobulin test ordering rates. Female GP requesting rates were 
81% greater than male GPs (IRR: 1.81; 95% CI: 1.45-2.26, p<0.001). GPs with less 
than ten years’ medical experience were also more likely to request immunoglobulin 
tests (IRR: 2.72; 95% CI: 1.47-3.51, p<0.001). 
There were no statistically significant associations between the practice-level factors 
(location or practice type) and GP immunoglobulin test ordering rates. 
Table 5.2 Physician and patient-level factors associated with GP immunoglobulin 
test ordering patterns, 2013 
 MODEL 1 (physician only) MODEL 2 (physician + practice) 
Variables* IRR1 (95% CI) p-value2 IRR1 (95% CI) p-value2 
Physician level        
GP gender 
  Female 
  Male 
 
1.80 
1 
 
(1.45-2.34) 
 
<0.001 
 
 
 
 
1.81 
1 
 
 
 
(1.45-2.26) 
 
<0.001 
 
Experience  
   <10 years 
   10-20 years 
   >20 years 
 
2.12 
1.09 
1 
 
(1.39-3.23) 
(0.86-1.39) 
0.003  
2.27 
1.17 
1 
 
(1.47-3.51) 
(0.80-1.42) 
 
0.001 
 
Practice level        
Location 
   Rural 
   Urban 
    
0.88 
1 
 
(0.70-1.10) 
0.26 
Practice type 
   >4 GPs 
   2-4 GPs 
   Single handed 
    
1.17 
1.07 
1 
 
 
(0.88-1.56) 
(0.80-1.42) 
0.52 
 
 
*Final fully adjusted model  1Cluster grouping: primary care practices, Groups: 214 2p-values based on likelihood 
test ratio 
 
 
 
 
5.4.5 Sensitivity analysis 
Table 5.3 presents the results of the sensitivity analysis on the over 70 age category 
(fully adjusted model). Results were similar to that of the full model including all 
patient age groups. The strongest difference was among females, where the strength 
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of the association was greater in the subgroup analysis compared with the full dataset. 
Based on the fully adjusted model, female GPs requested over twice as many tests 
compared to males (IRR: 2.37; 95% CI: 1.76-3.18). Experience also remained strongly 
associated with test ordering among patients over 70. Those with less than ten years’ 
experience were more than twice as likely to order a test compared to those with more 
than 20 years’ experience (IRR: 2.55; 95% CI: 1.43-4.52). 
Table 5.3 Physician and patient-level factors associated with GP  
Immunoglobulin test ordering patterns (70 age category), 2013 
 MODEL 2 (physician + practice) 
Variables* IRR1 (95% CI) p-value2 
Physician level     
GP gender 
  Female 
  Male 
 
2.37 
1 
 
 
 
(1.76-3.18) 
 
<0.001 
 
 
 
 
 
Experience 
   <10 years 
   10-20 years 
   >20 years 
 
2.55 
1.34 
1 
 
(1.43-4.52) 
(0.97-1.86) 
 
<0.001 
 
 
Practice level    
Location 
   Rural 
   Urban 
 
0.81 
1 
 
(0.60-1.10) 
0.17 
Practice type 
   >4 GPs 
   2-4 GPs 
   Single handed 
 
1.37 
1.07 
1 
 
 
(0.93-2.00) 
(0.73-1.58) 
0.18 
*Final fully adjusted model  1Cluster grouping: primary care practices 2p-values based on 
likelihood test ratio 
 
 
       
 
 
 
5.5 Discussion 
5.5.1 Summary of main findings 
This study evaluated the relationship between certain physician and practice 
characteristics and the use of serum immunoglobulin tests over one year. The strongest 
predictors of test requests were physicians’ gender and medical experience (years 
since graduating with a medical degree). No associations were found between 
practice-level factors and immunoglobulin test ordering rates.  
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5.5.2 Strengths and limitations 
Unique strengths of this study are the inclusion of all GP requests for immunoglobulin 
tests in two large adjacent regions with a population in excess of 650,000, the use of 
patient list size and composition to allow for the fair comparison of different GPs and 
the use of multilevel modelling to separate GP and practice effects. An important 
limitation of our study is the use of HSE-PCRS data to characterise GP list size and 
composition. This data excludes private patients for which no accurate data is available 
in Ireland. Private patients account for approximately 66% of the average GPs list in 
Ireland [121]. However, a sensitivity analysis which included only patients over 70 
years old, 97% of whom are covered by the GMS scheme, found the same physician 
factors to be associated with immunoglobulin test ordering rates. A further limitation 
is our exclusion of other predictor variables which may influence test requesting 
patterns such as the presence of an electronic ordering system in the practice [122]. 
5.5.3 Comparison with existing literature 
Physicians’ gender. This study showed that being a female GP was associated with 
higher serum immunoglobulin test ordering rates. This is consistent with previous 
studies examining the characteristics of GPs and test ordering behaviour [111, 123]. 
With the proportion of female physicians rising in most European countries [124], is 
important to investigate why females may be ordering more tests than their male 
counterparts. Previous research suggests that higher test ordering rates of female GPs 
may relate to differences in practice styles [125]. In Ireland, a recent national survey 
reported that female GPs see fewer patients on average per session than males [126]. 
The same report found less female GPs practice full-time, compared to males (70% 
versus 100% in the under 40 age group) and also retire at a younger age [126]. It is 
87 
 
possible that the experience of part-time GPs with certain low-volume tests falls below 
a critical threshold which leads them to excessive ordering.  
Medical experience. GPs with less than ten years' experience were significantly higher 
requesters in this study. Previous research also found a statistically significant inverse 
association between years of experience and test ordering [112]. Further, in a previous 
qualitative study with GPs from this sample, it was suggested that younger GPs may 
be more likely to request serum immunoglobulins [114]. Potential reasons for this 
include a lack of confidence in their clinical judgement at this stage of their career and 
a fear of missing serious cancers such as myeloma [114].  
Practice location and type. This study found no significant association between 
practice location (urban/rural), practice type (single-handed, 2-4, or 4 or more GPs) 
and GP test ordering patterns. This is in contrast with previous research reporting 18% 
fewer tests among GPs in group practices compared to those in single handed or two-
person practices [113]. Working in an urban practice rather than a rural practice has 
also previously been linked to higher test ordering patterns [111]. It is possible that 
the practice level effects seen in previous studies were driven by physician level effects 
such as the gender and experience of GPs: these effects have been accounted for in 
our study. For example, it is possible that the excessive test ordering rates by urban 
practices was driven by the tendency for younger or less experienced GPs to work in 
these settings [126].  
5.5.4 Implications for research and/or practice 
Our research suggests that education programmes about the nature and uses of serum 
immunoglobulins, targeted at female GPs and those with less experience, may be 
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required. However, we recommend that further qualitative research is performed first 
to explore why female GPs and less experienced GPs order greater volumes of serum 
immunoglobulins. It must be emphasised that our study was not designed to detect 
inappropriate test ordering. It is possible that female GPs and those with less medical 
experience are behaving with an appropriate level of caution. The consequences of 
finding (or missing) pathology are very significant for the doctor and patient. Further 
study of the clinical utility of serum immunoglobulin test orders is required and 
currently ongoing in our study region. 
5.6 Ethical approval 
Ethical approval was granted by the clinical research ethics committee of the Cork 
University Teaching Hospitals (ref: ECM (ii) 07/01/14). 
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6.1 Abstract 
Background   
Implementation science experts recommend the use of tailored and theory-driven 
behaviour change interventions when targeting health care professionals. It has also 
been suggested that interventions designed with the involvement of those for whom it 
is intended, may be more effective. This study protocol describes the development of 
intervention material and details of the implementation plan for a strategy targeting 
the use of serum immunoglobulin tests in primary care. 
Methods/Design 
Segmented Poisson regression analysis of interrupted time series data (SRAITSD) will 
be performed to determine the impact of the intervention, both immediately (change 
in level) as well as over time (change in trend). The dataset will include routine 
laboratory data on all GP immunoglobulin requests between January 2012 and July 
2016. Data will be arranged into fortnightly time segments (providing 96-time points 
pre- and 20 post-intervention) and analysed using Stata v12. The study results will be 
presented as incidence rate ratios (IRRs) with their corresponding 95% confidence 
intervals along with parameter coefficients and standard errors.  
Discussion 
This intervention strategy will respond to the specific needs of GPs identified using 
semi-structured interviews, which have been previously discussed in this thesis 
(Chapter 4). This will be combined with evidence from a systematic review of 
interventions that have previously worked (Chapter 1). Intervention components for 
this strategy were selected using a combination of behaviour change theories to 
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identify the ‘mechanisms for change’ and the intervention functions that are important 
for optimising immunoglobulin test ordering in primary care. This protocol describes 
how this information has been used to develop intervention material and devise an 
implementation plan. It also presents details of the proposed statistical analysis 
methods. 
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6.2 Background   
Healthcare budgets face increasing pressure to reduce costs and remove inefficiencies 
while maintaining quality and safety. Laboratory testing plays an important role in 
healthcare expenditure [34]. An estimated €76 million is spent on laboratory services 
each year, accounting for 3-4% of the national health budget [20]. Despite this 
relatively small proportion of healthcare budget expenditure, laboratory testing often 
underpins more costly downstream care such as outpatient visits and radiology 
requests [127]. 
Many approaches for reducing unnecessary test ordering in primary care have been 
attempted [88], including changing order forms [54], cost displays [128] and various 
methods of disseminating guidelines [48, 50, 77]. We conducted a systematic review 
aimed at identifying and evaluating existing interventions for improving the use of 
laboratory tests among primary care physicians [88]. While included studies differed 
considerably in relation to the tests they assessed, some key findings were highlighted. 
Our review found that education-based interventions were successful at improving GP 
laboratory testing patterns [47, 49, 77], in particular, when used to deliver clinical 
guidelines [48]. Similar primary care activities have also shown positive effects of 
educational reminder-based interventions [58]. For example, the addition of 
educational messages to X-ray reports have been found to be effective for reducing 
radiography requests among primary care physicians [58], which also appeared to be 
sustainable in the long term [129].  
Research suggests that interventions tailored to address identified barriers and enablers 
to change, were more effective when targeting healthcare professionals’ behaviour 
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[91]. However, few studies explain how they choose a particular combination of 
interventions [72]. Intervention components for our study were identified using a 
combination of previously explained behaviour change theories to target the key 
barriers and enablers for changing immunoglobulin test ordering behaviour in primary 
care (Chapter 4). This protocol describes how this information has been used to 
develop and implement intervention material. 
6.2.1 Aims and objectives 
The aims of this study are to  
1.  Implement an education-based strategy among GPs in the South of Ireland.  
2. Evaluate the effectiveness of this strategy using a quasi-experimental segmented 
regression of an interrupted time series design.  
Specifically, the following research question will be addressed:  
Does the addition of automated interpretive educational messages to 
laboratory results, combined with a guideline algorithm alter GP use of 
immunoglobulin tests? 
6.3 Methods 
6.3.1 Study sample 
The sample will include all GP requests for serum immunoglobulin tests in the Cork-
Kerry region. Routine laboratory data will be extracted on all test orders between 
January 2012 and July 2016.  
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6.3.2 Ethical approval 
Ethical approval for the study was obtained from the Cork Research Ethics Committee 
(ref: ECM (ii) 07/01/14) which can be found in Appendix 2. 
6.3.3 Intervention development 
The intervention strategy was designed based on the combined findings of our 
systematic review (Chapter 3) [88] and theoretical paper (Chapter 4) [114] previously 
discussed. The latter identified six BCTs and four corresponding intervention 
functions for designing an education-based strategy to improve immunoglobulin test 
use in primary care [95]. These intervention functions include education, enablement, 
persuasion and environmental restructuring. Definitions of each can be found in Table 
6.1. 
Table 6.1 Definitions of intervention functions [94] and selected intervention 
component 
Function Definition Intervention component 
Education Increasing knowledge or 
understanding 
• Provide guidelines on when to 
request the test and how to 
manage abnormal results 
using an algorithm design. 
Persuasion Using communication to 
induce positive or negative 
feelings or stimulate action 
• Provide guidance on how to 
manage patients with 
abnormal immunoglobulin test 
results. 
Environmental 
restructuring 
Changing the physical or 
social context 
• Provide automated 
interpretive comments to test 
reports. 
Enablement Increasing means/reducing 
barriers to increase 
capability or opportunity 
• Provide details on how to 
interpret test results. 
 
95 
 
6.3.4 Description of the intervention content 
The intervention consists of two components targeting test requesting behaviour issues 
raised by primary care physicians in our qualitative interviews (Chapter 4): a lack of 
knowledge about when to request the test, how to manage patients with abnormal 
results and uncertainty around how to interpret test results.  
Algorithm guideline 
The first component of the intervention targets the problem of when to request an 
immunoglobulin test and how to manage a patient with a raised (abnormal) 
immunoglobulin result. To do so, a one-page algorithm was designed based on current 
UK guidelines and can be found in Appendix 9 [29]. This provides information on 
when to request an immunoglobulin test, as well as the steps for managing patients 
who have raised immunoglobulins. The algorithm assists GP decision making on 
requesting further tests or when to refer a patient to see a consultant haematologist. 
Interpretive messages 
The second component of the intervention targets the issue of interpreting the test 
results. Educational messages providing interpretative comments will be added to the 
end of test results. In total, eight educational messages have been developed based on 
Myeloma guidelines and specialist input from consultant haematologists’ and 
laboratory scientists [29]. Primary care test ordering motivations differ from that of 
secondary care specialists. To ensure GP responsiveness, the interpretive comments 
were reviewed and edited by a Professor of General Practice. These messages will 
provide guidance on how to interpret the test results, both in terms of possible 
diagnoses and future patient management decisions. The eight messages will be built 
into the laboratory IT system and added to test results electronically based on ‘action 
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cues’.  For example, “diffusely raised IgG” prompts the automated addition of the 
following interpretive message “Pattern of persistent infection or inflammation”. A 
table outlining each of the educational messages and their corresponding ‘action cues’ 
can be found in Appendix 10.   
Table 6.2 highlights how both components of the intervention align with the four 
intervention functions identified in the theoretical design paper.  
Table 6.2 Details of the intervention component selected based on corresponding 
BCTs and functions 
 
Strategy component 
    Intervention content 
BCTs1 Functions1 
The guideline algorithm 
Provides details on when to request 
and how to interpret results 
 
Instructions on how to 
perform behaviour 
 
Education 
 
Clearly communicates situations 
where immunoglobulin testing is not 
beneficial (i.e. screening)  
 
Designed by consultant 
haematologists using UK guidelines 
and revised by a primary care 
representative to ensure GP 
responsiveness 
Information about health 
consequences 
 
 
Credible source 
Persuasion 
 
 
Persuasion 
Educational messages 
Provides interpretive comments 
detailing consultant advice on the test 
results 
 
 
Restructuring the 
physical environment 
 
 
Environmental 
restructure 
 
Provides details on possible diagnoses 
 
Attached to the test results 
Prompts/cues 
 
Adding objects to the 
environment 
Enablement 
 
Enablement 
1 Identified in theoretical paper previously described (Chapter 4) 
6.3.5 Implementation and evaluation plan 
The intervention study will include a two-phase process (Figure 6.1). The first phase 
(implementation phase) will involve programming the interpretive educational 
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messages into the hospital's laboratory system, along with the corresponding ‘action 
cues’ for each message. These will be tested for errors using hypothetical patients for 
a number of weeks prior to the intervention going live. This phase will also involve 
sending a copy of guideline algorithm to all GPs in the region.  
Once the intervention has been implemented, phase two will involve evaluating the 
effect on GP test ordering patterns after a nine-month time-period. 
Figure 6.1 Two-phase process for implementing and evaluating the combined 
guideline and educational reminders intervention  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intervention tools 
• A one-page guideline algorithm 
detailing when to request the 
test and how to manage patients 
(Appendix 9) 
 
• Eight educational messages 
interpreting test results 
(Appendix 10) 
 
 
Phase One 
Implementation of the 
intervention 
• The educational messages will 
be programmed into the 
laboratory system with 
electronic cues for action. 
 
• The messages will be tested 
using hypothetical patients’ 
before going live.  
 
• Guideline will be posted in hard 
copy format to all GPs. 
Phase Two 
Evaluation of the intervention – 
Interrupted time series (ITS) 
design 
• To assess the impact of the 
intervention on GP ordering 
immunoglobulin tests. 
 
• ITS – multiple assessments of 
GP immunoglobulin test orders.  
Data collection 
• Baseline phase (fortnightly test 
ordering data for 3 years prior to 
intervention)  
• Intervention phase (9 months) 
Data points 
• 106 data points – 96 before and 
20 data points after the 
introduction of the intervention 
Data analysis 
• ITS analysis with a segmented 
Poison regression models will be 
performed using Stata v12 
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6.3.6 Study design  
The combined guidelines and educational messages intervention will be evaluated 
using a quasi-experimental ITS design. These designs include a range of non-
randomised intervention studies, and are frequently used when it is not logistically 
feasible to conduct a randomised controlled trial (RCT). For example, medical 
informatics interventions are often difficult to randomise to individual healthcare 
providers. This is the case with our education messages strategy – the laboratory IT 
system does not facilitate the automated provision of educational messages to 
individual primary care practices.  
 
A stepped-wedge trial is an alternative study design used in cases where individual 
level randomisation is not possible. In particular, it has been recommended as a 
potentially efficient and pragmatic alternative randomised study design for the 
evaluation of service delivery interventions where outcomes are based on routinely 
collected data [130]. However, they are time consuming with a long follow-up period 
required.  Moreover, efficiency depends on the intra-cluster correlation and cluster 
size. Finally, it is unlikely that GP practices will be able to follow the randomisation 
schedule [131].  
 
Research has found that quasi-experimental designs are strong alternatives to RCTs 
and stepped wedge designs [132]. Three quasi-experimental designs exist, which 
include latin squares, factorial and time series designs [133]. An interrupted time series 
design using segmented regression models was deemed most appropriate [132]. The 
additional time and resources required for the alternative study designs were not 
available whereas, the resource for a time series analysis was readily available.  For 
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example, in latin square designs there are many experimental groups; each receives 
multiple treatments, in different sequences [133]. Similarly, in factorial designs there 
are many experimental groups; each gets a combination of treatments [132]. By 
contrast, in time series designs there is one group and one or more treatments; many 
observations over time [132]. In particular, this design can address secular trends 
including a change in the outcome over time, history such as a seasonal trend for times 
where requesting may be higher irrespective of the intervention; and random 
fluctuations with no discernible patterns [131].  
 
Finally, access to high-quality routine laboratory data pertaining to all GP test orders 
along with the centralisation of laboratory services in the studied region, provides the 
necessary resources for implementing a region-wide strategy involving 100% of the 
target population. Our study design was developed in accordance with the quality 
criteria for ITS studies adapted by Ramsay and colleagues [131], which can be found 
in Appendix 11. 
6.3.7 Sample size calculations 
In ITS studies, sample size calculations are related to the estimation of the number of 
observations or time points at which data will be collected. A sufficient number of 
time points before and after the intervention is needed to conduct segmented 
regression analysis [131]. A general recommendation is for 12 data points before and 
12 data points after the intervention [131], although this number is not based on 
estimates of power. There also need to be a sufficient number of observations (a 
minimum of 100 is desirable) at each fortnight segment to achieve an acceptable level 
of variability of the estimate at each time point [131]. Having at least 48 fortnightly 
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time-points pre-intervention permits an adequate evaluation of seasonal variation and 
other trends in the pre-intervention data [131]. Our ITS will include 96 data points 
before the introduction of the intervention (three years of data in two-week segments) 
and 20 data points after the introduction of the intervention (nine months of data in 
two-week segments). 
6.3.8 Data analysis plan 
Segmented Poisson regression analysis of interrupted time series data (SRAITSD) will 
be used to determine the impact of the intervention (Figure 6.2), both immediately 
(change in level) as well as over time (change in trend). SRAITSD is an excellent 
analysis method for pragmatic studies because it minimises threats to internal validity 
while maximising external validity [131]. The analysis will be performed using Stata 
v12. The full segmented regression model will include the intercept (β0), baseline 
trend (β1), change in level (β2) and the change in trend after the introduction of the 
intervention (β3). The following model will be applied to estimate the effect of the 
intervention: 
Yt  = β0 + β1T + β2Xt + β3TXt. 
 
Where β0 represents the baseline level at T=0, β1 is interpreted as the change in 
outcome associated with a unit time increase (i.e. represents underlying pre-
intervention trend), β2 is the level change following the intervention and β3 indicates 
the slope change following the intervention (using interaction term for time and 
intervention: TXt.). The analysis will estimate the effect of the intervention while 
taking account of time trends, seasonal effects and autocorrelation among the 
observations. Results of the individual, full and most parsimonious models will be 
presented.  
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Figure 6.2: ITS study design with changes in level and trend (slope) 
 
 
 
 
 
 
 
 
 
 
 
6.4 Potential limitations and methodological issues 
Our proposed study has some potential limitations. The ITS design is susceptible to 
several potential threats to internal validity. However, we designed our methodology 
according to the ITS quality criteria recommended by Ramsay et al. [132] (Appendix 
11) and the Strengthening the Reporting of Observational Studies in Epidemiology 
statement [134] (Appendix 12) to help overcome these threats.  
The first potential limitation is changes in clinical practice independent of the 
introduction of the intervention may occur from the influence of other system changes 
or activities during the study period. For healthcare professionals and physicians, in 
particular, these include continuing professional development activities (e.g., 
participation in continued medical education (CME) activities such as didactic 
lectures, small-group workshops, and attendance at conferences).  However, CUH is 
the only centre providing specialist haematological services for the region and other 
education strategies pertaining to serum immunoglobulin test use are unlikely. 
Volume of tests 
 
Time 
 
 Intervention  
introduced 
Change in level 
Slope pre 
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A second limitation is many laboratory tests have a seasonal pattern due to the nature 
of the condition for which the test is requested. Seasonality can cause autocorrelation 
and overdispersion. We will assess the data for seasonality using Fourier terms (pairs 
of sine and cosine functions) [135]. Long-term patterns can be modelled more 
smoothly by fitting Fourier terms in the Poisson model. These are pairs of sine and 
cosine functions of time with an underlying period reflecting the full seasonal cycle 
(i.e. calendar year) and are particularly suited to capturing very regular seasonal 
patterns. A single sine/cosine pair will model seasonal variation in the outcome as a 
regular wave with a single peak and trough per calendar year (the position of the peak 
and trough are guided by the data). We will use extra sine/cosine pairs with shorter 
wavelengths which result in more flexible functions. Extreme values known as wild 
data points will also be dealt with by assessing the data plot for any outliers and follow 
recommended methods for handling such data [77]. 
6.5 Conclusion 
This protocol has outlined the development of intervention material incorporating 
previously identified theoretical content (Chapter 4). The intervention will be rolled 
out in October 2015 in accordance with the described protocol. The effect of the 
intervention will be assessed using nine-months of post-intervention laboratory data 
following the methods described.  
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7.1 Abstract 
Background Implementation science experts recommend that theory-based 
strategies, developed in collaboration with healthcare professionals, have a greater 
chance of success. In this study, the impact of a theory-based strategy for optimising 
the use of serum immunoglobulin testing in primary care is evaluated. 
Methods We devised an intervention comprising of a combined guideline and 
educational messages based strategy, targeting previously identified general 
practitioner issues relevant to testing for serum immunoglobulins in the South of 
Ireland. The intervention was evaluated using an interrupted time series with 
segmented Poisson regression models using routine laboratory data from January 
2012- July 2016. The data was organised into fortnightly segments (96-time points 
pre- and 20 post-intervention) and analysed using incidence rate ratios with their 
corresponding 95% confidence intervals along with parameter coefficients and 
standard errors.  
Results In the full segmented regression model (including both change in level and 
change in slope pre- and post-intervention), the change in trend before and after the 
introduction of the intervention was statistically significant. The intervention was 
associated with a 1.5% percent reduction in the slope per fortnight (-1.51; 95% CI: -
1.16, -1.86, p<0.001).  
Conclusion Our tailored guideline combined with educational messages reduced 
serum immunoglobulin test ordering in primary care. Given the rarity of the conditions 
for which the test is utilised and the fact that we only have population (and not 
106 
 
individual patient level) data, further investigation is required to examine the clinical 
effects of this change in test ordering patterns. 
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7.1 Background 
Healthcare budgets worldwide face increasing pressure to reduce costs and remove 
inefficiencies, while maintaining quality and safety. Laboratory testing is a major 
component of healthcare budgets, and demand for laboratory testing is increasing 
faster than other medical activity [34]. There are many reasons for this rise, including 
the availability of new tests [33] and clinical practice guidelines advising earlier 
screening to detect occult disease [5]. Given the increasing financial pressure on health 
systems, judicious laboratory testing is imperative. However, evidence suggests that 
many laboratory tests are ordered unnecessarily [4, 5]. As well as the cost implications, 
this can lead to harmful downstream effects such as further follow-up testing, 
specialist referrals and invasive diagnostic procedures [3, 14]. 
Serum immunoglobulins are a group of tests that pose particular challenges for 
primary care physicians. The test is primarily used to help with the diagnosis of 
haematological disorders such as myeloma and lymphoma. These disorders are rare, 
and their symptoms can be vague, non-specific and overlap with a wide range of other 
conditions [29]. Thus, immunoglobulin testing is probably best undertaken as a 
second-line investigation where there are other tests, such as a full blood count or 
radiological abnormalities, which indicate the possibility of a haematological disorder. 
Deciding when to request immunoglobulins can be challenging for primary care 
physicians and requires clinical judgement in the context of non-specific clinical 
features [114]. In the UK, one of the largest increases in primary care test use between 
2005 and 2009 was for serum immunoglobulins with a relative increase of 73.4%, 
from 61 to 106 tests per physician per year [11]. There has been no contemporaneous 
increase in the incidence of blood dyscrasias that might explain this rise [118]. This 
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suggests that there is potential to improve the use serum immunoglobulin tests in 
primary care. 
Our recent systematic review found that educational strategies, feedback and changing 
test order forms may improve the efficient use of laboratory tests in primary care [88]. 
In a related study, we used interviews with primary care physicians to explore different 
options for improving the use of serum immunoglobulins [114]. The interviewees 
expressed a lack of confidence in their ability to use the tests and were concerned about 
factors that could lead them to overuse the test in some circumstances (e.g. fear of 
litigation) and underuse them in others (e.g. the extra workload associated with liaising 
with haematology specialists). The study also found that interventions focused on 
education (increasing knowledge or understanding - what to do and why), enablement 
(increasing means/reducing barriers to increase capability or opportunity), persuasion 
(using communication to induce positive or negative feelings or stimulate action) and 
environmental restructuring (changing the physical or social context) were most likely 
to help the interviewees successfully change their ordering behaviours [88, 114].  
Prior qualitative research by us was used to develop a theory-based intervention to 
improve the use of serum immunoglobulins by General Practitioners (GPs) [114]. 
Theory-based interventions utilise a combination of behaviour change models to select 
and design an intervention strategy [32]. The mechanisms for changing test ordering 
(barriers and enablers) were identified using the theoretical domains framework (TDF) 
and corresponding capability, opportunity and motivation conditions of the ‘behaviour 
change wheel’ known as the COM-B model [95]. Intervention content was then 
specified in terms of component behaviour change techniques (BCTs) [114].  
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These BCTs are based upon the four intervention functions identified in our qualitative 
research [95]. The intervention provides guidelines on when to request the test 
(education/enablement). It also clearly communicates situations where testing is 
beneficial for patient care (education) and how to manage patients with abnormal test 
results (enablement/persuasion). Finally, it provides details on how to interpret results 
(education/enablement) by attaching comments to test reports (environmental 
restructuring).   
In this study, we use laboratory data and an interrupted time series (ITS) design to 
determine the impact of this intervention on serum immunoglobulin ordering rates. 
7.2 Methods 
7.2.1 Study sample and setting 
Participants were all GPs located in the Cork-Kerry region of the Republic of Ireland. 
The region has a combined population of 664,534 and all serum immunoglobulin tests 
for the population are performed at one laboratory, located in Cork University Hospital 
(CUH). 
7.2.2 Study design 
The combined guideline and educational messages intervention was evaluated using a 
quasi-experimental ITS design and complies with the quality criteria for ITS studies 
adapted by Ramsay and colleagues (Appendix 11)[132].  
7.2.3 Ethical approval 
Ethical approval for the study was obtained from the Cork Research Ethics Committee 
(ref: ECM (ii) 07/01/14). 
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7.2.4 Description of the intervention 
The first component of the intervention targets when to request an immunoglobulin 
test and how to further evaluate a patient with an abnormal finding. This involved 
creating a one-page guideline algorithm designed based on current UK guidelines, and 
can be found in Appendix 9 [29]. These guidelines provide information on when to 
request an immunoglobulin test, along with a patient evaluation plan following the test 
request.  
The second element of the intervention assists with the interpretation of test results. 
Eight educational messages were developed by a multidisciplinary team of senior 
laboratory scientists and consultant haematologists based on myeloma guidelines [29] 
and reviewed by a Professor of General Practice to ensure they were appropriate for a 
GP audience (Appendix 10). The brief educational messages provide interpretative 
comments on test results and are added to the test reports sent to the requesting GP. 
These messages are activated using electronic ‘action cues’ which are defined as 
triggers or prompts for an action to be taken [136]. For example, “raised IgM with a 
normal electrophoresis” prompts the addition of the following interpretive message to 
the test results: “Patient has a slightly raised IgM. If anti-mitochondrial antibodies are 
negative, this may be consistent with recent infection, particularly viral. If anti-
mitochondrial antibodies are positive, this may be consistent with primary biliary 
cirrhosis”. Previously, GPs detected a “raised IgM with a normal electrophoresis” 
based on the provided reference ranges for abnormal levels (>2.9g/L). Now, the GP 
receives an interpretive comment added to the test result, which further explains the 
test result and possible cause or diagnosis. This information supports the GP with their 
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patient management plan. The eight ‘action cues’ and their corresponding educational 
messages can be found in Appendix 10. 
7.2.5 Delivery of the intervention 
The intervention strategy was introduced in October 2015. This involved sending a 
one-time hard copy of the guideline to all GPs practising in the Cork-Kerry region. 
GPs were identified using the HSE-GP list of GPs using the laboratory services at 
CUH. The laboratory-based educational messages were programmed into the 
laboratory system at CUH by the chief laboratory scientist. A three phase quality 
testing process (initial assessment, implementation plan and a review of effectiveness) 
was performed by the laboratory before the intervention was implemented using 
hypothetical patients. The messages were activated and embedded in electronic GP 
test reports each time the ‘action cue’ occurred. 
7.2.6 Data collection 
The count of immunoglobulin tests ordered by GPs in the Cork and Kerry region 
between January 2012 and July 2016 was compared before and after the introduction 
of the intervention. This routinely collected data was extracted from the hospital's 
laboratory system using Cognos Impromptu data extraction software and imported 
into Stata v12 for analysis.  
7.2.7 ITS design 
Total immunoglobulin requests were calculated at fortnightly time points. Time was 
rescaled so that the starting fortnightly segment is 1 (17/01/12), with time being 
measured backwards and forward from the date the intervention was introduced 
(20/10/16). This resulted in 96-time points pre- and 20-time points post-intervention. 
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A sufficient number of time points before and after the intervention is needed to 
conduct segmented regression analysis [131]. A general recommendation is for 12 data 
points before and 12 data points after the intervention [131], although this number is 
not based on estimates of power. There also needs to be a sufficient number of 
observations (a minimum of 100 is desirable) at each fortnight segment to achieve an 
acceptable level of variability of the estimate at each time point [131]. Having a greater 
number of time points pre-intervention (at least 48 fortnightly time-points) permits an 
adequate evaluation of seasonal variation and other trends in the pre-intervention data 
[131].   
7.2.8 Statistical analysis 
A segmented regression was used to examine the impact of the intervention, estimating 
the trend in the volume of immunoglobulin test orders before the intervention (January 
2012-October 2015) and the changes in trend following the intervention (October 
2015- July 2016). Segmented regression analysis of ITS data allow us to assess how 
much an intervention changes an outcome of interest, immediately (level change) and 
over time (trend change). When a separate control group is not available, analysis of 
the outcome of interest in the study group does not allow control for other events that 
may have influenced the outcome. However, the level and trend of the pre-intervention 
segment serve as the control for the post-intervention segment in single group time 
series, and still addresses important threats to internal validity and represent a 
methodologically acceptable design for measuring the impact of 
interventions. This technique that has previously been recommended for evaluating 
healthcare-based interventions [132, 137]. The three outcomes in the ITS analysis are 
the change in the count of test orders immediately after the intervention, the difference 
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between pre-intervention and post-intervention slopes (trend change), and the 
estimation of fortnightly average intervention effect after the intervention. 
7.2.8.1 Regression analysis definitions 
Four variables were included in the dataset. T: the time elapsed since the start of the 
observation period (17/01/12) expressed in fortnightly segments; Xt: a dummy 
variable indicating the pre-intervention period (coded 0) and post-intervention period 
(coded 1); TXt: the time elapsed since the intervention and Yt: the outcome at time t. 
The following segmented regression model was used for this analysis:  
Yt  = β0 + β1T + β2Xt + β3TXt. 
Where β0 represents the baseline level at T=0, β1 estimates the change in mean 
fortnightly test orders that occurs with each fortnight before the intervention (i.e. 
represents underlying pre-intervention trend), β2 estimates the level change in the 
mean number of test orders immediately after the intervention, that is from the end of 
the preceding segment; and β3 estimates the change in the trend (slope) in the mean 
fortnightly number of test orders after the intervention, compared to the trend before 
the intervention (using interaction term for time and intervention: TXt). The sum of β1 
and β3  is the post-intervention slope. 
7.2.9 Checking for seasonality and wild data points 
Many laboratory tests have a seasonal pattern due to the nature of the condition for 
which the test is requested. Seasonality can cause autocorrelation and overdispersion. 
We checked for seasonality using Fourier terms (pairs of sine and cosine functions) 
[135]. 
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Long-term patterns can be modelled more smoothly by fitting Fourier terms in the 
Poisson model. These are pairs of sine and cosine functions of time with an underlying 
period reflecting the full seasonal cycle (i.e. calendar year) and are particularly suited 
to capturing very regular seasonal patterns. A single sine/cosine pair will model 
seasonal variation in the outcome as a regular wave with a single peak and trough per 
calendar year (the position of the peak and trough are guided by the data). We used 
harmonics (extra sine/cosine pairs with shorter wavelengths) which result in more 
flexible functions. Extreme values that did not seem to fit in the series, known as wild 
data points were dealt with by assessing the data plot for any outliers and follow 
recommended methods for handling such data [77]. 
7.3 Results 
In total, 17,239 tests were requested in the pre-intervention period (January 2012-
October 2015) and 3,627 tests in the post-intervention period (October 2016-July 
2016). 568 fewer tests than expected (based on pre-intervention trend) were requested 
in the nine-month post-intervention period. The mean volume of requests per fortnight 
was 181 before the intervention and 172 after the intervention. Table 7.1 presents an 
overview of the patient demographics associated with test orders in the pre and post-
intervention periods. 
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Table 7.1 Overview of serum immunoglobulin test orders pre and post  
intervention and characteristics of the patients’ for which these tests were  
ordered 
 
 
               
7.3.1 The effect of the intervention 
Table 7.2 provides details of the parameter estimates for the effects of the intervention 
on fortnightly GP requests for immunoglobulins. Table 7.3 contains the estimated 
differences in test ordering pre-and post-intervention with corresponding confidence 
intervals and p-values. 
Table 7.2 Parameter estimates, standard errors and p-values from the full and  
most parsimonious segmented regression models predicting the fortnightly  
IGG counts before and after the intervention 
Model1 Coefficient Std. error P-value 
a) Model with level change 
    Intercept β0  5.1444 0.0155 <0.001 
    Baseline trend β1    0.0015 0.0003 <0.001 
    Level change after intervention β2                            -0.1286 0.0241 <0.001 
 
b) Model with trend change* 
    Intercept β0   5.1310 0.0152 <0.001  
    Baseline trend β1   0.0019 0.0003 <0.001 
    Trend change after intervention β3  -0.0152 0.0018 <0.001  
 
 
                                           Pre-intervention    
                                             Total         (%) 
 Post-intervention 
Total      (%)  
Test orders 
Total requests 
Mean count  per fortnight 
 
17,239          
181 
 
(100) 
 
 3,627* 
172 
 
(100) 
Patient age category     
<30 1917 (11.1) 406 (11.2) 
30-45 2630 (15.3) 569 (15.7) 
45-60 4,046 (23.5) 823 (22.7) 
60-70 3,613 (20.9) 752 (20.7) 
>70 5,033 (29.2) 1,086 (29.9) 
Patient gender     
Female 10,316 (60.0) 2,173 (59.9) 
Male 6,894 (40.0) 1,454 (40.1) 
*Based on the pre-intervention trend, the expected volume of tests in the post-
intervention period was 4,195 
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c) Full segmented regression model2 
    Intercept β0  5.1353 0.0155 <0.001 
    Baseline trend β1  0.0017 0.0003 <0.001 
    Level change after intervention β2  0.0654 0.0362   0.07 
    Trend change after intervention β3 -0.0191 0.0029 <0.001 
  1 All models are adjusted for the four outliers occurring in December each year 
   2 Adjusted for change in slope (trend change) 
  * Most parsimonious model: log-likelihood in model: 557.53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.3.1.1 Model A: level change following the intervention 
Model A (baseline trend and level change only) found an immediate drop in test 
ordering counts following the implementation of the guideline and education-based 
intervention (Figure 7.1).  
Table 7.3 Estimated change in immunoglobulin counts before and after the 
introduction of the guideline and education-based intervention 
Model1                                           Estimates (%)           95% CI      p-value 
a) Model with level change 
     Trend +0.15     0.10,     0.20 <0.001 
     Level change after intervention                            -12.07 -7.82,  -16.13 <0.001 
 
b) Model with trend change* 
    Trend before intervention +0.19     0.14,   0.23 <0.001 
    Trend after intervention  -1.32   - 1.01,  -1.65      <0.001 
    Absolute change in trend -1.51   -1.16,  -1.86  <0.001 
 
c) Full segmented regression model2 
    Level change  +6.75 -0.56, 14.60   0.07 
    Trend before intervention +0.17  0.12,   0.23 <0.001 
    Trend after intervention -1.87  1.35,   2.40 <0.001 
    Absolute change in trend -1.70  1.18,   2.23 <0.001 
1 All models are adjusted for the four outliers occurring in December each year 
 2 Adjusted for change in slope (trend change) 
* Most parsimonious model  
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Figure 7.1 ITS model with a level change regression model (Model A).   
Blue line: predicted slope based on the regression model allowing for a December 
effect. Red dashed line: the introduction of intervention. The time-points at 
fortnights 25, 52, 77 and 103 (dips in data) represent the same fortnightly time-
period in December each year. 
 
Before the introduction of the intervention, total test orders per fortnight were 
increasing at a rate of 0.15% (Table 7.3-A). In the first fortnight following the 
intervention, there was a 12.1% (p<0.001) drop in the count of test orders compared 
to the predicted trend (based on the pre-intervention time trend). 
7.3.1.2 Model B: Change in trend following the intervention 
In model B, the change in test ordering trend was modelled on its own (baseline trend 
and trend change only). There was a statistically significant reduction in the slope after 
the introduction of the intervention (Figure 7.2). 
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Figure 7.2 ITS model with a trend change regression model (Model B). 
Blue line: predicted slope based on the regression model allowing for a December 
effect. Red dashed line: the introduction of intervention. The time-points at 
fortnights 25, 52, 77 and 103 (dips in data) represent the same fortnightly time-
period in December each year. 
 
 
Before the introduction of the intervention, test orders were increasing at a rate of 
0.19% per fortnight (p<0.001). After the strategy had been implemented, test orders 
were falling at a rate of 1.3% per fortnight (p<0.001), with an absolute reduction of 
1.5% in the slope pre- and post-intervention (Table 7.3-B). 
7.3.1.3 Model C: The full segmented regression model  
The fully adjusted segmented regression model (Figure 7.3) estimated both the level 
change and trend changes associated with the intervention, controlling for baseline 
level and trend.  
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Figure 7.3 ITS model with a level change and trend change regression model 
(Model C). 
Blue line: predicted slope based on the regression model allowing for a December 
effect. Red dashed line: the introduction of intervention. The time-points at 
fortnights 25, 52, 77 and 103 (dips in data) represent the same fortnightly time-
period in December each year. 
 
This model found that before the implementation of the combined guideline and 
educational messages strategy, test orders were increasing at a rate of 0.17% per 
fortnight (p<0.001). Post-intervention, test orders were falling at a rate of 1.9% per 
fortnight (p<0.001), with an absolute reduction of 1.7% in the slope pre- and post-
intervention (Table 7.3-C). There was no statistically significant drop in the level of 
test orders immediately after the intervention (p=0.07).  
7.3.1.4 The most parsimonious model 
After stepwise elimination of non-significant terms in the fully adjusted model, the 
most parsimonious model was model B which contained the intercept, baseline trend 
and the significant trend change in the volume of test orders (Tables 7.2-B and 7.3-B). 
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7.3.2 Adjusting for seasonality and outliers 
Figure 7.4 illustrates the effect of the guideline combined with educational messages 
strategy after adjusting for seasonality using a Fourier term. The association was 
largely unaffected by seasonality. Five outliers were evident in the data. At fortnight 
68 (August 2015) an IT laboratory system failure was responsible for marked drop in 
requests. This time-point was dropped from the segmented regression model. 
Fortnights 25, 52, 77 and 103 all mark the same two-week period in December each 
year (2012-2016) with consistently low test orders. These time-points were controlled 
for in each of the segmented regression models (Table 7.2). 
 
Figure 7.4 ITS model with a level change and trend change regression model 
(Model C adjusted for seasonality).  
Solid red line: predicted trend based on seasonally adjusted regression model. Solid 
red line: predicted trend based on seasonally adjusted regression model allowing for 
a December effect. Faded blue line: de-seasonalised trend. Red dashed line: The 
introduction of intervention. The time-points at fortnights 25, 52, 77 and 103 (dips in 
data) represent the same fortnightly time-period in December each year.
60
80
10
0
12
0
14
0
16
0
18
0
20
0
22
0
24
0
To
ta
l i
m
m
un
og
lo
bu
lin
 re
qu
es
ts
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 10
0
10
5
11
0
11
5
12
0
Fortnight
Immunoglobulin requests Seasonally adjusted mean
Predicted mean immunoglobulin requests
121 
 
7.4 Discussion 
7.4.1 Summary of findings 
To our knowledge, this is the first study to systematically design an intervention using 
a combination of theoretical approaches to improve test ordering in primary care. A 
nine-month evaluation of the effectiveness of this intervention found a statistically 
significant, sustained 1.5% fortnight-to-fortnight reduction in the volume of test orders 
for serum immunoglobulins.  
7.4.3 Interpretation of the findings 
This study set out to optimise laboratory ordering, using serum immunoglobulin tests 
as a case study. At the outset, there was a possibility of test ordering increasing, 
decreasing or remaining the same. We observed a reduction in test orders post-
intervention. Therefore, a reasonable interpretation of our findings is that before the 
intervention, the level of test overuse was larger than the level of underuse, and our 
intervention, which deals with both problems, has led to a net reduction in test 
ordering. A possible explanation for this is the detailed interpretive comments 
provided on the test results. Prior, to the intervention, GPs expressed the need for 
specialist interpretation of test results, ideally accompanying the test result, as they do 
not always know or may be unable to recall all the possible reasons for particular 
findings [114]. Most abnormal results consist of benign elevations of 
immunoglobulins which do not have cancer (or pre-cancer correlates of the para-
proteins). Thus, these messages may have shaped GP ordering behaviour by constantly 
reminding them of the benign nature of most abnormal serum immunoglobulin results. 
GPs also mentioned ‘fear of litigation’ and ’fear of missing a myeloma’ as other 
drivers of test ordering [114]. Providing clear guidelines and interpretive comments 
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on results may have increased confidence in GPs to request fewer tests. On the other 
hand, it is also probable that in a smaller group of patients, tests are now being ordered 
where they previously would not have been. For example, a small number of GPs 
expressed concern that they were unaware of certain clinical scenarios where 
immunoglobulin evaluation could be useful. The educational requesting algorithm 
should have increased awareness of these clinical scenarios [114]. However, it is 
important to note that regression to the mean is present. Hence, the most extreme 
requesters will always have the largest reduction regardless of whether you intervene 
or not. Exploring the phenomenon of regression to the mean and individual GP impact 
of the intervention is difficult, as this study was designed to look at the impact on 
ordering behaviours in all GPs as a group rather than on individuals.  
This research provides an important insight into the behavioural factors influencing 
laboratory testing among GPs. The incorporation of behavioural theory, specifically 
the COM-B, TDF and BCT taxonomy, has supported the identification of factors such 
as knowledge and the social and environmental context, which are key for 
understanding testing behaviours. Prior to the intervention, a local audit on the clinical 
value of GP serum immunoglobulin test orders suggested probable overuse of the test 
in primary care. We have observed a reduction in test ordering in line with an expected 
improvement in appropriateness following the interventions. It is also reassuring that 
the demographic profile of patients before and after the intervention is very similar 
which suggests the test not being denied to any particular patient group to whom it 
was previously being provided. However, we still cannot say definitively that 
appropriateness has been improved. The most extreme requesters will always have the 
largest reduction regardless of whether you intervene or not. Further research, using 
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individual patient level data, is required – particularly to exclude the possibility that 
the intervention has led to tests being denied to patients who need them.  
7.4.4 Strengths and limitations 
A strength of this study was the systematic use of both qualitative and quantitative 
research methods, with explicit use of theory to create an intervention tailored to target 
barriers to changing clinicians behaviour [32]. A multidisciplinary team including 
biochemistry, haematology and primary care representatives, were involved in the 
development of the intervention. Finally, all immunoglobulin results requested by GPs 
in the two studied counties were analysed. 
Segmented regression models have some limitations. The unit of analysis in the model 
was the fortnightly count of immunoglobulin tests, rather than each GP’s individual 
test ordering counts per fortnight. Contrary to cross-sectional analysis methods, such 
as logistic regression, segmented regression analysis of time series data does not allow 
control for the patient or GP-level covariates. These would only confound the time 
series results, however, if they predicted the outcome and changed in relationship to 
the time of the intervention – this is unlikely to be the case. Finally, although the 
interpretive messages devised in this study were based on best practice guidelines [29], 
we have not measured the potential impact on the diagnosis of blood dyscrasias.  
7.4.5 Conclusions and policy implications 
Our findings suggest that GP test ordering can be improved by an intervention based 
on a guideline with educational messages. The use of a laboratory system to deliver 
interpretive comments on test results is a transferable strategy for all laboratories in 
Ireland, and internationally also as hospital pathology laboratories generally have 
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customisable systems with the capacity to readily alter the end user report. It is also 
likely that the behaviour change strategy used in this research is applicable to other 
specialised tests. 
In total, 568 fewer tests than expected (based on pre-intervention trend) were requested 
in the nine-month post-intervention period. A cost comparison for reagent suppliers 
for the same time-period pre and post-intervention identified a reduction of €1,000 per 
month. We estimate that the reagent supply costs associated with serum 
immunoglobulin activity at CUH will decrease by €12,000 annually. While modest 
the financial benefits to the public health service in Ireland will be much larger if our 
intervention is applied to other settings and is found to work for other tests.  This study 
was designed to target the key issues around GP serum immunoglobulin test ordering 
behaviour. At a policy level, the findings point to the possible benefits of laboratories 
becoming more actively engaged in GP education about test ordering. Any such 
engagement should seek to understand drivers of the GP behaviour first, and 
interventions should be jointly developed with GPs on the basis of sound behaviour 
change theory. 
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8. OVERALL DISCUSSION 
8.1 Introduction 
This thesis has studied the design, implementation and evaluation of an intervention 
to optimise serum immunoglobulin test use in primary care. This chapter summarises 
the main findings of each of the papers included in the thesis. The main strengths and 
limitations are outlined. Some key health services research and policy implications are 
discussed. Areas for future research are proposed and a brief conclusion to the overall 
thesis is provided. 
 
8.2 Summary of main findings 
8.2.1 Effectiveness of previous interventions  
The systematic review synthesised data on the effectiveness of previous interventions 
targeting laboratory testing behaviours among primary care physicians (Chapter 3). 
The review found that different interventions were of variable efficacy at changing 
primary care physician requesting patterns. Some interventions had no measurable 
effect. Even the most effective strategies (multi-faceted interventions and those 
involving educational strategies) show a modest effect. The number of relevant studies 
in this area is small and the validity and generalisability of some of the findings, 
questionable. Therefore, the review concluded that further high-quality research was 
needed in this area. In particular, there was a paucity of theory-based interventions in 
relation to doctors’ test ordering behaviour. As a result, the determinants of success 
and failure remain unclear, and interventions may not be applicable to specific tests. 
This research systematically examined the contextual and organisational factors likely 
to influence the behaviour change and implementation. 
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8.2.2 Barriers and enablers for behaviour change 
Building on the findings of the systematic review (Chapter 3), an intervention was 
designed using a combination of theoretical models (Chapter 4). This included 
identifying and addressing the barriers and enablers for changing immunoglobulin test 
ordering behaviour. Seven of domains from the TDF were identified as key barriers. 
These domains and their corresponding COM-B constructs aligned with seven BCTs, 
and four intervention functions were selected using the BCT framework: education, 
persuasion, enablement and environmental restructure. The incorporation of 
behavioural theory, specifically the COM-B, TDF and BCT taxonomy, has supported 
the identification of factors such as knowledge and the social and environmental 
context, which are key for understanding testing behaviours. Selected BCTs and 
intervention functions provided the groundwork for developing a theory-based 
intervention to improve appropriate immunoglobulin testing in primary care.  
8.2.3 Determinants of higher test ordering 
Using multilevel analysis of routine cross-sectional data for one year, the determinants 
(GP and practice characteristics) of higher test ordering for immunoglobulin tests were 
identified (Chapter 5). Adjusting for GP patient list size and composition, female 
gender and having fewer than ten years of clinical experience were found to be 
associated with higher test ordering patterns. This research suggests that education 
programmes about the nature and uses of serum immunoglobulins, targeted at female 
GPs and those with less experience, may be required. However, further qualitative 
research is required to explore why female GPs and less experienced GPs order greater 
volumes of serum immunoglobulins.  
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8.2.4 Implementation and evaluation of intervention 
The combined guideline and educational messages intervention was designed based 
on the findings of the systematic review (Chapter 3), theoretical design paper (Chapter 
4) along with considerations for the determinants of higher test ordering (Chapter 5). 
The four intervention functions identified in the theoretical study (Chapter 4) were 
used to develop the strategy material. The intervention provides guidelines on when 
to request the test (education/enablement). It also clearly communicates situations 
where testing is beneficial for patient care (education) and how to manage patients 
with abnormal test results (enablement/persuasion). Finally, it provides details on how 
to interpret results (education/enablement) by attaching comments to test reports 
(environmental restructuring). A nine-month evaluation of the effectiveness of this 
intervention found a statistically significant 1.5% fortnight-to-fortnight reduction in 
the test ordering trend for serum immunoglobulins (Chapter 6). 
8.3 Strengths and limitations of thesis 
This section provides a synopsis of the overall strengths and limitations of this thesis. 
The strengths and limitations of the four individual papers have been acknowledged 
and addressed in the previous chapters. 
Given the increased pressures on the Irish health service, improving inefficiencies and 
reducing waste, while maintaining the quality of care is at the forefront of healthcare 
planning. Promoting optimal laboratory service utilisation could play a key role in 
reducing health expenditure, in particular by preventing the unnecessary use of costly 
downstream services that often arise as a result of testing. This study is the first to 
explore test use among GPs in Ireland. This work has been recognised as important by 
conference organisers and peers. The author has had many opportunities to present at 
128 
 
scientific conferences both nationally or internationally (listed at the beginning of this 
thesis) To date, two of the included papers have been published in peer-reviewed 
scientific journals (Appendix 13) a third is currently under review and the fourth has 
been submitted for review. 
A key strength of this thesis is the clinical importance of studying serum 
immunoglobulin test ordering in primary care. In 2013, GPs in the study region 
requested 5,990 tests. Clinical audit of these orders identified 1,052 patients with a 
detectable paraprotein. 2.4% of these (25/1,052) had an abnormal paraprotein level 
which warranted follow-up or referral to specialist haematology services. Nine of 
these patients were existing myeloma patients attending haematology services, that 
were being monitored in primary care. 
A further strength of this thesis lies in the four years of accurate and complete routine 
laboratory data used to explore test ordering patterns and to evaluate the impact of the 
intervention on test orders. The outcome of interest for both quantitative papers was 
an objective measure (volume of test orders). Data was available for 100% of the target 
population and the required demographic and practice level data were merged using 
unique identifiers, ensuring no room for error.  
 
This thesis also has some limitations. As the data used in this thesis is cross-sectional, 
causal inference must be tentative. There are well-established criteria for causal 
inference which are extensively used in the interpretation of findings in 
epidemiological research. Another limitation of this research is the follow-up period 
after the intervention. The nine-month follow-up following the intervention is short, 
and although sufficient to demonstrate a positive result, longer follow-up is desirable. 
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In particular, given the low-volume nature of test ordering for serum immunoglobulins 
and the use of reinforcing educational messages, the effect of the intervention may 
increase with time as GPs become more familiar with the guidance of the interpretative 
comments. 
The results of the thesis may be generalisable to other laboratory test ordering, but 
would have to be applied with caution, recognising the immunoglobulin specific issues 
that this work has identified.  
8.4 Health services research and policy implications 
This thesis has addressed a timely and relevant health services priority in Ireland – 
optimising the use of laboratory services.  To our knowledge, this research is the first 
of its kind in Ireland to evaluate primary care test ordering practices, using serum 
immunoglobulins as an example. In 2008 the Royal College of Physicians of Ireland 
(RCPI) Faculty of Pathology undertook the development and implementation of a 
National Quality Assurance Programme aimed at minimising diagnostic error and 
ensuring timely, accurate and complete pathology diagnosis and reports. The National 
Quality Assurance Intelligence System (NQAIS) is now being used to centrally 
monitor the practices involved in analysing and interpreting patient samples.  The 
programme identifies variations from best practice in laboratories and produces an 
overall national report.  Ireland became the first country in the world to publicly report 
national metrics on the quality of its pathology system. This system for monitoring the 
quality of testing (pathology reporting) at hospital laboratories has been described as 
a breakthrough in managing the care of patients with breast, bowel and other cancers 
and diseases. However, this quality assurance programme does not assess the utility 
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of the laboratory tests ordered. International literature suggests that as much as 70% 
of test orders may not be necessary or benefit patient care [3].  
 
The first step to ensuring that expensive and specialised laboratory blood tests are 
effectively used is to delineate ordering practice. Any attempts to improve patient 
outcomes by optimising laboratory testing will involve close collaboration between 
the laboratory and its GP users.  Funded frameworks to promote research like that 
which we report, would be welcome and most likely cost effective. Evaluating the 
clinical impact of a test which is ordered and leads to an unnecessary referral to 
hospital services (or the effect of a test which was not ordered and leads to a delay in 
diagnosis) is difficult and requires intersectoral health services input and excellent 
clinical IT systems. The latter are currently lacking, while laboratory IT systems are 
relatively advanced and well embedded in accredited quality systems. This makes the 
analysis of laboratory activity as a gateway to improving quality for patients in general 
practice and the hospital an attractive place for research to commence.  
The recent increased emphasis on financing health services research within the 
funding bodies in Ireland is welcome, and this work and that of others may mark an 
increased era of policy focuses on laboratory medicine in Ireland. 
8.5 Future research recommendations 
This thesis has identified some of the key drivers for higher immunoglobulin test 
ordering (Chapter 5) which include female gender and fewer years of clinical 
experience. Future studies are needed to explore why test ordering is higher among 
these specific GP groups. This research also identified a reduction in test order 
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volumes following the implementation of a behaviour change intervention tailored to 
target key barriers to change. Further investigation of the appropriateness of GPs’ 
laboratory ordering patterns is required to investigate the impact of reduced test 
ordering following the implementation of our intervention. A simple measure of a 
number of tests ordered pre- and post-intervention only allows us to speculate on the 
impact of the intervention, and not the appropriateness of test orders. It is important 
that the clinical impact of reduced test ordering is studied to ensure patient care is not 
negatively impacted.  This aspect of research is more difficult because of the less 
advanced clinical IT systems in the HSE. We also propose that other laboratory tests 
may benefit from analysis and intervention, including haematinic testing, 
thrombophilia testing and endocrine requests.  
8.6 Conclusion 
Considerable growth in laboratory workload generated by GP test orders has led to 
concerns about the appropriateness of this ordering, in particular of specialist tests 
such as immunoglobulins. This thesis explored the GP and practice characteristics 
associated with higher test ordering for immunoglobulins, along with the barriers and 
facilitators that need to be considered when designing a strategy to optimise test use 
in primary care. GP factors contributing to higher immunoglobulin test ordering 
include female gender and fewer years of clinical experience. Lack of clear guidelines 
and knowledge on how to interpret the test results posed greatest problems for GPs. 
Following the introduction of a guideline and education based strategy targeting these 
two key issues, test orders for serum immunoglobulins dropped significantly. This 
suggests that tests were being overused prior to the intervention. This was further 
supported by an audit (using one year of data) of the clinical impact of GP serum 
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immunoglobulin test orders on patients prior to the intervention, which indicated 
inefficiencies in test use. Once adequate time has elapsed to allow patient follow-up, 
there is a need to re-assess the clinical impact of test orders requested since the 
intervention was introduced. 
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10.  APPENDICES 
Appendix 1 Details of additional publications, awards, training and teaching activities 
during the PhD 
 
Additional non-thesis related publications published during the PhD 
 
Beirne PV, Hennessy S, Cadogan SL, Shiely F, Fitzgerald T, MacLeod F. Needle 
size for vaccination procedures in children and adolescents. Cochrane Database of 
Systematic Reviews 2015, Issue 6. Art. No.: CD010720. DOI: 
10.1002/14651858.CD010720.pub2 
 
Cadogan SL, Keane E, Kearney PM. The effects of individual, family and 
environmental factors on physical activity levels in children: a cross-sectional study. 
BMC Pediatrics. 2014;14:107. doi:10.1186/1471-2431-14-107. 
 
McNamee T, Hyland T, Harrington J, Cadogan S, Honari B, Perera K, Fitzgerald 
AP, Perry IJ, Cahill MR. Haematinic deficiency and macrocytosis in middle-aged 
and older adults. PloS one. 2013 Nov 7;8(11):e77743. 
 
 
Committee membership 
2013-2016 Member of the College of Medicine and Health Graduate Committee  
 
International experience 
2015 Five weeks were spent working with Professor Jeremy Grimshaw and a team 
of implementation science experts at Ottawa Hospital Research Institute, Ottawa, 
Canada. 
 
Awards 
2014 Finalist in UCC Doctoral Showcase, June 2014 
2015 Co-author of paper awarded HSE Open Access Research Paper of the Year 
(primary care category) 
2015 Awarded a place on the IEA 7th International Course on Epidemiological 
Methods in Pokhara, Nepal, April 2015 (event cancelled due to earthquake) 
2015 Article accepted for publication in UCC Boolean Journal: Snippets of Doctoral 
Research, Nov 2015 
2016 Awarded UCC Student Travel Bursary to present at HTAi Conference, Tokyo, 
Japan. May 2016. 
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Table 10.1 Details of training and workshops attended during PhD 
Extra-credit modules, University College Cork 
Year Course Facilitator 
2012 PG7016 Systematic reviews for the health sciences Prof John Browne 
2013 PG6003 Teaching and Learning Dr Marian McCarthy 
 
Other workshops attended while on the PhD scholars’ programme 
Year Course/ workshop Facilitator 
2013 Turbocharge your writing  Mr Hugh Kearns 
2013 Seven secrets of highly successful PhD students  Mr Hugh Kearns 
2014  NVIVO qualitative software training, Day 1 & 2 Mr Ben Meehan 
2014 Grant preparation and writing workshop Dr Kathleen Bennett 
2014 Cochrane Systematic Review Training Mr Martin Burton 
2014 Publishing in a peer review journal  Dr Sara Scroter, BMJ 
2014 Presentation Skills Irish Times Training Irish Times representative 
2014 Using Network analysis in policy analysis Dr Niamh Humphries 
2014 Multi-level modelling using Stata Dr Gordon Lecke 
2014 Present without PowerPoint Dr Susan Steele 
2015 The media and your research Dr Sara Burke 
 
 
Table 10.2 Teaching and supervision contributions to the Department of 
Epidemiology and Public Health 
Year Course Module Role 
2012-2016 BSc Public Health EH1004 Epidemiology 1 Teaching assistant 
2012-2016 BSc Public Health EH3000 Epidemiology 3 Teaching assistant 
2012-2015 MPH (campus) EH6052 Applied Research 
for Public Health 
Guest lecturer 
2013-2015 BSc Public Health EH3012 Data Management 
for Public Health 
Teaching assistant 
2014-2016 BSc Public Health EH1010 Introduction to 
Public Health 
Student mentor 
2014-2016 MPH (online) EH6076 Applied Research 
for Public Health I (Online) 
Teaching assistant 
Discussion board 
facilitator 
2014 Graduate Entry 
Medicine 
GM1020 Health and 
Disease in Society I 
Guest lecturer  
2015 BSc Public Health EH4007 Research Project Guest lecturer 
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Appendix 2 Copy of ethical approval letter from Cork Research Ethics Committee 
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Appendix 3 Search terms and search records for PubMed, Cochrane, Embase and 
Scopus databases 
 
Table 10.3 Search terms and search records returned for the included databases 
Search terms* Database+  
 Scopus  
(Feb 09th 
2014) 
LIMIT: 
humans 
EMBASE  
(Feb 09th 
2014) 
LIMIT: 
humans & 
English 
language 
Cochrane 
(1981-Feb 
09th 2014 ) 
LIMIT: 
humans 
PubMed 
(1981-Feb 
09th 2014) 
LIMIT: 
humans 
 records 
returned 
records 
returned 
records 
returned 
records 
returned 
1. Laboratory test 355,218 193,805 7,536 92,822 
2. Laboratory tests 355,218 59,254 7,536 77,746 
3. Laboratory testing 109,218 52,719 7,531 37,044 
4. Clinical laboratory 
tests 
140,878 42,669 4,466 36,286 
5. Laboratory 
requests 
3,280 1,052 117 753 
6. Laboratory orders 79,088 1,467 1,135 1,219 
7. Clinical laboratory 
requests 
1,476 785 65 429 
8. Test orders 332,695 1,253 9,244 1,829 
9. Laboratory use 1,105,378 103,694 7,952 566,999 
10. Laboratory test 
utilization 
4,928 1,842 76 1,731 
11. Laboratory test 
requests 
1,561 484 75 297 
12. Lab requests 367 232 5 95 
13. #1#2#3#4#5#6#7#
8#9#10#11#12 
904 310,976 20,635 568,963 
14. Physician* 533,906 429,285 14895 379,721 
15. Family physician 74,269 70,155 1942 55,359 
16. Family physicians 74,269 59,685 1942 36,904 
17. Family doctor 30,996 45,788 565 41,742 
18. Family doctors 30,996 7694 565 45,361 
19. Primary care 
physician 
53,707 46,722 888 14,235 
20. Primary care 
practice 
80,473 72,714 559 46,756 
21. Primary care 
physicians 
53,707 50413 888 24,292 
22. General 
practitioners 
97,606 38,029 2,877 28,285 
23. General 
practitioner 
97,606 90,422 2,877 30,719 
24. General practice 206,566 149,377 3607 114,625 
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25. Primary care 
doctors 
14,931 6,299 28 30,123 
26. Primary health care 178,733 177,459 3,447 137,689 
27. Primary care 
provider 
18,856 8,065 323 5,963 
28. Primary care 
providers 
18,856 14150 323 11,314 
29. #14#15#16#17#18
#19#20#21#22#23
#24#25#26#27#28 
18,768 700,614 29,622 570,365 
30. intervention 733,111 386,906 80,333 282,989 
31. Strategy 1,384,949 188,906 21706 159,097 
32. Inappropriate 69,485 37,868 11339 32,513 
33. Ordering 
performance 
6,465 695 2681 491 
34. Efficiency 1,384,080 103,505 6633 283,575 
35. Volume, tests 174,045 18,932 9794 35,253 
36.   
#30#31#32#33#34
#35 
9,759  18,952 112,391 594,617 
37. Trial 157,8224 1,082,279 305342 915,699 
38. Article 1,889,975 8,184,301 79285 11,905,601 
39. Audit 65,946 38,002 1098 27,870 
40. Systematic review 133,162 116,281 19396 1,588,086 
41. Before and after 
study 
3,097,342 300,765 54656 990,275 
42. #37#38#39#40#41 481,205 8,668,501 365251 11,976,838 
43. #13#29#36#42 ^ 681 2,262 837 2,386 
 
+ Updated searches performed on all databases November 2014    
* Row 13: Search included laboratory test OR laboratory tests OR laboratory testing OR clinical laboratory tests 
OR laboratory requests OR laboratory orders OR clinical laboratory requests OR test orders OR laboratory use 
OR laboratory test utilisation OR laboratory test requests or lab requests (combination of search terms for 
laboratory testing from rows 1-12) 
^ Full search: all search terms for laboratory test (row 13) AND all search terms for primary care physician (row 
29) AND all search terms for intervention characteristics (row 36) AND all search terms for study designs (row 
42) 
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Appendix 4 Example data extraction form for one of the studies included in the review 
 
Table 10.4 Data extraction for one of the included studies in the systematic review 
Paper: Thomas et al, 2006 
Setting: Scotland, United Kingdom 
Number of General Practitioners: 85 primary care practices (370 GPs) 
Number receiving intervention: 
- Feedback only: 22 practices 
- Reminders only: 22 practices 
- Both feedback and reminders: 21 practices 
- Control group: 20 practices 
Study design, duration and follow-up: 
Cluster RCT, 2x2 factorial design. 
Duration: 12 months (commenced in Feb 2002) 
Data: 12-month pre-intervention and 12 month intervention period 
Intervention: 
Reminders group: Brief educational messages were added as 
reminders to the test result reports for nine laboratory tests 
sent to the requesting practice. The messages were activated 
by the laboratory system using cues and were presented at the 
same time as the test result. 
Feedback group: Feedback was quarterly, and consisted of a 
six-sided colour booklet presenting graphs of practice level 
data for each of the nine targeted tests and for each laboratory 
discipline as a whole. Every graph showed rates of test 
requesting over the previous three years (number per 10 000 
patients per 6 months) for the practice compared with the 
regional rates. The booklets were posted to each family 
practitioner within each intervention group practice on four 
occasions (updated every three months from the start of the 
intervention period). 
Feedback and reminders group: The feedback was enhanced 
with the educational messages which were included alongside 
the graphs for each of the targeted tests.  
Control: 
Usual practice. 
Outcome measures:  
- The volume of laboratory tests ordered per practice were obtained for the 12 
months before (pre-intervention) and during the 12 months of the intervention 
period. 
Results: 
                                               Pre-intervention            Post- intervention 
- Control group:                        1,071 (783-1,804)          1,226 (726-2,057) 
- Feedback only:                       1,233 (601-1,954)          1,079 (575-1,818) 
- Reminders only:                     1,329 (688-1,726)          1,317 (719-1,590) 
- Both:                                       1,166 (492-1,749)          1,041 (362-1,515) 
 
NOTE: Data are median (IQR) test requests per 10,000 patients per practice 
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• Practices that received either feedback or reminders were less likely than the 
control group to request the targeted tests in total (enhanced feedback OR: 
0.87, 95%CI 0.81-0.94; p= 0.0004; reminder messages OR: 0.89, 95%CI: 
0.83-0.93; p=0.003). 
 
• Practices that received the combined (feedback and reminders group) were 
also significantly less likely than the control practices to request the target 
tests (OR: 0.78, 95%CI: 0.71-0.85). 
 
• The effect varied across the target tests, although the general pattern was that 
of a reduction in test volumes.  
 
• The enhanced feedback strategy reduced test ordering for all nine tests, which 
reached statistical significance (P<0.05) for four tests. (antibody screen, FSH, 
TSH and vitamin B12). 
 
• The brief educational reminders messages showed a reduction in test requests 
for eight of the nine target tests, of which three reached statistical significance 
(carcino-embryonic antigen, TSH and vitamin B12) 
 
Losses to follow-up: no losses to follow-up  
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Appendix 5 Topic Guide for GP interviews based on the Theoretical Domains 
Framework  
 
Table 10.5 Topic Guide for interviews based on Theoretical Domains Framework 
TDF Domains TDF Definitions 
(Constructs) 
       Prompt questions 
Knowledge An awareness of the existence 
of something. 
(Knowledge including 
knowledge of 
condition/scientific rationale. 
Procedural knowledge. 
Knowledge of task 
environment.) 
• Are you familiar with any 
guidelines for requesting 
immunoglobulins? 
 
• Are you comfortable 
interpreting results of 
immunoglobulin tests? 
 
• Knowledge their own and 
other GP requesting patterns 
(procedure knowledge) 
• Knowledge about problems 
associated with requesting 
(knowledge of task 
environment) 
Skills An ability or proficiency 
acquired through practice. 
(Skills 
Skills development 
Competence 
Ability 
Interpersonal skills 
Practice 
Skill assessment) 
• Do you know how to do it/able 
to use tools? 
 
Social 
professional role 
and identity 
A coherent set of behaviours 
and displayed personal 
qualities of an individual in a 
social or work setting. 
(Professional identity 
Professional role 
Social identity 
Professional boundaries 
Professional confidence 
Group identity 
Leadership 
Organisational commitment) 
 
• When would you request an 
immunoglobulin test? 
 
• Do you think immunoglobulins 
are important/appropriate part 
of your role?  
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Beliefs about 
capabilities 
Acceptance of the truth, 
reality, or validity about an 
ability, talent, or facility that a 
person can put to constructive 
use. 
(Self-confidence 
Perceived competence 
Self-efficacy 
Perceived behavioural control 
Beliefs 
Self-esteem 
Empowerment 
Professional confidence) 
• How confident would do you 
feel about requesting 
immunoglobulin tests? 
 
• Any difficulties in interpreting 
results or deciding when to 
test? 
 
 
 
Beliefs about 
consequences 
Acceptance of the truth, 
reality, or validity about 
outcomes of behaviour in a 
given situation. 
(Beliefs 
Outcome expectancies 
Characteristics of outcome 
expectancies 
Anticipated regret 
Consequences) 
• How do you deal with an 
abnormal result? 
 
Intention A conscious decision to 
perform a behaviour or resolve 
to act in a certain way. 
Mental representations of 
outcomes or end state that an 
individual wants to achieve. 
(Stability of intentions 
Stages of change model 
Trans-theoretical Model and 
stages of change 
Implementation intention) 
• Why do you do these tests? 
 
Goals Goals (distal/proximal) 
Goal priority 
Goal/Target setting 
Goals 
(autonomous/controlled) 
Action planning 
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Memory, 
attention and 
decision 
processes 
The ability to retain 
information, focus selectively 
on aspects of the environment 
and choose between two or 
more alternatives. 
(Memory 
Attention 
Attention control 
Decision making 
Cognitive overload/tiredness) 
• Is it something you do 
routinely? 
Environmental 
context and 
resources 
Any circumstance of a 
person’s situation or 
environment that discourages 
or encourages the 
development of skills and 
abilities, independence, social 
competence, and adaptive 
behaviour. 
(Environmental stressors 
Resources/material resources 
Organisational culture/climate 
Salient events/critical 
incidents 
Person x environment 
interaction 
Barriers and facilitators) 
• Do resources influence 
whether you perform the test 
(e.g. any guidelines you 
follow)? 
 
• Are there clear guidelines 
available? 
 
• Are there clear communication 
channels (laboratories/ 
consultants etc.)? 
 
• Adequate communication 
telephone/written 
correspondence with 
Consultants prior to referral 
 
• Useful interaction with 
consultants where necessary 
 
Social influences Those interpersonal processes 
that can cause individuals to 
change their thoughts, 
feelings, or behaviours. 
(Social pressure 
Social norms 
Group conformity 
Social comparisons 
Group norms 
Social support 
Power 
Intergroup conflict 
Alienation 
Group identity 
Modeling) 
• Do you seek opinions of 
colleagues in decision making / 
interpreting test results?  
 
• Why might there be variation 
in requesting patterns between 
GPs 
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Emotion A complex reaction pattern, 
involving experiential, 
behavioural, and 
psychological elements, by 
which an individual attempts 
to deal with a personally 
significant matter or event. 
(Fear  
Anxiety 
Affect 
Stress 
Depression 
Positive/negative effect 
Burn-out) 
• If appropriate…indirectly 
probe for any significant 
reasons such a fear of missing 
something or fear of litigation 
as motivators for testing. 
Behavioral 
regulation 
Anything aimed at managing 
or changing objectively 
observed or measured actions. 
(Self-monitoring 
Breaking habit 
Action planning) 
• Are there any guidelines you 
follow? 
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Appendix 6 Behaviour Change Technique (BCT) groups and corresponding BCTs 
and definitions 
 
Table 10.6 Behaviour Change Technique (BCT) groups, corresponding BCTs and 
definitions 
BCT grouping [94]  Relevant BCT and definition [102] 
1) Goals and planning N/A 
2) Feedback and 
monitoring  
 
Feedback on behaviour: 
- Monitor and provide informative or evaluative feedback 
on performance of the behaviour 
3) Social support N/A 
4) Shaping knowledge 
 
Instructions on how to perform the behaviour 
- Advise or agree on how to perform the behaviour 
(includes ‘skills training’) 
5) Comparison of 
behaviour 
N/A 
6) Associations 
 
Prompts and cues 
- Introduce and define environmental or social stimulus 
with the purpose of prompting or cueing the behaviour. 
The prompt or cue would normally occur at time/place of 
performance 
7) Repetition and 
substitution  
N/A 
8) Comparison of 
outcomes 
 
Credible source 
- Present verbal or visual communication from a credible 
source in favour of or against the behaviour 
9) Reward and threat N/A 
10) Antecedents 
 
Restructuring the physical environment 
- Change, or advise to change the physical environment in 
order to facilitate performance of the wanted behaviour or 
create barriers to the unwanted behaviour (other than 
prompts/cues, rewards/punishments) 
Adding objects to the environment 
- Add objects to the environment to facilitate performance 
of the behaviour 
11) Identity N/A 
12) Scheduled 
consequences 
N/A 
13) Self-belief N/A 
14) Natural 
consequences 
 
Information about health consequences 
- Provide information (e.g. written, verbal, visual) about 
health consequences of performing the behaviour 
15) Regulation N/A  
16) Covert learning N/A  
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Appendix 7 Mapping of behaviour change techniques (BCTs) to key domains for inclusion in the intervention 
Table 10.7 Mapping of behaviour change techniques (BCTs) to key domains for inclusion in an intervention targeting immunoglobulin testing behaviour of 
General Practitioners 
TDF Domain BCTs identified using Cane et al. [101]* BCTs identified using Michie et al. [44]* Selected and excluded BCTS 
Knowledge 1. Feedback on behaviour  
2. Biofeedback 
3. Antecedents 
4. Health consequences 
  5. Instructions on how to perform  
     behaviour 
Selected BCT: 3, 4, 5 
 
BCT 3/5: Provide information and training 
about immunoglobulin use in primary care, i.e. 
provide guidelines on when to request and 
how to interpret results. 
 
BCT 4: Clearly communicate situations where 
immunoglobulin testing is not beneficial. (i.e. 
develop an algorithm of scenarios where tests 
should be performed). 
 
Non-selected BCTs: 1, 2 
 
BCT 1: Individual GP feedback on requesting 
patterns, not within the scope of this project. 
 
BCT 2: Not relevant for the context of the 
study. 
Memory, attn. & 
decision-making 
none   1. Self-monitoring  
  2. Planning, implementation 
  3. Prompts, triggers, cues 
Selected BCTs: 3 
Mapped to behaviour regulation – see below 
for description) 
 
Non-selected BCTs: 1,2 
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BCT 1: Not feasible for GPs to monitor 
behaviour in this instance. 
BCT 2: Not applicable for interventions in this 
setting.  
Environmental 
context & 
resources 
1. Restructuring the physical environment  
2. Restructuring the social environment 
3. Avoidance/changing exposure to cues   
    for the behaviour 
4. Discriminative (learned) cue 
5. Prompts/cues 
  6. Environmental changes (i.e. adding  
     objects to facilitate behaviour) 
Selected BCTs: 1, 5, 6 
 
BCTs 1, 5 6: Provide automated notes 
detailing consultant advice on the test results 
(ideally provided on the end of the test results) 
and with cues for activation.  
 
Non-selected BCTs: 2,3,4 
 
BCT 2: Not possible in this context to 
restructure the social environment of GPs 
 
BCT 3: Not applicable for the target behaviour 
as the aim is to promote effective testing 
among GPs where provided cues to support 
decision making is useful rather avoiding 
exposure to such support/cues. 
 
BCT 4: Not within scope to offer any financial 
reward based on laboratory testing 
Beliefs about 
capabilities 
1. Focus on past success 
2. Verbal persuasion to boost self-efficacy 
 
 
 
 
 
 
  3. Self-monitoring  
  4. Graded tasks, starting with easy tasks 
  5. Increasing skills: problem solving,  
      decision-making, goal-setting 
  6. Coping skills 
  7. Rehearsal of relevant skills 
  8. Social process of encouragement, 
pressure and support 
Selected BCTs: BCT 8 (mapped to 
professional role and identity – see description 
below) 
 
Non-selected BCTs: 1-7, 9-11 
 
BCTs 1, 2, 6, 7, 9: Not feasible for this project 
due to variation in requesting patterns. For 
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  9. Feedback 
10. Self-talk 
11. Motivational interviewing 
example, GPs would require individually 
tailored verbal persuasion. 
 
BCT 3: Immunoglobulin tests often require 
advice from consultants’/ lab scientists and the 
GP self-monitoring would not be feasible for 
this project. 
 
BCTs 4, 5: Not feasible due to the likely 
lengthy time-period and administration 
required to implement successfully. 
 
BCTs 10, 11:  Not applicable for 
immunoglobulin testing behaviour change. 
Beliefs about 
consequences 
1. Vicarious reinforcement 
2. Covert sensitisation 
3. Covert conditioning 
4. Emotional consequences 
5. Threat 
6. Pros and cons 
7. Comparative imagining of future   
    outcomes 
  8. Self-monitoring  
  9. Persuasive communication (credible   
      source) 
10. Information regarding   
      behaviour/outcome 
11. Feedback 
Selected BCT: 9, 10 
 
BCTs 9, 10: Clearly communicate situations 
where immunoglobulin testing is not 
beneficial (i.e. develop an algorithm of 
scenarios where tests should be performed, 
supported by consultant haematologists and 
GPs. 
 
Non-selected BCTs: 1-8, 11 
 
BCTs 1-7: Not applicable for immunoglobulin 
testing behaviours. 
 
BCT 8: Immunoglobulin tests often require 
advice from consultants’/ lab scientists and the 
GP self-monitoring would not be feasible for 
this project. 
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BCT 11: Not feasible for this project due to 
variation in requesting patterns. For example, 
GPs would require individually tailored verbal 
persuasion. 
Professional role 
and identity  
No BCTs are linked to this domain 1. Social process of encouragement,  
pressure and support 
Selected BCTs: 1 
 
BCT 1: Deliver a strategy developed by 
specialists and laboratory scientists’ in 
conjunction with GPs to provide the 
necessary, feasible support/ guidelines on 
immunoglobulin testing procedures in primary 
care. 
Behavioural 
regulation  
1. Self-monitoring of behaviour 2. Goal/target specified behaviour or     
    outcome 
3. Contract 
4. Planning, implementation 
5. Prompts, triggers, cues 
6. Use of imagery 
Selected BCTs: 2, 5 
 
BCT 2, 5: Provide automated notes detailing 
consultant advice on the test results (ideally 
provided on the end of the test results) and 
with cues for activation.  
 
Non- selected BCTs: 1, 3, 4, 6 
 
BCT 1: Immunoglobulin tests often require 
advice from consultants’/ lab scientists and the 
GP self-monitoring would not be feasible in 
this project. 
 
BCT 3: Contractual strategies not applicable 
for this laboratory testing behaviour change. 
 
BCT 4, 6: Not applicable for this context of 
this project.  
*Selected BCTs are in italics 
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Appendix 8 Public patient list size demographics, 2013 
 
1 Mean number of patients per GP by characteristic, 2013 (Overall mean=210.6 GMS patients) 
2 Mean number of male patients per GP by characteristic, 2013 
3 Mean number of female patients per GP by characteristic 
 
 
 
 
 
 
  Table 10.8 GP mean patient list size (HSE-PCRS), 2013 (crude and standardised for patient gender and age category) 
    All Males  Females 
 Mean1 <30 30-45 45-60 60-70 >70 Total
2 <30 30-45 45-60 60-70 >70 Total3 
Gender (GP)              
  Males 271.14 38.89 71.91 49.77 45.72 126.5
 
71.70 46.16 87.49 48.55 44.77 133.8
 
77.67 
  Females 144.51 18.61 44.49 28.08 25.26 53.55 36.81 30.53 67.17 35.41 30.78 87.42 52.01 
Experience              
   <10years 62.76 20.86 28.16 16.71 16.44 57.83 31.07 28.00 52.33 25.00 31.33 61.35 44.03 
   10-20 years 176.76 17.15 55.03 35.36 31.44 77.98 50.206
 
32.72 71.96 31.53 29.63 80.37 51.20 
   >20 years 273.36 35.88 67.27 46.55 42.75 111.2
 
64.53 41.16 82.83 48.09 43.14 138.1
 
74.43 
Location            
   Urban 213.04 32.86 63.19 42.94 36.73 95.74 57.54 38.39 79.60 41.19 38.24 114.6
 
65.27 
   Rural 205.88 25.79 58.54 40.13 40.17 93.30 59.64 35.67 72.42 43.97 37.83 110.6
 
65.21 
County             
   Cork  
 
204.43 29.29 59.04 40.24 35.44 89.82 55.15 36.21 
 
 
75.28 40.44 35.65 109.9
 
63.42 
  Kerry 231.66 35.14 68.69 48.35 47.90 124.4
 
69.24 42.96 84.95 47.63 46.44 126.3
 
71.89 
Practice type            
   > 4 GPs 241.36 631.7
 
57.14 37.19 34.62 95.45 54.72 36.07 67.09 21.00 36.09 109.9
 
62.26 
   2-4 GPs 224.71 32.31 65.11 44.12 40.59 88.83 58.51 42.94 87.17 39.23 38.04  104.7
 
66.47 
   Single-handed 185.85 28.00 62.00 45.28 39.39 112.3
3 
63.20 29.52 76.21 43.94 41.76 141.4
9 
69.54 
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Appendix 9 Copy of the MGUS guidelines algorithm sent to the GPs 
 
 
Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, D'Sa S, Soutar R, Waage A, Gulbrandsen N et al: UK Myeloma 
Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and 
the management of monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 2009, 147(1):22-42. 
 
 
Raised Gamma globulins or raised 
beta globulin with no paraprotein  
Paraprotein or monoclonal band 
detected  
Look for reactive or 
inflammatory causes 
Eg Connective tissue 
disease, Viral infection 
(inc HIV), chronic 
infection  
IgG, IgA, IgD, IgE IgM 
• Assess patient for symptoms or 
signs of myeloma. 
• Exclude anaemia, 
hypercalcaemia & renal 
impairment  
• Assess patient for symptoms or signs of 
lymphoproliferative disorder 
• Examine for lymphadenopathy, 
hepatosplenomegaly. 
• Evaluate blood count for anaemia, 
thrombocytopenia, altered white cell count  
Low Risk Group 
• IgG paraprotein <10 g/l 
• IgA paraprotein <5 g/l  
• Asymptomatic  
• No other abnormal results 
• Bence Jones Protein positive or negative 
• Uninvolved immunoglobulins normal   
High Risk Group  
• Symptomatic of suspected myeloma or 
lymphoproliferative disorder  
• Abnormal physical signs suggestive of underlying 
plasma cell or lymphoproliferative disorder 
•  Unexplained abnormal investigation results (blood or 
x-ray) 
• IgG paraprotein > 10g/l 
• IgA paraprotein > 5 g/l 
• Any IgD or IgE paraprotein irrespective of 
concentration  
•  Any IgM paraprotein irrespective of concentration  
Follow up by non-haematologist 
• Repeat serum or urine electrophoresis every 
3-4 months and extend interval to 6-12 
months if stable and no symptoms  
• Supply patient with information leaflet  
Refer to Haematologist for 
investigation and management  
Raised Immunoglobulins detected 
Screening normal populations for M-proteins for clinical purposes is not recommended.  
 
• Immunoglobulin electrophoresis of serum and urine should be requested in all patients with a 
persistent elevation of ESR above 30 mm/h, anaemia, renal failure or hypercalcaemia with no 
other obvious explanation.1  
• Send spot urine for detection of Bence Jones Protein  
 
When should testing for monoclonal gammopathy be carried out? 
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Appendix 10 Details of the eight educational interpretive comments attached to test 
reports 
 
Table 10.9 Targeted laboratory tests, educational interpretive comments, and cues 
for adding interpretive messages to results report 
Test  Action Cue  Brief educational message provided with 
result 
ELE Raised alpha-1 and 
alpha-2 globulins  
Pattern may be consistent with low-grade 
inflammation. 
IgG Diffusely raised IgG Pattern of persistent infection or 
inflammation. 
IgG, 
IgA 
Diffusely raised  IgG 
and IgA  
Polyclonally raised IgG and IgA - Pattern of 
persistent infection or inflammation. 
IgA, 
IgG, 
IgM 
IgA deficiency (IgA 
must be <0.1g/l with 
a normal IgG and 
IgM with a normal 
pattern) 
Normal electrophoretic pattern but very low 
total IgA concentration – would be consistent 
with IgA deficiency. This is seen in approx. 
1/500 of the population and often without 
clinical consequence. 
IgM Raised IgM with a 
normal 
electrophoresis 
Patient has a slightly raised IgM.  If Anti-
Mitochondrial antibodies are negative, this 
may be consistent with recent infection, 
particularly viral. If Anti-Mitochondrial 
antibodies are positive this may be consistent 
with primary biliary cirrhosis. 
IgA, 
ELE 
Raised IgA with a 
normal 
electrophoresis 
Normal Electrophoresis pattern with a slightly 
raised IgA – may be consistent with mucosal 
inflammation, autoimmune illnesses or liver 
disease. 
IgM Low IgM in an older 
patient (>70yrs) with 
normal 
electrophoresis 
Slightly low IgM – this may be an incidental 
finding, particularly in older patients, but it 
may also be an indicator of some secondary 
immune suppression. 
Interpretative comment for when a paraprotein is present 
PARA If a faint band is 
present 
Serum shows a small paraprotein with normal 
background gamma. This pattern could be an 
incidental finding in a patient of this age or 
may be seen secondary to recent infection. 
However, urine must be checked for Bence 
Jones protein and suggest recheck serum in 3-4 
months to assess any progression. If you do 
have strong clinical indications e.g. 
hypercalcaemia, renal impairment, anaemia, 
bone pain, etc. suggest investigate further. 
* IgG: Immunoglobulin G, IgA: Immunoglobulin A, IgM: Immunoglobulin M, ELE: serum protein 
electrophoresis and PARA: paraprotein 
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Appendix 11 Quality criteria followed in the design of the intervention 
Table 10.10 Quality Criteria guidelines for Interrupted Time Series study designs1 
Criteria Comment 
1. Intervention occurred independently of other changes over time  
 
DONE The intervention occurred independently of other changes over 
time  
NOT CLEAR Not specified (will be treated as NOT DONE if 
information cannot be obtained from the authors)  
NOT DONE Reported that intervention was not independent of other 
changes in time 
 
DONE 
2. Intervention was unlikely to affect data collection 
 
DONE Reported that intervention itself was unlikely to affect data 
collection (for example, sources and methods of data collection were the 
same before and after the intervention  
NOT CLEAR Not specified (treated as NOT DONE if information 
cannot be obtained from the authors)  
NOT DONE Intervention itself was likely to affect data collection (for 
example, any change in source or method of data collection reported)  
 
DONE – data 
collection 
methods the 
same before 
and after 
intervention 
3. The primary outcome was assessed blindly or was measured 
objectively  
 
DONE Stated explicitly that primary outcome variables were assessed 
blindly or outcome variables are objective e.g., length of hospital stay, 
drug levels assessed by a standardised test 
NOT CLEAR Not specified (treated as NOT DONE if information 
cannot be obtained from the authors)  
NOT DONE Outcomes were not assessed blindly 
 
DONE – 
objective 
outcome 
4. The primary outcome was reliable or was measured objectively  
 
DONE Two or more raters with agreement ≥90% or kappa ≥0.8 or 
outcome assessment is objective, e.g., length of hospital stay, drug 
levels assessed by a standardised test  
NOT CLEAR Reliability not reported for outcome measures obtained 
by chart extraction or collected by an Individual (will be treated as NOT 
DONE if information cannot be obtained from the authors)  
NOT DONE Two or more raters with agreement 
 
DONE- 
objective 
outcome 
5. The composition of the data set at each time point covered at least 
80% of the total number of participants in the study  
 
DONE Data set covers 80–100% of total number of participants or 
episodes of care in the study  
DONE – 
complete data 
set 
anticipated 
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NOT CLEAR Not specified (will be treated as NOT DONE if 
information cannot be obtained from the authors)  
NOT DONE Data set covers less than 80% of the total number of 
participants or episodes of care in the study  
 
6. The shape of the intervention effect was pre-specified  
 
DONE A rational explanation for the shape of intervention effect was 
given by the author(s)  
NOT CLEAR Not specified  
NOT DONE Any of the conditions above are not met 
 
DONE 
7. A rationale for the number and spacing of data points was described  
 
DONE Rationale for the number of points stated (e.g., monthly data for 
12 months post-intervention was used because the anticipated effect was 
expected to decay) or sample size calculation performed  
NOT CLEAR Not specified  
NOT DONE Any of the conditions above are not met 
 
DONE – 
methods 
section 
8. The study was analysed appropriately using time series techniques  
 
DONE ARIMA models were used or time series regression models 
were used to analyse the data and serial correlation was adjusted/tested 
for  
NOT CLEAR Not specified  
NOT DONE Any of the conditions above are not met ITS, interrupted 
time series; ARIMA, autoregressive integrated moving average 
 
1   Source: Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE: Interrupted time series 
designs in health technology assessment: lessons from two systematic reviews of 
behaviour change strategies. Int J Technol Assess Health Care 2003, 19(4):613-623. 
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Appendix 12 Methodological and reporting recommendations for interrupted time 
series studies 
 
Table 10.11 Methodological and reporting recommendations for interrupted time 
series studies 
Item Item 
no 
Recommendation 
Title and abstract 1 Indicate the study design (interrupted time 
series) in the title or abstract 
Introduction 
Background/rationale 2 Provide background regarding the intervention 
and setting under investigation to support the 
study rationale and methods 
 
Objectives 3 (a) State specific objectives and any pre-
specified hypotheses 
(b) Distinguish between primary and 
secondary    
      objectives 
Methods 
Intervention 4 Define the intervention time point(s) used in 
the analysis 
 
Participants 5 (a) List eligibility criteria and methods of 
selection 
(b) Define subgroups 
(c) Consider including a comparison group not 
exposed to the intervention as a secondary 
group of participants 
 
Data sources and 
measurement 
6 (a) List data source(s) 
(b) Comment on data completeness, validity, 
and changes in data coverage over time 
 
 Variables 7 (a) Define all variables 
• Outcome variable(s) 
• Descriptive and stratifying variable(s) 
(b) Comment on change in variable coding 
over time 
(c) Consider including details of variable 
coding in supplemental material, for example, 
appendix or research Web site 
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 Statistical methods 8 (a) Report all statistical methods 
  • Study time intervals, for example, monthly, 
quarterly 
  • Regression model, for example, ARIMA,  
     linear, segmented 
        i) For ARIMA models, indicate the 
intervention function, for example, 
point, ramp, or step 
       ii) Indicate the appropriateness of linear 
model(s) when applied 
  • Number of pre-intervention, Post-
intervention, and between intervention data 
points 
(b) Define the study period and number of pre-
intervention data points used in forecasting 
(c)  Indicate how autocorrelation, non-
stationarity, and seasonality were tested and 
handled 
(d)  Consider a lag period if intervention 
effects are gradual or delayed 
(e)  Define and distinguish between primary 
and secondary or sensitivity analyses 
(f)   Consider use of comparison outcome(s) 
and/or population(s) not exposed to the 
intervention(s) as secondary analyses 
(g)  Report statistical software used for 
analysis 
Results 
Participants 9 (a)  Report the number of individuals and/or 
observations in each group analysed 
(b)  Consider use of a flow diagram 
(c)  Describe characteristics and indicate 
missing data 
 
Outcome data 10 (a)  Report the number of outcomes examined 
over the study period 
(b) Report the average, minimum, and 
maximum number of outcomes across time 
intervals 
(c)  Report on data variability 
(d) Comment on outliers and ceiling or floor 
effects where relevant 
 
 Main results 11 (a) Present results using a graphical display 
with intervention time point(s) clearly defined 
(b) Consider including forecasted results 
graphically 
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  (c) Report absolute and/or relative change(s) 
and their significance, for example, clinical or 
policy and statistical 
 
 Other analyses 12 Report additional results (secondary and 
sensitivity analyses) in the article, appendix, or 
research Web site 
 Discussion 
 Key results 13 Summarise key results with reference to study 
objectives 
 
 Context 14 (a) Provide context related to possible 
confounding 
• Discuss relevant co-interventions that 
occurred during the study period 
•Comment on the stability of participant 
characteristics over time 
•Comment on the stability of outcome coding 
over time 
(b) Discuss results of comparison analyses or 
provide a rationale if no comparison group 
was considered 
 
 Limitations 15 (a) Discuss limitations of the study 
(b) Comment on data variability and 
appropriateness of the number of data points 
(c) Comment on ceiling or floor effects and 
outliers where relevant 
(d) Discuss direction and magnitude of any 
potential bias 
 
 Interpretation 16 Provide overall interpretation of results 
considering objectives, limitations, results 
from similar studies, and other relevant 
evidence 
 Other information 
 Funding 17 List funding source(s) and role of funders 
 
 References 18 Reference methodological articles that support 
statistical methods used 
Source: Adapted from the Strengthening the Reporting of Observational Studies in Epidemiology 
statement [134] 
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Appendix 13 PDF versions of the two papers published in Implementation Science 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
